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ABSTRACT 
Gap junctions are intercellular ion channels comprised of molecules known as 
connexins (Cxs), and are important for the coordination and conduction of endothelial 
vasomotor responses and the maintenance of vascular tone. Gap junctions are found in the 
vascular wall connecting adjacent endothelial cells, and adjacent smooth muscle cells 
(Christ et al. 1996), while myoendothelial gap junctions are found connecting the two cell 
layers (Sandow et al. 2000). Four Cxs, Cx37, 40, 43 and Cx45, have been identified in the 
vascular wall (Severs, 1999; Kruger et al. 2000). Changes in endothelial function and 
signal conduction via gap junctions may be involved in the pathology of disease states such 
as hypertension. In the aorta of hypertensive rats, changes have been reported in the 
expression of Cx43, suggesting some coincidence between pressure and Cx expression in 
blood vessels (Haefliger et al. 1999). 
Real-time polymerase chain reaction (PCR) and immunohistochemistry, using Cx 
specific antibodies, was used to quantify the expression of mRNA and protein for Cxs 3 7, 
40, 43 and 45, separately in the smooth muscle and endothelium of two functionally 
different arteries, the thoracic aorta and caudal artery of young normotensive Wistar rats. 
Furthermore, changes in Cx expression were examined in these vessels during the 
development of hypertension and were correlated with changes in morphology of the 
smooth muscle and endothelium. Endothelial cell morphology and Cx expression was also 
assessed in other blood vessels known to be involved in the control of peripheral resistance. 
Finally, the effect any such changes may have on vascular function was examined in the 
caudal and mesenteric arteries during hypertension. 
In young Wistar rats, results show that Cx37 was the major Cx present in gap 
junctions in the media of the caudal artery, while Cx43 was important in gap junctional 
coupling within the media of the thoracic aorta. Cxs 37, 40 and 43 were present in the 
endothelium of both arteries, while Cx45 was absent. These results highlight the 
heterogeneity of Cx expression amongst functionally different vascular beds. 
The effect of blood pressure on vascular morphology and Cx expression, was 
examined in the thoracic aorta, caudal, mesenteric and basilar arteries of the spontaneously 
hypertensive rat (SHR) in comparison to the Wistar-Kyoto (WKY). The development of 
hypertension in the SHR was shown to begin at approximately 4 weeks of age with animals 
becoming hypertensive compared to age matched control WKY at 9 weeks of age. 
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Endothelial cell size was decreased in the caudal and mesenteric arteries of the SHR and 
this was accompanied by a decrease in the expression of Cx40 in the endothelium of the 
caudal artery and Cx37 in the mesenteric artery. Endothelial cell size was not altered in the 
thoracic aorta or basilar artery of the SHR; however expression of Cx37 in the endothelium 
was reduced in both arteries. Remodeling of the vascular media was also observed in both 
the caudal and mesenteric arteries, both vessels undergoing medial hypertrophy. In the 
caudal artery, such remodeling occurred in association with a reduction in the expression of 
Cx45. Medial remodeling was not observed in either the aorta or the basilar artery, 
however, in the aortic media expression of Cxs 43 and 45 was significantly reduced. 
In the caudal artery of the WKY, endothelial cell size and the expression of Cxs 37, 
40 and 43 was maximal at 3 weeks, while in the SHR cell size and the expression of Cx40 
decreased during the development of hypertension. In the thoracic aorta, endothelial cells 
increased in size during development in both the WKY and SHR. Similarly, the expression 
of Cxs 37, 40 and 43 also was also increased in both strains. In the media of the caudal 
artery, the increase in expression of Cx45 during development was greater in the WKY 
than in the SHR, while in the aortic media, expression of Cxs 43 and 45 increased in the 
WKY during development but not in the SHR. 
Vascular function during hypertension was examined in the caudal and mesenteric 
arteries of the SHR using tension myography and electrophysiology. In the caudal artery, 
results demonstrated that endothelium-derived hyperpolarizing factor (EDHF)~mediated 
hyperpolarization of the vascular media was reduced in the SHR, however there was no 
change in vessel relaxation. During examination of nerve-mediated excitatory junction 
potentials in the caudal artery, reduced radial coupling of the media in the SHR was 
demonstrated. In the mesenteric artery, conducted EDHF-mediated hyperpolarization and 
relaxation was reduced in the SHR; however, evidence suggests that this may be due to the 
involvement of K1R channels during hypertension. 
Changes in Cx expression and remodeling of the vascular smooth muscle and 
endothelium occur in some blood vessels during hypertension, however there is extensive 
heterogeneity amongst different vascular beds. In the caudal artery, vascular remodeling 
and altered Cx expression may have a causative role in the development of hypertension. 
The changes described here have demonstrated that vascular remodeling in combination 
with reduced cellular coupling could contribute significantly to endothelial dysfunction and 
altered vascular function during hypertension. 
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Cx( s) connexin( s) 
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CHAPTER 1 
INTRODUCTION 
1.1 STRUCTURE AND FUNCTION OF GAP JUNCTION CHANNELS 
Gap junction channels are expressed in almost all mammalian tissues where they 
facilitate chemical and electrical communication between adjacent cells. As such, gap 
junctions are essential for a number of functions, including the maintenance of homeostasis, 
embryonic development, cellular differentiation, proliferation and migration (Loewenstein, 
1979; Kumar & Gilula, 1996; Delorme et al. 1997). Gap junction communication has also · 
been demonstrated in inflammatory processes and wound healing (Larson & Haudenschild, 
1988; Beyer & Steinberg, 1991 ). In electrically excitable tissues such as the myocardium 
and vascular tissue, gap junctions are essential for cellular communication via the 
propagation of action potentials. In a similar manner, metabolites and second messengers 
including cyclic adenosine monophosphate ( cAMP), inositol triphosphate and calcium 
(Ca2+) are able to pass though gap junction channels from one cell to another (Gilula et al. 
1972; Tsien & Weingart, 1976; Saez et al. 1989; Veenstra et al. 1995; Carter et al. 1996). 
1.1.1 Gap junction structure 
Gap junctions are intercellular channels formed in the plasma membrane, linking 
the cytoplasm of adjacent cells, allowing the direct transfer of electrical current and small 
molecules of less than one kilodalton (1 kD) in molecular weight, between coupled cells 
(Kumar & Gilula, 1996). Gap junction channels are comprised of a family of membrane 
proteins known as connexins (Cxs ). Six individual Cx proteins oligomerize in the plasma 
membrane of one cell to form a connexon or h~michannel. A complete gap junction 
channel results from the docking of two connexons, one from each of two apposing cells 
(Musil & Goodenough, 1993; Falk et al. 1997). Each connexon may be comprised of a 
single Cx isotype or multiple isotypes, forming homomeric or heteromeric connexons, 
respectively. Consequently, gap junction channels may be either homotypic or heterotypic 
in nature depending on the type of connexon contributed from each cell (Goodenough et al. 
1996; Brink et al. 1997; White & Paul, 1999) (Figure 1. 1 ). 
1 . 
Figure 1.1 
Figure 1.1. 
· Structure of gap junction channels. Six connexin proteins oligomerize forming a 
hemichannel or connexon in the plasma membrane of one cell. A complete gap 
junctional channel linking two adjacent cells results from the docking of two 
connexons, one from each of the two apposing cells. Connexons may be homomeric 
(A, B)_or heteromeric (C, D) in nature depending of whether a single Qr multiple types 
of connexins are present in each connexon. Homotypic (A, D) or heterotypic (B, C) gap 
junction channels may also form depending on the Cx type in the two connexons. 
A. Homomeric 
Homotypic 
Connexon 
B. Homomeric 
Heterotypic 
C. Heteromeric 
Heterotypic 
Connexin 
D. Heteromeric 
Homotypic 
Plasma membrane 
cell 1 
lntercellular 
gap 
Plasma membrane 
cell 2 
While the formation of homotypic or heterotypic gap junction channels has been 
demonstrated in vitro, less is known regarding their expression in vivo. The ability of a cell · 
population to express each type of gap junction channel depends on the number of Cx 
proteins expressed within that population. Thus, heteromeric and heterotypic gap junctions 
may be formed when two or more Cx isotypes are expressed within the cell population. 
Brink et al. (1997) demonstrated that a cell population expressing more than one Cx 
isotype has the potential to form up to 196 structurally and physiologically distinct channel 
types, although it has been shown that not all Cx isotypes are able to form connexons, 
therefore limiting this theoretical number to less than 196 in practice (Brink et al. 1997). _ 
In cultured A 7r5 cells, experiments have demonstrated the co-localization of Cxs 40 and 43 
(He et al. 1999), while in HeLa cells the co-localization of both Cxs 40 and 43 have been 
demonstrated in some . hemichannels (Valiunas et al. 2001 ). Furthermore, 
electrophysiology and dye permeation experiments have demonstrated the presence of 
functional heterotypic and heteromeric gap junction channels between Cxs 40 and 43, and 
Cxs 40 and 45 in cells in vitro (Steinberg et al. 1994; Elfg3:ng et al. 1995; Moreno et al. 
1995; He et al. 1999; Valiunas et al. 2000, 2001; Cottrell & Burt, 2001; Burt et al. 2001; 
Cottrell et al. 2002; Martinez et al. 2002). 
Co-localization of several Cx proteins has also been demonstrated in a number of 
tissues, indicating that these cells have the potential to form heterotypic and heteromeric 
gap junction channels (Nicholson et al. 1987; Gros & Jongsma, 1996; Severs, 1999; Beyer 
et al. 2000; Falk, 2000a,b ). For example, in endothelial cells of the rat aorta and 
pulmonary artery, immunohistochemical and ultrastructural studies have shown that Cxs 
3 7, 40 and 43 are commonly co-localized in the same gap junctional plaque (Yeh et al. 
1997a, 1998; Ko et al. 1999). A gap junction plaque may be formed by the aggregation of 
several to many thousands of gap junction channels (McNutt & Weinstein, 1970; Lagaud et 
al. 2002a). In a similar manner, Cxs 40 and 43 have been found to co-localize within the 
atrioventricular node and Purkinje fibres (Gourdie et al. 1993), while Cx43 has been found 
to co-localize with Cx45 in a restricted zone of the sinoatrial node of the rat heart (Coppen 
et al. 1999). In cultured cells, experiments have demonstrated that dye transfer is absent in 
the absence of Cx plaques and in the presence of very small plaques (Bukauskas et al. 
2000). Dye transfer was present in cells displaying larger gap junction plaques estimated to 
contain at least 400 channels. In these plaques~ it was found that only a small percentage of 
channels present within the plaque were open at the one time. These results suggest that 
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clustering of gap junction channels into plaques may be required for effective cellular 
coupling as smaller plaques contained fewer open gap junction channels at any one time. 
1.1.2 Connexin proteins 
To date, 20 Cx proteins have been identified in mammalian tissue (Willecke et al. 
2002; Gustincich et al. 2003). Each protein, commonly named after its molecular weight 
in kDa, is encoded by a single gene consisting of one exon and one or two intrans within 
the 5' untranslated region (White & Paul, 1999). All Cxs have the same basic molecular 
structure, each consisting of four a-helical membrane-spanning domains, two extracellular 
loops, one intracellular loop and three cytoplasmic regions (Yeager & Gilula, 1992; Falk et 
al. 1994). The distinct functional properties of each Cx protein arise from amino acid 
sequences specific for each Cx, located in the intracellular loop and carboxy terminus. The 
two extracellular loops contain highly conserved cysteine residues, which are involved in 
the docking of the two hemichannels the formation of heterotypic gap junction channels 
(Yeager & Nicholson, 1996; Sosinsky, 1996). The four a-helical membrane-spanning 
domains are highly conserved in their amino acid sequence. The second transmembrane 
domain contains a praline residue, shown to be important for voltage gating of the channel, 
while the third transmembrane domain is amphipathic in nature and is thought to line the 
central pore of the gap junction channel (Yeager & Nicholson, 1996; Kumar & Gilula, 
1996; Tearle, 2002). 
1.1.3 Functional properties of gap junction channels 
Gap junction channels demonstrate unique electrical and biochemical properties 
depending on the constituent Cx isotypes present. Functional properties of gap junction 
channels such as unitary conductance, voltage gating and permeability have been studied 
using single Cx expression systems in cell culture (van Veen et al. 2001). For example, 
homotypic channels containing . Cx37 have high unitary conductance values of 
approximately 300-400 picoSiemens (pS) (Veenstra et al. 1994b ). Homotypic channels 
containing Cxs 40 or 43, have unitary conductance values of approximately 150-200 pS and 
90-115 pS respectively (Veenstra et cil. 1992; Moreno et al. 1994; Traub et al. 1994; 
Beblo et al. 1995), while Cx45 channels demonstrate low unitary conductance values of 
25-30 pS (Veenstra et al. 1994a; Moreno et al. 1995). The permeability of gap junction 
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channels to dyes and small molecules also vanes depending on the constituent Cxs. 
Homotypic channels formed in HeLa cells expressing Cx43 are non-ion selective and are 
readily permeable to dyes such as Lucifer yellow (Martinez et al. 2002). On the other 
hand, homotypic channels comprised of Cx45 show greater selectivity for cations than 
anions and are permeable to Lucifer yellow (van Veen et al. 2001), whilst Cx40 channels 
are cation selective and permeable to Lucifer yellow, 2'7' -dichlorofluorescein and 6-
carboxyfluorescein (van Veen et al. 2001). 
The formation of heterotypic and heteromeric channels, expressing more than one 
Cx, has been shown to confer channel properties that are distinct from homotypic channels 
formed from each of the individual Cxs (Brink, 1998; Beyer et al. 2000; Cottrel & Burt, 
2001; Valiunas et al. 2000; Burt et al. 2001; Valiunas et al. 2002; Steinberg et al. 1994; 
Martinez et al. 2002). These studies suggest that the heteromeric nature of gap junction 
channels depends on the properties of the individual Cxs within the channel and the ratio in 
which each Cx is expressed. Recently, it has been demonstrated that altering the ratio of 
Cxs 40 and 43 expressed in cultured cells affects the chemical, but not the electrical 
permeability of the channel. Heterotypic channels were shown to adopt the biochemical 
characteristics of the more permeably restrictive chapnel (Burt et al. 2001; Cottrel et al. 
2002). The above studies thus suggest that the functional properties of a cell population 
may be altered by changes in Cx expression (Beyer et al. 2000; Brink et al. 2000). Thus, 
this demonstrates the importance of determining the specific Cx composition of the gap 
junctional channels formed in any particular artery or arteriole, since this is likely to have a 
significant influence on vascular function. 
1.2 GAP JUNCTION REGULATION 
The electrical and biochemical properties of gap junction channels can be 
modulated in both the short or long term. Short-term regulation of gap junctions may 
involve rapid and reversible changes in channel conductance by altering channel open 
probability or channel turnover. Long-term regulation involves alterations in gene 
expression at the mRNA and protein levels. Gap junctional conductance may be modulated 
by a number of different mechanisms such as the phosphorylation of Cx proteins, changes 
in intracellular Ca2+ concentration and pH. Furthermore, Cx expression may also be 
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regulated by changes in Cx synthesis and turnover rates (Severs et al. 1996; van Veen et 
al. 2001). 
1.2.1 Gap junction phosphorylation 
Almost all Cx proteins can be characterized as phosphoproteins (Goodenough et al. 
1996). It is likely that the phosphorylation occurs as a form of posttranslational 
modification that regulates gap junctional protein trafficking, assembly into gap junctional 
plaques, channel conductance and turnover (Musil & Goodenough, 1991; Saez, 1998). 
Phosphorylation has been demonstrated to both increase and decrease gap junctional 
communication depending on the cell type examined (Munster & Weingart, 1993; Kwak & 
Jongsma, 1996; Lampe & Lau, 2000). Cx phosphorylation is induced by the activation of 
various protein kinases such as protein kinase C (PKC) (Saez et al. 1997), PKA (Traub et 
al. 1994; van Rijen et al. 2000), PKG (Takens-Kwak & Jongsma, 1992), mitogen-
activated protein (MAP) kinase (Warn-Cramer et al. 1996), as well as many unknown 
protein kinases (Lampe & Lau, 2000). Phosphorylation of Cx proteins occurs 
predominantly on serine residues, with tyrosine phosphorylation also occurring, although to 
a lesser extent (Crow et al. 1990; Laing et al. 1994; Kanemitsu et al. 1997; van Veen et 
al. 2000). For Cx43, the majority of these residues are putative sites for PKC 
phosphorylation, however there are also several sites known to be phosphorylated by PKA, 
PKG and MAP kinase (Kanemitsu & Lau, 1993; Lau et al. 1996; Warn-Cramer et al. 
1996; Lampe & Lau, 2000). The number and location of specific phosphorylation sites for 
each Cx protein vary according to the species of sequence origin, although most serine 
phosphorylation sites are found within a highly conserved region of the carboxy terminus 
(Laing et al. 1994; Lampe et al. 2000; van Veen et al. 2001 ). 
Just as phosphorylation of Cx proteins by protein kinases has profound effects on 
gap junctional communication, dephosphorylation of Cxs by protein phosphatases also has 
important modulatory effects on gap junction function, having been shown to have a role in 
trafficking and degradation of Cx proteins (Lampe & Lau, 2000). Inhibition of protein 
phosphatases has been shown to increase Cx43 phosphorylation and alter channel 
conductance in vitro (Moreno et al. 1994). 
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1.2.2 Intracellular calcium and pH 
The diffusion of Ca2+ through gap junctions at concentrations outside normal 
physiological ranges has been shown to cause channel closure (Burt, 1987; Brink et al. 
2000). Studies in lens epithelial cells demonstrate reduced gap junctional coupling 
following sustained increases in intracellular Ca2+ (Churchill et al. 2001 ), while other 
studies describe reduced Cx43 phosphorylation and gap junctional coupling following an 
increase in Ca2+levels within physiological ranges (Crow et al. · 1994). 
Intracellular pH has also been shown to affect intercellular communication through 
gap junction channels (Morley et al. 1997). In vitro, lowering pH, significantly reduces 
channel conductance, while at very low pH, conductance is completely inhibited, likely a 
result of reduced channel open probability (Hermans et al. 1995; Morley et al. 1997). The 
sensitivity of gap junction channels to changes in pH depends on the particular Cx isotype 
(Werner et al. 1991; Stergiopoulos et al. 1999; Gu et al. 2000; Thomas et al. 2002). The 
cytoplasmic loop of the Cx protein, an area rich in pro line residues, may be involved in the 
sensitivity of Cx43 to changes in pH (Ek-Vitorin et al. 1996; Calero et al. 1998). In a 
similar manner, histidine residues within this same region have been shown to be essential 
for both normal channel formation and pH gating (Spray & Burt, 1990; Ek et al. 1994; 
Hermans et al. 1995). Several studies have suggested that pH gating of Cxs involves 
interaction between the cytoplasmic loop of the protein and specific sequences in the pore 
region acting as a receptor site (Ek et al. 1994; Morley et al. 1996, 1997). 
1.2.3 Synthesis, trafficking and degradation of gap junctions 
Synthesis, aggregation and degradation of gap junction channels are all targets for 
the regulation of intercellular communication. Although, the formation of gap junction 
channels has been extensively studied, the process of Cx biosynthesis and assembly into 
gap junctions is complex and many unanswered questions remain. 
Many studies have shown that the biosynthesis of Cx proteins is similar to that of 
other membrane proteins, in that synthesis · occurs in the endoplasmic reticulum (ER) 
following translocation into the ER membrane (see . Yeager et al. 1998; Falk, 2000a,b). 
Whether post-translational modification of Cx proteins and the formation of connexon 
hemichannels occurs in the ER or later in the Golgi apparatus is a point of some debate, as 
there is evidence in support of both pathways (Musil & Goodenough, 1993; Kumar et al. 
1995; Ahmad et al. 1999). Transportation of Cxs from the ER to the plasma membrane via 
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the Golgi apparatus occurs predominantly via the secretory pathway (Musil & 
Goodenough, 1993; George et al. 1999; Martin et al. 2001 ), although it has been 
suggested that some Cxs use an alternative transportation mechanism dependent on 
microtubules and G proteins (George et al. 1999; Lampe et al. 2001; Martin et al. 2001). 
Thus, there is evidence that the exact location of hemichannel assembly and the 
mechanisms involved in their transportation to the plasma membrane may differ depending 
on the Cx isotype (Yeager et al. 1998; Geroge et al. 1999; Sarma et al. 2002). 
As mentioned above, following insertion of Cxs into the plasma membrane, the 
formation of a complete gap junction channel requires the docking of two hemichannels 
within the plasma membrane of two apposing cells (Musli & Goodenough, 1993). 
Experiments using Cxs tagged with fluorescent proteins hav_e demonstrated that 
hemichannels may be inserted either directly into a gap junction plaque or randomly into 
the plasma membrane, whereby they are able to move laterally along the plasma membrane 
and become integrated into the edge of an existing plaque (Yeager et al. 1998; Gaietta et 
al. 2002; Lauf et al. 2002). The formation of gap junctions and the clustering of channels 
into gap junction plaques may be facilitated by cell adhesion molecules including E-
cadherin, liver cell adhesion molecule, and N-cadherin (Musil et al. 1990; Jongen et al. 
1991; Meyer et al. 1992; Yeager et al. 1998). More recently a role for cytoskeletal 
proteins such as zonula occludens-1 (ZO-1) and a-spectrin have also been identified 
(Toyofuku et al. 1998). The exact mechanisms involved may depend on the Cx isotype, 
although this is currently unknown. 
Unlike other membrane proteins, Cxs have a short half-life of between 1-5 hours 
(Darrow et al. 1995; Laird et al. 1991; Hertlein et al. 1998). Such rapid turnover presents 
a dynamic way of controlling cellular communication by up- or down-regulation of Cx 
synthesis, assembly, trafficking and degradation. The degradation of Cx proteins, like other 
plasma membrane proteins occurs either at the ER via proteasomal dependent mechanisms 
in response to protein mis-folding and improper oligomerization, or at the plasma 
membrane, resulting in the degradation of complete gap junction channels (Gropper et al. 
1991; Musil et al. 2000; Jordan et al. 2001 ). Degradation of gap junction channels in the 
plasma membrane is not well understood. However, it is thought to involve both lysosomal 
and proteasomal pathways (Laing et al. 1997; Laing & Beyer, 1995; McGee et al. 1996; 
Musil et al. 2000). Double membrane vesicular bodies composed of gap junction 
channels, termed annular gap junctions (Naus et al. 1993) have been suggested to be initial 
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degradation products formed following the internalisation of gap junction channels or large 
fragments of gap junction plaques (Severs et al. 1989; Jordan et al. 2001; Gaietta et al. 
2002). Gap junction channels contained within annular gap junctions are subsequently 
targeted for either protesomal or lysosomal degradation (Laing et al. 1997; Beardslee et al. 
1998; Laing , et al. 1998; Musil et al. 2000). Therefore, the formation of annular gap 
junctions may provide a mechanism by which large numbers of gap junction channels can 
be simultaneously degraded (Jordan et al. 2001 ). 
Recently, there has been some suggestion that the processes involved in the 
synthesis, trafficking and degradation of gap junction channels present potential targets for 
therapeutic regulation of cellular coupling. However, drugs currently used to inhibit these 
mechanisms in experimental conditions are not specific for Cx proteins, having widespread 
effects on many cellular proteins (Brink, 2002; Beyer & Berthoud, 2002; Lagaud et al. 
2002a). More recently, it has been suggested that modulation of gap junction gating, can be 
achieved using peptides synthesised to mimic sequences of the extracellular loops of Cx 
proteins (Berman et al. 2002). The application of such peptides has been shown to inhibit 
gap junctional communication in vivo and in vitro, while also being selective to specific Cx 
isotypes (Chaytor et al. 1997; Kwak & Jongsma, 1999; Berman et al. 2002). 
1.3 GAP JUNCTION EXPRESSION IN VASCULAR TISSUE 
Communication via gap junctions between cells in the vascular wall has been 
implicated in a range of functions, including coordination and conduction of endothelial 
cell responses modulating vasomotor tone (Christ et al. 1996). Studies involving 
immunofluorescence, electron microscopy and electrophysiology have identified · gap 
junctions connecting adjacent endothelial cells (Ko et al. 1999), adjacent smooth muscle 
cells (Beny & Connet, 1992) and adjacent endothelial and smooth muscle cells via 
myoendothelial gap junctions (MEGJs, Sandow & Hill, 2000). At the ultrastructural level , 
gap junctions are identified by their electron dense pentalaminar structure, with a total 
thickness of approximately 9-10 nm, whereby the proximity of the outer membrane of the 
two apposing cells is seen as a single dark line. In some cases, at this point a gap of 
approximately 3 nm in width is visible (Unwin & Zampighi, 1980), which delineates the 
two adjacent connexon oligomers. 
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Within cardiovascular tissue, four Cxs have been reported, Cxs 37, 40, 43 and 45 
(Severs, 1999; Hill et al. 2001 ). All four Cxs have been identified in vascular smooth 
muscle, while Cxs 37, 40 and 43 have been detected in the endothelium of most vessels 
(see Hill et al. 2001). More recently, two new Cxs have been identified in mouse and 
human vascular smooth muscle, Cxs 31.9 and 30.2 (White et al. 2002; Nielsen et al. 2002; 
Nielsen & Kumar, 2003). Overall, the current data suggests that there is significant 
heterogeneity in Cx expression \Vithin and between species and vascular bed, indicating 
that vessels of differing function may express different Cx isotypes (Hill et al. 2001 ). 
Localized differences in Cx expression have been described in the media and endothelium 
of the rat aorta and human internal mammary artery (Ko et al. 1999a,b; Ko et al. 2001 ), in 
the endothelium of afferent renal arterioles (Gabriels & Paul, 1998; Guo et al. 1998), and 
in areas of increased shear stress, such as at aortic branch points (Gabriels & Paul, 1998). 
Furthermore, the expression of Cx proteins in the aortic endothelium has also been shown 
to vary with age (Yeh et al. 2000). 
Given that the different Cx isotypes may form channels with unique electrical and 
biochemical properties, the heterogeneity in Cx expression amongst different vessels may 
contribute to the heterogeneity in vascular responses (Severs, 1999; Hill et al. 2001 ). 
1.3.1 Smooth muscle 
Whilst the specific Cx composition in different arteries varies, Cx43 is the 
predominant Cx expressed in the vascular smooth muscle of large elastic arteries such as 
the thoracic aorta (Hong & Hill, 1998; Yeh et al. 1998; Nakamura et al. l 999; Hong & 
Hill, 1998; van Kempen & Jongsma 1999). Comparative studies of Cx43 expression in 
such large conduit arteries show that expression decreases with distance from the heart (Ko 
et al. 2001 ). Cx45 has also been detected in the media of the thoracic aorta (Ko et al. 
2001; Li & Simard, 2002), although its expression is significantly less than that of Cx43. 
Interestingly, expression of Cxs 43 _and 45 in the aorta seems to be dependent on smooth 
muscle cell phenotype. Smooth muscle cells of the synthetic phenotype express high levels 
of Cx43, while differentiated cells of the contractile phenotype express low levels of Cx43. 
Furthermore, Cx45 expression appears to be approximately inverse to that of Cx43 in most 
regions of the aorta (Ko et al. 2001 ). Fully differentiated smooth muscle cells of an adult 
non-diseased artery are · predominately of the contractile phenotype. Together these studies 
suggest that Cx43 1nay be important for the synthesis and maintenance of the extracellular 
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matrix, while Cx45 may be more important in mature contractile smooth muscle cells 
(Rennick et al. 1993; Blackburn et al. 1997; Ko et al. 2001). Other Cxs found in the 
media of elastic arteries include Cx40, which has been described in the aorta of several 
animal species including cow and pig, although it is absent in the rat thoracic aorta (van 
Kempen & Jongsma, 1999). Studies have also described the presence of medial Cx37 in 
the aorta and pulmonary artery of the rat (Nakamura et al. 1999), although such 
observations have not been universally supported (van Kempen & Jongsma, 1999). Such 
discrepancies are likely to be due to the specificity of Cx antibodies used in each particular 
study (Severs et al. 2001 ). Recent studies have demonstrated the expression of protein for 
the newly identified Cx3 l .9 in smooth muscle cells of the human aorta (Nielsen et al. 
2002). 
Studies investigating the major Cx isoform within the media of muscular arteries 
provide evidence for a similar heterogeneity amongst different vascular beds and animal 
species. A number of studies have reported that Cx43 is absent in the media of muscular 
arteries, including the caudal, basilar, mesenteric and coronary arteries (Bastide et al. 
1993; Bruzzone et al. 1993; Gros et al. 1994; Yeh et al. 1997b; Hong & Hill, 1998; Li & 
Simard, 1999). However, other studies have reported the presence of Cx43 in the media of 
pial and cremaster arterioles and the basilar artery of the rat and cheek pouch arterioles of 
the hamster (Li & Simard, 1999; Little et al. 1995a). Cx40 has been demonstrated in the 
media of the coronary artery in a number of species (van Kempen & Jongsma, 1999), as 
well as in the basilar artery (Li & Simard, 1999), in preglomerular and cremaster arterioles 
of the rat (Little et al. 1995a; Arensbak et al. 2001; Haefliger et al. 2001 ), and in hamster 
check pouch arterioles (Little et al. 1995a); although Cx40 is absent from mesenteric 
arterioles of the rat (Gustafsson et al. 2003). A number of studies have identified Cx45 in 
vascular smooth muscle of embryonic and adult mice (Kruger et al. 2000; Kumai et al. 
2000; Alcolea et al. 1999), while more recently, Cx45 has been demonstrated in the media 
of cerebral vessels of the rat (Li & Simard, 2002). While generally considered to be an 
endothelial Cx, Cx37 has been identified in the media of the coronary artery of the rat (van 
Kempen & Jongsma, 1999) and in collateral vessels during coronary arteriogenesis in the 
dog (Cai et al. 2001). Recently, studies have demonstrated the expression of the Cxs 31.9 
and 30.2 in vascular smooth muscle cells of human and mouse testis and brain (Nielsen et 
al. 2002; White et al. 2002; Nielsen & Kumar, 2003). 
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The extent of Cx staining in the media of muscular arteries and arterioles suggests 
the incidence of gap junction channels may be less than that observed in the endothelium or 
in the media of conduit vessels (Xia et al. 1995; Beny, 1999). At the ultrastructural level, 
pentalaminar gap junctions between smooth muscle cells are rarely observed, and where 
described are smaller (<100 nm) than those observed in the endothelium (Berne & Rubio, 
1979; Beny & Connat, 19~2; Sandow & Hill, 2000; Sandow et al. 2003b ). Interestingly, 
dyes such as Lucifer yellow readily pass between endothelial cells of large muscular 
arteries and arteries of the microcirculation (Emerson & Segal, 2000a,b; Sandow et al. 
2003b), and between smooth muscle cells of large muscular arteries such as the caudal 
artery (Sandow et al. 2003b ); which is in contrast to arterioles of the microcirculation 
where such dye movement between adjacent smooth muscle cells is absent (Segal & Beny, 
1992; Emerson & Segal, 2000a,b ). In the smooth muscle of the caudal artery, dye 
movement occurred in a preferential manner, between smooth muscle cells in a radial, but 
not a longitudinal direction (Sandow et al. 2003b ). Results such as these further suggest 
differences between the coupling within the two cell layers. 
Indeed, discrepancies in reported Cx staining in some vessels, such as the cheek 
pouch arteriole (Little et al. 1995a; Sandow et al. 2003d) are likely due to non-specificity 
of antibodies and /or poor experimental technique; thus accounting further for the range of 
reported heterogeneity in Cx expression (Hill et al. 2001; Severs et al. 2001 ). To date, 
there have been few studies which have systematically investigated the expression of all 
four Cxs in vascular tissue using rigorously tested antibodies. 
1.3.2 Endothelium 
In the vascular endothelium, Cxs 37, 40 and 43 have been commonly identified in 
both large and small arteries, but unlike vascular smooth muscle, Cx expression shows less 
variation amongst vascular bed and species. At the ultrastructural level, large areas of 
intact pentalaminar gap junctions, up to and more than 1 µm in length, have been found, 
confirming the view that endothelial cells are well coupled throughout the vasculature (Yeh 
et al. 1998; Ko et al. 1999; Sandow et al. 2003d). Similarly, at the light microscope 
level, gap junctions appear punctate, delineating the border of endothelial cells (Yeh et al. 
1998). 
The gap junction protein most widely expressed throughout the vasculature in a 
number of different animal species is Cx.40. Expression of protein for Cx40 has been 
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identified in the aorta of the rat, cow, pig and embryonic mouse (Delorme et al. 1997; Yeh 
et al. 1997a, 1998; Gabriels & Paul, 1998; van Kempen & Jongsma, 1999), and in the 
carotid and pulmonary arteries of the rat (Ko et al. 1999; Yeh et al. 1998, 2000). Cxs 37 
and 43 are also expressed in the endothelium of the aorta, carotid and pulmonary arteries of 
the rat (Hong & Hill, 1998; van Kempen & Jongsma, 1999; Yeh et al. 1997a; 1998, 2000; 
Gabriels & Paul, 1998; Nakamura et al. 1999). Cx43 expression is also found in the pig 
aorta (van Kempen & Jongsma, 1999). In the rat aorta and pulmonary artery, all three Cxs 
are frequently co-localized in the same gap junctional plaque, thus suggesting the ability of 
these tissues to form heteromeric gap junction channels (Ko et al. 1999; Yeh et al. 1997a, 
1998). Some studies have found that the expression of Cx37 in the rat aorta is 
heterogeneous in nature, unlike the abundant expression of Cxs 40 and 43 (van Kempen & 
Jongsma, 1999; Yeh et al. 1997a). In contrast to these studies, Gabriels & Paul (1998) 
show that the expression of Cx43 is heterogeneous along the length of the rat aorta, with 
ten-fold greater expression in the thoracic aorta compared to the abdominal aorta. 
Expression of Cx3 7 was also detected in the aorta of the embryonic mouse, while Cx43 was 
absent (Delorme et al. 1997; Simon & McWhorter, 2003). In culture, Cx37 has been 
detected between endothelial cells derived from the porcine and bovine aorta (Reed et al. 
1993; Carter. et al. 1996), while Cx43 is present in cells from the porcine aorta and the 
bovine pulmonary artery (Lash et al. 1990; Pepper et al. 1992b ). However, it should be 
noted that expression in culture has been shown to differ from that in intact vessels (van 
Kempen & Jongsma, 1999). 
All three Cxs are also expressed in the endothelium of muscular arteries in a number 
of species, Cx40 being the most widely expressed of the three Cxs. Expression of Cx40 
was detected in the coronary artery of the rat, mouse, bovine, pig and in collateral vessels 
of the dog (Bastide et al. 1993; Gros et al . . 1994; Yeh et al. 1997a, 1998; van Kempen & 
Jongsma, 1999; Cai et al. 2001). The mesenteric and basilar arteries of the rat also 
expresses Cx40 (Li & Simard, 1999; Gustafsson et al. 2003), as do human umbilical 
arteries and the pial and cremaster arterioles of the rat and the cheek pouch arterioles of the 
hamster (Little et al. 1995; van Rijen et al. 1997). Vessels of the mouse renal vasculature 
including the interlobular arteries and the afferent and efferent arterioles also express Cx40 
(Seul & Beyer, 2000). Like Cx40, expression of Cx37 is also found in the coronary artery 
of the rat, mouse, pig and collateral vessels of the dog (Yeh et al. 1997 a, 1998; van 
Kempen & Jongsma, 1999; Cai et al. 2001), however the distribution of Cx37 is more 
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heterogeneous in nature compared to the abundant expression of Cx40 in these vessels. 
Cx37, while absent from the endothelium of the bovine coronary artery (van Kempen & 
Jongsma, 1999), is found in small arteries of the lung parenchyma in humans and rats (van 
Rijen et al. 1997). In the rat mesentery, expression of Cx37 was present in some, but not 
all vessels examined (Gustafsson et al. 2003). The distribution of Cx43 in muscular 
arteries is less than that of Cxs 37 and 40. While Cx43 was detected in the endothelium of 
the pig coronary artery, in the cow this expression was found only in the proximal vessels 
and was absent in the rat coronary artery except in areas towards the aortic junction (Yeh et 
al. 1997a, 1998; Hong & Hill, 1998; van Kempen & Jongsma, 1999). Cx43 was also 
'-
detected in the mesenteric arteries and in pial and cremaster arterioles of the rat, in cheek 
pouch arterioles of the hamster (Little et al. 1995; Gustafsson et al. 2003), and in human 
umbilical artery endothelial cells (van Rijen et al. 1997). 
1.3.3 Myoendothelial gap junctions 
Myoendothelial gap junctions (MEGJs) form when projections ans1ng from an 
. endothelial cell or a smooth muscle cell abut the plasma membrane of a cell from the 
opposite layer (Sandow & Hill, 2000). MEGJs are smaller and less frequent than 
homocellular endothelial cell gap junctions and their incidence varies throughout the 
vasculature (Sandow & Hill, 2000; Sandow et al. 2002). For example, ultrastructural 
~xperiments have demonstrated that the number of MEGJ s in the rat mesenteric artery 
varies along the length of the vessel, with significantly more MEGJs in the distal compared 
to the proximal mesenteric artery (Sandow & Hill, 2000). Furthermore, while MEGJs have 
been identified ultrastructurally in the caudal artery of the adult rat, no MEGJ s were found 
in the rat femoral artery (Sandow et al. 2002, 2003b ), while the incidence of MEGJs in the 
lateral branch of the saphenous artery is significantly greater in the juvenile than in the 
adult WKY rat (Sandow et al. 2003c). Furthermore, it has been shown that the incidence 
of MEGJs in the blood vessel wall increases as the size of the vessel decreases (Sandow & 
Hill, 2000; Hill et al. 2002; Sandow et al. 2003a). Coupling of the smooth muscle and 
endothelium has also been demonstrated electrophysiologically in the hamster cheek pouch 
arteriole and the porcine ciliary artery with the direct transfer of dye between the two cell 
layers, thus indicating the presence of MEGJs (Little et al. 1995b; Beny, 1999). In a 
similar manner, in the rat mesenteric and the hamster retractor feed arteries, resting 
membrane potential of endothelial and smooth muscle cells were not significantly different; 
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thus further supporting the presence of direct electrical coupling of the two cell layers 
(Emerson & Segal, 2000a, 2001; Sandow et al. 2002). Furthermore, in several vascular 
beds, agonist induced hyperpolarization of the endothelium evokes a similar 
hyperpolarization of the smooth muscle suggesting that the two cell layers are coupled 
· (Sandow et al. 2002; Emerson & Segal, 2000a, 2001). At the ultrastructural level , MEGJs 
have been identified in several tissues in rat, hu1nan, rabbit and mouse vessels (Spagnoli et 
al. 1982; Aydin et al. 1991; Sandow & Hill, 2000; Sandow et al. 2003 b; Dora et al. 
2003), however, identification of the Cx isotype present at MEGJs is yet to be determined. 
The above discussion highlights the significant heterogeneity of Cx expression 
amongst different vascular beds, · and also between animal species. The presence of 
heterogeneity may contribute to the differences in functional characteristics present 
amongst these vascular beds. 
1.3.4 Variation in connexin expression due to physical factors 
The vascular endothelium consists of a single layer of cells', separated from the 
smooth muscle by the internal elastic lamina, and as such is exposed to varying 
hemodynamic forces arising from the flow of blood; a phenomenon known as shear stress 
(Davies & Tr_ipathi, 1993; DePaola et al. 1992). Changes in blood flow and consequently 
shear stress have been .shown to result in adaptive responses within the endothelium, 
including changes in endothelial cell morphology, gene expression and vascular function 
(Davies et al. 1992; Resnick et al. 2003). Thus, changes in shear stress can modulate 
vasomotor tone and blood flow. Blood flow within arteries is generally laminar, except in 
areas of bifurcation or in curved regions where blood flow is turbulent (Davies & Tripathi, 
1993). Recent- studies examining Cx expression in the vascular endothelium have shown 
that expression of Cx43 in the rat aorta is increased in areas of aortic bifurcation (Gabriels 
& Paul, 1998). Expression of Cx43 was specifically increased in areas 1ownstream of 
vessel branch points. Cx37 was down-regulated upstream of aortic branch points, while 
Cx40 was constant along the length of the aorta. In a similar manner, when a segment of 
the abdominal aorta, devoid of branch points, was surgically ligated, reducing the diameter 
of the vessel and increasing shear stress, expression of Cx43 was significantly up-regulated 
downstream of the ligation site. In contrast, Cx37 expression was down-regulated at 
upstream sites, while the expression of Cx40 was not altered (Gabriels & Paul, 1998). 
Other experiments performed in vitro demonstrate that an increase in fluid shear stress 
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results in the up-regulation of Cx43 mRNA (Cowan et al. 1998; DePaola et al. 1999), 
with a corresponding increase in intracellular dye transfer (DePaola et al. 1999). In 
agreement with this, in cultured vascular smooth muscle cells subject to mechanical stretch, 
an increase in expression of Cx43 mRNA and protein occurs (Cowan et al. 1998). 
Mechanical strain and fluid shear stress used in these experiments mimic physiological 
conditions which occur during hypertension, where an increase in blood pressure 
corresponds to changes in total peripheral resistance and vessel distensibility (Resnick et al. 
2003). 
Atherosclerotic regions of blood vessels are subject to turbulent flow, and thus 
represent areas of altered shear stress (Davies, 1986). The development of atherosclerotic 
lesions also coincides with an increase in Cx43 expression in the blood vessel wall 
(Blackburn et al. 1995; DePaola et al. 1999). Several studies have demonstrated that an 
increase in shear stress can cause transient disruption to the plasma membrane of 
endothelial cells as seen in areas around arterial branch points (Davies et al. 1986; Yu & 
McNeil, 1992). Furthermore, mechanical injury of the vascular endothelium has been 
shown to increase the expression of Cx43 in endothelial cells in some studies (Pepper et al. 
19926; Yeh et al. 1997 a), while others show no alteration in vascular Cx43 expression 
(Polacek et al. 1997). Yeh et al. (2000) demonstrated a significant decrease in the 
expression of Cxs 37, 40 and 43 immediately following mechanical injury of the aortic 
endothelium, followed by a slower progressive increase in the expression of all three Cxs as 
the endothelium regenerates. In cultured endothelial cells, the release of basic fibroblast 
growth factor following injury has been suggested to initiate an increase in Cx43 (Pepper et 
al. 1992a). Such injury corresponds with the mechanical disruption of endothelial cells, 
which may occur during angioplasty, and also results in the transformation of underlying 
smooth muscle cells from the contractile to the synthetic phenotype (Schwartz et al. 1978; 
Ross, 1995). As discussed in section 1.3 .1, an increase in Cx43 expression in the vascular 
media has been shown to correspond with phenotypic transformation of smooth muscle 
cells (Rennick et al. 1993; Yeh et al. 19976; Ko et al. 19996 ). 
Despite the many studies demonstrating an up-regulation of Cx expression in areas 
of shear stress and mechanical strain~ the role of such up-regulation in blood vessel function 
is largely unknown. Gabriels & Paul (1998) suggest that the up-regulation of Cx43 may 
enhance cell communication with the vascular smooth muscle and cells of the immune 
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system also expressing Cx43, ultimately minimizing cell damage and thus restoring 
vascular function. 
1.4 ROLE OF GAP JUNCTIONS IN REGULATING ARTERIOLAR TONE 
The maintenance of arteriolar tone is achieved . via a balance between 
vasoconstrictor and vasodilator responses. Alterations to this balance have been implicated 
in a number of disease states such as hypertension and atherosclerosis (Mombouli & 
Vanhoutte, 1999). 
1.4.1 Vasodilator responses 
Endothelium-dependent relaxation has an important function in the control of 
vascular tone through the release of several mediators that act on the underlying smooth 
muscle to cause a relaxation. The actions of such mediators, which include nitric oxide 
(NO), prostaglandins and endothelium-derived hyperpolarizing factor, are induced in 
response to hemodynamic forces such as shear stress, or in response to agonists such as 
acetylcholine (ACh) or bradykinin (EDHF, Palmer et al. 1988; Taylor & Weston, 1988). 
The role of each vasodilatory factor has been shown to vary depending on a number of 
variables including the vascular bed and animal species (Hill et al. 2001 ). Both NO and 
EDHF have been shown to play major roles in endothelium-dependent vasodilation, while 
prostaglandins may play a more minor role (Bauersachs et al. 1997). 
1.4.1.1 Nitric oxide 
NO is formed by the conversion of L-arginine to L-citrulline in a reaction catalyzed 
by NO synthase (NOS, Palmer & Moncada, 1989). Several isoforms of NOS have been 
identified, and are characterized according to where they were first demonstrated; 
endothelial NOS ( eNOS), neuronal . NOS and inducible NOS (Busse & Mulsch, 1990; 
Moncada et al. 1991 ). Endothelial NOS can be stimulated to produce NO in response to 
agonist or in response to increased vasoconstriction and shear stress (Fleming & Busse, 
1995; Vargas et al. 1990). Basal production of NO in a number of vessels has also been 
demonstrated- (Moncada et al. 1991 ), NO production in the endothelium is released to 
diffuse to the smooth muscle where it acts to relax the cells by initiating the guanylate 
cyclase production of cyclic 3 ' 5' guanosine monophosphate ( cGMP, Rapoport & Murad, 
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1983). While it is possible that in large vessels gap junctions within the media might be 
involved in the spread of vasodilatory responses to NO, this is unlikely to be so critical in 
the microcirculation, where the media is comprised of only one or two smooth muscle cell 
layers (Christ et al. 1996; Beny, 1999; Hill et al. 2001 ). Indeed, in the caudal artery of the 
rat, and in the rabbit iliac artery, NO-mediated relaxation was not affected by gap junction 
blockers (Chaytor et al. 2002; Sandow et al. 2003 b ). 
1.4.1.2 Prostaglandins 
_Prostaglandins are derived from the cyclooxygenase metabolism of arachidonic 
acid, producing prostaglandin H2 (Smith et al. 1991 ). Cell specific synthesis of individual 
prostanoid products including the vasodilator, prostacyclin and vasoconstrictor, 
thromboxane A2, occurs via the action of specific synthases (Smith et al. 1991; Smith, 
1992). Prostaglandins have been shown to have a role in endothelium-dependent relaxation 
in several vascular beds; the endothelium is known to be a major site of prostacyclin 
production (Moncada et al. 1977; DeWitt et al. 1983). Like NO, the mechanism by which 
prostaglandins are involved in smooth muscle cell relaxation is through the regulation of 
cGMP synthesis (Smith, 1992). Prostaglandins are able to diffuse from the endothelium to 
activate receptors in the smooth muscle and initiate a hyperpolarization (Parkington et al. 
1993). A role for gap junctions in the mediation of this response may be limited to large 
vessels containing several layers of smooth muscle. 
1.4.1.3 Endothelium-derived hyperpolarizing factor (EDHF) 
Endothelium-dependent relaxation in response to agonists may also be evoked by a 
factor independent of NO and prostaglandins (Bolton et al. 1984). This unknown factor 
has been termed EDHF (Taylor & Weston, 1988). To date, the identity of EDHF is still 
controversial, however, it is widely accepted that the actions of EDHF are mediated by the 
activation of Ca2+ activated potassitJm (Kea) channels, located on endothelial cells. The 
activation of Kea channels results in hyperpolarization of the endothelium, followed by the 
hyperpolarization and subsequent relaxation of the smooth muscle due to reduced Ca2+ 
influx through voltage dependent Ca2+ channels (VDCC~ Garland et al. 1995; Tomioka et 
al. 1999; Bolz et al. 2001 ; Ohnishi et al. 2001 ). The inhibition of Kea channels with a 
combination of apamin and charybdotoxin, to inhibit small (S), intermediate (I) and / or 
large (B) conductance Kea channels, respectively, has been shown to prevent relaxation in a 
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number of vascular beds (Edwards & Weston, 1998). Indeed, in the absence of NO and 
prostaglandins, the action of these antagonists is considered to be the hallmark of EDHF-
mediated responses. Several possible candidates for EDHF have been proposed. Putative 
candidates include chemical factors, such as cytochrome P450 metabolites of arachidonic 
acid (Bauersachs et al. 1994; Randall et al. 1996; Campbell & Harder, 1999), hydrogen 
peroxide (Matoba et al. 2002) and potassium ions (Edwards et al. 1998; Bussemaker et al. 
2003). Alternatively, the direct electrical coupling of the smooth muscle and endothelium 
via MEGJs may account for EDHF activity (Beny & von der Wied, 1991; Sandow et al. 
2002, 2003b ). In this case, EDHF may be more accurately described as EDH. 
Endothelium-dependent vasodilation, and specifically EDHF activity, has been 
shown to vary depending on the vascular bed (Shimokawa et al. 1996; Zygmunt et al. · 
1995; Hill et al. 2001 ). In general, the importance of EDHF as a vasodilator is increased 
as the vessel size and the number of smooth muscle cell layers decreases (Shimokawa et al. 
1996; Urakami et al. 1997; Tomioka et al. 1999; Sandow et al. 2002; Berman et al. 
2002; Hill et al. 2002). Thus, EDHF-mediated vasodilation is likely to play a significant 
role in the microcirculation (Shimokawa et al. 1998; Hill et al. 2001). 
Evidence for the direct electrical coupling of the smooth muscle and endothelium 
has been demonstrated in a number of vascular beds from several species (von der Weid & 
Beny, 1993; Welsh & Segal, 1998; Chaytor et al. 1998, 2001, 2002; Taylor et al. 2001; 
Beny, 1997; Yamamoto et al. 1998; Edwards et al. 1998; Emerson & Segal, 2000; 
Coleman et al. 2001; Allen et al. 2002; Emerson et al. 2002; Goto et al. 2002; Sandow et 
al. 2002; Budel et al. 2003; Ujiie et al. 2003). For example, in the rat mesenteric artery, 
ACh induced hyperpolarization of the endothelium also evoked hyperpolarization of the 
smooth muscle. This data, coupled with the ultrastructural evidence of MEGJs, indicates 
electrical coupling of the two cell layers (Sandow et al. 2002). In parallel with the 
demonstrated role of EDHF in the microcirculation, the incidence of MEGJs has been 
shown to increase as vessel size decreases (Shimokawa et al. 1996; Sandow & HiH, 2000; 
Sandow et al. 2002; Sandow et al. 2003d). Indeed, in the rat femoral artery, no EDHF-
mediated relaxation is present (Zygmunt et al. 1995; Wigg et al. 2001 ; Sandow et al. 
2002), which correlates with an absence of MEGJs, while in the rat mesenteric artery, the 
presence of an EDHF-mediated relaxation is correlated with the presence of MEGJs 
(Sandow et al. 2002). Thus, several studies have provided support for the hypothesis that 
EDHF activity may simply be due to the direct passage of an endothelium-derived 
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hyperpolarization to the · smooth muscle via MEGJs. In contrast to the studies described 
above, Savage et al. (2003) have demonstrated a significant EDHF-mediated relaxation in 
the femoral artery of the rat, which was not completely abolished by blockade of NO, 
prostaglandins and Kea channels. The reason for this discrepancy is unknown, although it 
may relate to the region of artery taken. 
Further evidence for the importance of gap junctional coupling in EDHF activity 
has been provided via the use of gap junction inhibitors including the putative uncouplers, 
18a- and 18P-glycyrrhetinic acid (18P-GA) and Cx-mimetic (Gap) peptides, which 
reportedly alter gap junctional aggregation and channel gating, respectively (Goldberg et al. 
1996; Guan et al. 1996; Evans & Boitano, 2001; Berman et al. 2002). These inhibitors 
block endothelial-dependent hyperpolarization and subsequent relaxation of the smooth 
muscle in a variety of vascular beds (Yamamoto et al. 1998, 1999; Coleman et al. 2001; 
Sandow et al. 2002, 2003b; Chaytor et al. 2001; Griffith et al. 2002; Tare et al. 2002; De 
Vriese et al. 2002). Although in some vessels, including the guinea pig coronary artery, it 
has been shown that l 8P-GA is able to inhibit endothelial hyperpolarization directly (Tare 
et al. 2002). 
The above discussion provides evidence that electrical coupling between cells of the 
blood vessels wall occurs via gap junctions. MEGJ coupling has been demonstrated to be 
important for EDHF-mediated responses in small arteries and arterioles, and more recently 
in larger muscular arteries such as the caudal artery. Thus MEGJs are likely to contribute 
significantly to the coordination of vascular responses in these vessels (Chaytor et al. 
1998, 2001; 2002; Griffith et al. 2002; Sandow et al. 2003b ). 
1.4.2 Vasoconstrictor responses 
1.4.2.1 The myogenic response 
The myogenic response describes an endothelium-dependent vasoconstriction in 
response to increased transmural pressure and vasodilation in response to reduced pressure 
(Davis & Hill, 1999). This autoregulatory response is considered to be a major determinant 
of blood flow and vascular tone. Like many other vascular mechani sms, the myogenic 
response has been suggested to be more prominent in smaller vessels, and to be variable 
amongst vascular beds (Davis, 1993; Davis & Hill, 1999; Schubert & Mulvany, 1999). It is 
now well established that the myogenic response is initiated by the depolarization of 
vascular smooth muscle cells and an increase in the intracellular Ca2+ concentration due to 
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the influx of extracellular Ca2+ through VDCCs (Schubert & Mulvany, 1999). Recently, 
studies have provided evidence that suggests a role for gap junctions in the modulation of 
myogenic tone, whereby the response in rat cerebral arteries was attenuated in the presence 
of the putative gap junction inhibitor, l 8a-GA (Lagaud et al. 20026 ). A role for gap 
junctions in the myogenic response may be predicted to facilitate and coordinate the spread 
of vasoconstriction, which may be particularly important in larger vessels containing 
several layers of smooth muscle cells. 
1.4.2.2 Vasomotion 
Rhythmical contractions or vasomotion have been demonstrated in many different 
vascular beds including microcirculatory vessels of the systemic and cerebral circulation 
both in vivo and in vitro (Gustafsson, 1993; Hill et al. 1999; Haddock & Hill, 2002). 
While in some vascular beds vasomotion occurs spontaneously, in others stimulation with 
agonist is required (Gustafsson, 1993). Vasomotion is thought to be important in the 
maintenance of vascular resistance and blood flow (Gratton et al. 1998). The mechanisms 
underlying rhythmical contractions vary between vascular bed and species. However, the 
underlying mechanism involves oscillations in intracellular Ca2+ concentrations that occur 
through either voltage dependent or voltage independent mechanisms (Hill et al. 2001 ). 
Gap junctional coupling between adjacent smooth muscle cells has been suggested to be 
critical for the coordination of these oscillations. As such, putative gap junction inhibitors 
have been demonstrated to prevent vasomotion in a number of vascular beds (Chaytor et al. 
1997; Hill et al. 1999). The endothelium has also been shown to be involved in 
vasomotion in several vessels including the rat basilar and mesenteric arteries (Gustafsson, 
1993; Haddock & Hill, 2002), in which removal of the endothelium resulted in the loss of 
synchronized Ca2+ oscillations in the smooth muscle, suggesting an important role for 
electrical coupling of the endothelium and smooth muscle via MEGJs. 
1.4.3 Conducted vascular responses 
The regulation of tissue perfusion is an essential function of the microcirculation 
and results from the conduction of vasodilator and vasoconstrictor responses to vessels 
upstream in order to coordinate blood flow. Conducted vasodilation and vasoconstriction 
has been demonstrated in a number of vascular beds and relies on the electrotonic spread of 
current through gap junction channels in the vessel wall (Segal & Duling, 1989; Xia & 
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Duling, 1995). The morphological arrangement of endothelial cells along the length of 
arteries, combined with extensive coupling of endothelial cells provides a low resistance 
pathway for the conduction of hyperpolarization over large distances within a vascular bed 
(Haas & Duling, 1997; Dora, 2001; Segal et al. 2001; Y amamot,o et al. 2001; Sandow et 
al. 2003d). Stimulation of the endothelium with ACh initiates a bi-directional spread of 
vasodilatory responses, due to the conduction of hyperpolarization along the endothelium 
(Segal & Duling, 1989; Xia & Duling, 1995; Welsh & Segal, 1998; Segal et al. 1999; 
Hungerford et al. 2000; Emerson et al. 2001, 2002; Yamamoto et al. 2001; Budel et al. 
2003; Ujiie et al. 2003). In s_ome arterioles it has been shown that conducted vasodilation 
is mediated by the action of EDHF, while local vasodilatory responses are mediated by NO, 
prostaglandins and EDHF (Hungerford et al. 2000; Hoepfl et al. 2002). Thus, MEGJs are 
considered to play an important role at distal sites, allowing hyperpolarization to be 
· transferred from the endothelium to the smooth muscle in order to effect a relaxation. 
Furthermore, in cremaster and skeletal muscle arterioles of Cx40 knockout mice, conducted 
vasodilation was significantly attenuated, further demonstrating the importance of gap 
junctional coupling for this response ( de Wit et al. 2000; Figueroa et al. 2003). 
In contrast to the conduction of vasodilatory responses, vasoconstrictor responses 
are conducted within the smooth muscle, and not the endothelium in some vessels (Xia & 
Duling, 1995; Beny, 1997; Bartlett & Segal, 2.000; Budel et al. 2003), while in other 
vessels, vasoconstrictor responses are not conducted at all (Segal et al. ,l 999). Such results 
suggest differences in the extent of coupling within the smooth muscle of different arteries 
(Segal et al. 2001 ), as well as the modulation of Cxs therein (Sandow et al. 2003d). 
Conducted vasoconstriction results from the conduction of depolarizing current along the 
blood vessel wall via gap junctions within the media, followed by Ca2+ influx through 
VDCCs and subsequent vasoconstriction (Xia & Duling, 1995). Indeed, within hamster 
cheek pouch arterioles, vasoconstriction was conducted exclusively along the smooth 
muscle of the vessel, but was inhibited at sites of smooth muscle cell damage (Bartlett & 
Segal, 2000). In some vessels, responses arising in the smooth muscle can be conducted 
into the endothelium (Beny, 1997), further highlighting a role for MEGJs. 
1.5 STUDIES IN CONNEXIN DEFICIENT MICE 
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The deletion of a single Cx protein either globally or in a specific cell type can have 
significant effects on vascular function , while providing a unique method for determining 
the functional role of specific Cx isotypes in vascular responses. Cx43 knockout (Cx43_1_) 
mice die shortly after birth from an obstructed right ventricular outflow tract (Reaume ·et al. 
1995). However, the ability of the knockout mice to survive to term suggests other Cx 
isotypes may compensate for the lack of Cx43 in other tissues during development. More 
recently, knockout mice that are heterozygous for the Cx43 (Cx43+1-) gene have been 
developed and shown to be postnatally viable (Guerrero et al. 1997). These mice 
displayed a 50% reduction of Cx43 in both atrial and ventricular myocardium and a 
slowing of cardiac conduction in the ventricular myocardium (Guerrero et al. 1997; 
Thomas et al. 1998), suggesting that a functional compensation by Cx40, may be present 
in the atria, to thus prevent conduction abnormalities in the Cx43+/- mice (Thomas et al. 
1998). Indeed, mice deficient in both Cxs 43 and 40 die postnatally from severe cardiac 
abnormalities (Kirchhoff et al. 2000). In contrast, several studies have demonstrated a lack 
of significant changes in cardiac conduction parameters in Cx43+/- mouse (Morley et al. 
1999; Kirchhoff et al. 2000), supporting the suggestion of functional compensation by . 
other Cxs, such as Cxs 40 and 45, in the heart. Indeed, it has recently been demonstrated 
that Cx45 protein, while not upregulated in the heart of the Cx43+/- mouse, is redistributed 
within the ventricular myocardium (Johnson et al. 2002). Neither the expression nor 
distribution of Cx40 protein was altered in Cx43+/-mouse (Johnson et al. 2002). However, 
it is possible that the lack of effect on cardiac conduction in Cx43+/- mice simply resulted 
from the over-abundance of Cx43 such that a 50% reduction in expression had little 
physiological effect. In support of this hypothesis, recent studies by Gutstein et al. (2001 a) 
whereby Cx43 was inactivated exclusively in cardiomyocytes, have demonstrated that 
while heart structure and contractile function was not altered, mice developed ventricular 
arrhythmia due to reduced ventricular conduction (Gutstein et al. 2001 a). In addition, 
chimeric mice engineered to show heterogeneous disruption of Cx43 in the heart (Gutstein 
et al. 2001 b ), demonstrate reduced ventricular conduction. 
The role of Cx43 in vascular endothelial function has been examined in inice where 
Cx43 has been selectivity deleted in endothelial cells (Liao et al. 2001; Theis et al. 2001 ). 
Endothelial knockout mice were developed using the Cre/loxP mediated deletion of Cx43, 
and replacement of the coding region by the lacZ reporter gene. This method enabled the 
specific deletion of Cx43 in endothelial cells. Liao et al. (2001) found that endothelial 
22 
Cx43 knockout mice were hypotensive and displayed elevated levels of plasma NO and 
angiotensin. In contrast, endothelial Cx43 knockout mice developed by Theis et al. (2001) 
found no such alteration in blood pressure compared to control mice and concluded that 
there were no obvious changes in vascular development in these mice. 
Cx45 knockout (Cx4S-1-) mice show widespread abnormalities of the systemic 
vasculature and die early in embryonic development from impaired-formation of the yolk 
sack vasculature and other major arteries (Kumai et al. 2000; Kruger et al. 2000; Simon & 
Mc Whorter, 2002). Thus, these studies demonstrate ~hat Cx45 is essential for embryonic 
cardiovascular development. 
In contrast to Cx43_1_ or 45-I- knockout mice, mice lacking either Cx37 (Cx37_1_) or 
40 (Cx40-1-) are viable into adulthood. However, female Cx3 T 1- mice are infertile resulting 
from abnormal oocyte and follicular development (Simon et al. 1997), while Cx40-1- mice 
display abnormal cardiac conduction properties and are predisposed to cardiac arrhythmia 
(Kirchhoff et al. 1998; Simon et al. 1998; Tamaddon et al. 2000). While the absence of 
Cx40 does not appear to affect vascular development (Simon & Mc Whorter, 2002), Cx40-1-
mice show reduced conduction of endothelium-dependent vasodilatory responses following 
application of A Ch or bradykinin in the skeletal microcirculation ( de Wit et al. 2000). The 
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residual dilation present at upstream sites is thought to result from remaining gap junction 
channels, containing Cxs 37 and 43. Conducted vasoconstriction in skeletal muscle 
arterioles from Cx40-1- 1nice was not affected (Figueroa et al. 2003). 
The above studies demonstrate the essential role for Cxs 43 and 45 in the 
development of the cardiovascular system, while Cx40 plays an important role in the 
coordination of vasomotor responses in the vascular endothelium. Mice lacking either 
Cx40 or Cx3 7 survive into adulthood, while mice lacking both Cxs 3 7 and 40 die shortly 
after birth due to severe vascular abnormalities (Simon & Mc Whorter, 2002). Further 
studies in Cx37 and Cx40 knockout mice have shown that optimal expression of 
endothelial Cxs may be dependent on the activity of a co-expressed Cx (Kruger et al. 
2002; Simon & Mc Whorter, 2003). Indeed, expression of Cxs 37 and 40 in aortic 
endothelial cells is down-regulated in Cx40-1- and Cx37_1_ mice, respectively (Simon & 
Mc Whorter, 2003) with the deletion of Cx40 having a greater effect on Cx37 expression 
than vice versa. Reduced Cx expression also corresponds with a reduction in intercellular 
dye transfer, where again the deletion of Cx40 had a greater effect than deletion of Cx3 7. 
Double knockout mice showed complete abolition of intercellular dye transfer. The 
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expression of Cx43 was not altered in the endothelium of Cx37 and Cx40 double knockout 
mice (Simon & Mc Whorter, 2003), however both Cxs 37 and 43 were increased in the 
aortic media of Cx40-1-mice (Kruger et al. 2002; Simon & Mc Whorter, 2003). 
Furthermore, deletion of Cx40 had greater effects in embryonic Cx40 knockout mice than 
in adult mice, suggesting an increased role for Cx40 in vascular development. 
1.6 CHANGES IN GAP JUNCTIONS DURING DISEASE 
If gap junctions are essential for normal vascular function, then alterations in Cx 
expression and cellular coupling are likely to be implicated in the etiology of vascular 
diseases such as hypertension, atherosclerosis, diabetes and septic shock. 
1. 6.1 Hypertension 
Little is known regarding Cx . expression in muscular arteries during hypertension, 
with most studies having concentrated on Cx43 expression in the aorta of the rat (Haefliger 
et al. 1997 a,b, 2001; Haefliger & Meda, 2000). This is surprising, given that the aorta is a 
large elastic artery and is thus not directly involved in maintenance of peripheral resistance 
(Mulvany & Aalkjaer, 1990). Such studies are therefore unlikely to be relevant for 
elucidating the mechanisms associated with the etiology of diseases such as hypertension. 
However, the results of such studies do highlight the possibility that changes in Cx 
expression during hypertension may be related to the underlying cause of the disease. 
Indeed, it is interesting that variation in Cx expression has been found in the aortic media of 
different hypertensive rat models. In deoxycorticosterone acetate (DOCA)-salt and renal-
clip models of hypertension, Cx43 expression was increased in the thoracic aorta (Haefliger 
et al. 1997b; Watts & Webb, 1996; Haefliger & Meda, 2000), whilst in L-NAME induced 
hypertensive rats, Cx43 expression was decreased (Haefliger et al. 1999; Haefliger & 
Meda, 2000). Recently, Cx45 has also been examined in vessels from spontaneously 
hypertensive rats (SHR, Li & Simard, 2002), in which the expression of both Cxs 43 and 45 
was increased in the cerebral artery, while expression was unchanged in the aorta and 
femoral artery. Little is known regarding the cellular location of these changes, however it 
may be assumed that in the whole vessel preparations used in Western and Northern 
blotting experiments, smooth muscle is the predominate cell type. In contrast to Li & 
Simard (2002), recent studies of the SHR by Haefliger et al. (2001) have shown a decrease 
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in Cx43 expression; specifically in endothelial cells of the aorta. As discussed in section 
1.5, mice deficient in Cx40 have increased blood pressure and a significant attenuation of 
the conducted vasodilatory response ( de Wit et al. 2000). Together these results suggest a 
role for gap junctions in vascular function and hypertension. 
1. 6.2 Atherosclerosis, diabetes and inflammation 
Within vascular cells, changes in Cx expression have been reported to occur in 
association with other disease states including atherosclerosis, diabetes and inflammatory 
conditions such as septic shock. Increased Cx43 expression has been reported in 
atherosclerotic plaques, while in vitro, cells cultured in medium containing high glucose 
levels show reduced Cx43 expression and unaltered expression of Cxs 37 and 40 
(Blackburn et al. 1995; Sato et al. 2002; Kwak et al. 2002; 2003). During 
atherosclerosis, increased Cx43 expression may be required for increased smooth muscle 
cell proliferation, which occurs during lesion dev:elopment (Blackburn et al. 1995; Polacek 
et al. 1997; Kwak et al. 2002), and indeed this situation may reflect the general up-
regulation of Cxs in early developmental processes and cellular differentiation. In contrast, 
hyperglycemia associated with diabetes may increase the phosphorylation of Cx proteins 
and thereby reduce cellular coupling (Inoguchi et al. 2001 ; Oku et al. 2001 ). In a similar 
manner, inflammatory mediators lipopolysaccharide and cytokines, such as tumor necrosis 
factor a (TNF-a ), have been shown to modulate Cx phosphorylation, resulting in reduced 
cellular communication (Ferro et al. 1993; Hu & Cotgreave, 1997; Lidington et al. 2000, 
2002, 2003; Tyml et al. 2001). The expression of Cxs 37 and 40, but not Cx43 have also 
been shown to be down-regulated following exposure to TNF-a (van Rijen et al. 1998). 
From the above discussion, it is clear that while alterations in Cx expression are 
evident in some disease states, relatively little is known regarding the expression of the four 
vascular Cxs in the smooth muscle and endothelium of blood vessels during hypertension . 
1.7 EXPERIMENTAL HYPERTENSION 
Essential hypertension in humans is characterized by a sustained increase in blood 
pressure resulting from an increase in peripheral vascular resistance (Staessen et al. 2003). 
Hypertension is multifactorial in nature, with both genetic and environmental influences 
contributing to the etiology of the disease. Worldwide, essential hypertension affects 25-
25 
35% of the population, with the incidence increasing to 60-70% in the elderly population 
(Staessen et al. 2003). Hypertension is a major risk factor for the development of other 
cardiovascular diseases such as stroke and heart failure (Staessen et al. 2003). The study 
of hypertension encompasses the use of several genetic animal models, the SHR being most 
commonly _used as a model for human essential hypertension (Stoll & Jacob, 2001). The 
SHR is an inbred strain developed by Okamoto & Aoki (1963) through the mating of a 
male and female Wistar Kyoto (WKY) rat, both displaying elevated blood pressure. This 
was followed by successive inbreeding of hypertensive brother-sister pairs, resulting in a 
colony of rats with a 100% occurrence of spontaneous hypertension. Okamoto & Aoki 
( 1963) defined hypertension as a systolic blood pressure exceeding 150 mmHg, and it was 
demonstrated that hypertension progressively developed with age. Studies to date 
demonstrate that hypertension develops from approximately 4 weeks of age, however, this 
varies between individual studies, with established hypertension occurring by 10-12 weeks 
of age (Lais et al. 1977; Kihara et al. 1993; Dickhaut & Lee, 1998). Inbred WKY rats 
were initially developed as a normotensive control for the SHR (Hansen et al. 1973). 
However, valid questions have arisen as to the validity of the WKY as a genetic control for 
the SHR (Louis & Howes, 1990). Studies have shown significant genetic diversity between 
the WKY and the SHR, with the distribution of animals before they were fully inbred 
contributing to this variation (Kurtz & Morris, 1987; Kurtz et al. 1989; Alemayehu et al. 
2002). Furthermore, differences between WKY and SHR strains occur even between 
laboratories. Unfortunately, even in light of such differences, the WKY remains the most 
appropriate normotensive strain for comparative studies with the SHR. 
Both human and experimental hypertension are associated with marked alterations 
1n endothelial function and vascular structure, both of which may significantly affect 
vascular tone and peripheral vascular resistance (Mulvany & Aalkjaer, 1990). 
1. 7.1 Endothelial dysfunction 
As discussed above, the endothelium is essential for the maintenance of vasomotor 
tone, producing vasodilatory factors such as NO, prostaglandins and EDHF, and 
contracting factors, which include endothelin-1 , thromboxane A2, prostaglandin H2 and 
superoxide anion (Vanhoutte & Boulanger, 1995). Diseases such as hypertension and 
atherosclerosis are associated with the altered production and action of both endothelial-
derived vasodilator and vasoconstrictor substances, a process described as endothelial 
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dysfunction. Furthermore, the sensitivity of smooth muscle cells to these factors is altered. 
The end result, impaired endothelium-dependent vasodilation, compromises both normal 
vascular tone and arterial function (Boulanger, 1999; Mombouli & Vanhoutte, 1999; Puddu 
et al. 2000). 
Other factors involved irt the regulation of vascular tone include the action of 
angiotensin-converting enzyme (ACE). ACE plays an important role in the metabolism of 
vasoconstrictors such as angiotensin II (Angll), endothelin-1 and the vasodilator, 
bradykinin (Momose et al. 1993; Mombouli & Vanhoutte, 1999; Puddu et al. 2000). 
While AngII is generally not up-regulated in the SHR, receptor number and responsiveness 
to AngII is increased in some tissues (Schiffrin et al. 1984; Kost & Jackson, 1993; 
Campbell et al. 1995). 
1. 7.1.1 Vasodilator factors 
The mechanisms that underlie impaired endothe_lial function during hypertension 
vary with animal model and the vascular bed. For example, while reduced production of 
NO has been reported to underlie endothelial dysfunction in some hypertensive rat models 
(Rees et al. 1996; Hayakawa & Raij, 1998; Lou et al. 2001), in the SHR, eNOS activity is 
up-regulated. While the production of NO is increased or unchanged in the SHR, the 
biological activity of NO is inhibited, probably due to the increased activity of superoxide 
(Omar et al. 1992; Kerr et al. 1999). Moreover, the sensitivity of the smooth muscle to 
contractile factors is usually increased (Ge et al. 1995; Hayakawa et al. 1995; Nava et al. 
1995; Noris et al. 1995; Noll et al. 1997). Studies in several vascular beds have 
demonstrated that the endothelium-dependent relaxation attributed to NO and EDHF is 
reduced in SHR and the SHR-SP (Vanhoutte, 1989; Fujii et al. 1990; Sunano et al. 1999; 
Vazquez-Perez et al. 2001). In other studies, endothelium-dependent hyperpolarization in 
the caudal artery of the SHR, was reduced, while EDHF-mediated relaxation was not 
affected (Sandow et al. 2003b ). This apparent discrepancy was suggested to be accounted 
for by the compensatory increase in the incidence of MEGJs in the SHR, thus contributing 
to the maintenance of the EDHF-mediated relaxation in this vessel (Sandow et al. 2003b). 
Given the role for gap junctions in the coordination of the vascular response, the 
altered expression of gap junction in the endothelium and media may contribute to the 
impaired vasodilatory characteristics present endothelial dysfunction. 
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1. 7.1.2 Contracting factors 
Endothelin-1 is a potent vasoconstrictor, which is produced in the endothelium in 
response to various agonists including vasopressin and AngII (Schiffrin, 1998), and which 
acts on endothelin type A and B receptors found on smooth muscle and endothelial cells 
(Schiffrin, 1999). Expression of endothelin-1 in the endothelium can be modulated by the 
vasodilatory factors , NO and EDHF (Nakashima & Vanhoutte, 1993; Schiffrin, 1998), 
while stimulation of ET A and ET B receptors in the smooth muscle initiates vasoconstriction 
(Schiffrin, 1999). Increased endothelin-1 production has also been demonstrated in a 
number of models of hypertension including the stroke-prone SHR (SHR-SP), and DOCA-
salt hypertensive rats (Schiffrin, 1998, 1999). Thromboxane A2 is a prostanoid produced in 
shlall amounts in the endothelium, which acts to initiate a vasoconstriction following 
activation of receptors in the smooth muscle (Halushka et al. 1989). The oxygen free 
radical, superoxide, is produced in endothelial cells in response to stimuli such as ACh, 
bradykinin and shear stress (Shimizu et al. 1994), and has been shown to inactivate NO 
and inhibit vasodilation (Tschudi et al. 1996). In the SHR, increased expression of 
cyclooxygenase-1 results in the increased production of thromboxane A2 and prostaglandin 
H2 (Nakazono et al. 1991; Ge et al. 1995; Dohi et al. 1996; Bouloumie et al. 1997; 
Vaziri & Oveisi, 1998; Vaziri et al. 2001). In a similar manner, the activity of superoxide 
is increased during hypertension (Omar et al. 1992; Grunfeld et al. 1995; Rajagopalan et 
al. 1996; Kerr et al. 1999). Changes in Ca2+ sensitivity to the contractile apparatus have 
also been shown to contribute to the development of hypertension (Suzuki & Ford, 1992; 
Ungvari & Koller, 2000). 
1. 7.2 Vascular remodeling during hypertension 
During hypertension, the increase in peripheral vascular resistance contributes to the 
maintenance of increased blood pressure, which is frequently associated with structural 
remodeling of the blood vessel wall (Mulvany & Aalkjaer, 1990; Intengan & Schiffrin, 
2000; Touyz, 2000). Vascular remodeling, which occurs in both elastic and muscular 
arteries describes changes in the thickness of the media and luminal diameter (Mulvany et 
al. 1996). Small muscular arteries and arterioles are considered · to be the main sites of 
peripheral vascular resistance and therefore remodeling of these vessels has been 
implicated in the development of hypertension (Mulvany & Aalkjaer, 1990; Heagerty et al. 
1993). The definition of such vessels based on size is an arbitrary measure, as vessels less 
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than approximately 500 µm in diameter are considered to be the primary sites of peripheral 
vascular resistance (Mulvany & Aalkjaer, 1990). In contrast, large elastic arteries such as 
the aorta and the superior mesenteric artery are essentially conduit vessels. The role 
remodeling of such vessels plays in the development of hypertension is unknown. While 
there is substantial information regarding remodeling of the vascular smooth muscle, less is 
known regarding morphological changes that may occur in the vascular endothelium during 
hypertension. 
1. 7.2.1 Remodeling of the vascular smooth musc(e 
Several categories of vascular remodeling have been described, with the type often 
depending on the vascular bed examined. Hypertrophic remodeling results in a decrease in 
luminal diameter and hypertrophy of the vascular smooth muscle (Heagerty et al. 1993; 
Dickhaut & Lee, 1999; Dickhaut & Lee, 2000; Intengan & Schiffrin, 2000; Touyz, 2000). 
This type of remodeling is characterised by an increase in the media to lumen ratio and 
medial cross-sectional area (Intengan & Schiffrin, 2000). The increase in medial volume 
seen in hypertrophic remodeling may result from either hyperplasia or hypertrophy of 
smooth muscle cells in combination with an increase in the amount of extracellular protein. 
The second type of remodeling is termed eutrophic remodeling, and occurs when both the 
outer diameter and luminal diameter of the blood vessel are decreased (Mulvany et al. 
1996). This also .results in an increase in the media to lumen ratio, although the medial 
cross-sectional area is unchanged. In this type of remodeling, changes in the medial layer 
arise from the rearrangement of existing smooth muscle cells around a smaller lumen 
(Baumbach & Heistad, 1989; Intengan & Schiffrin, 2000). Increased apoptosis along the 
adventitial surface or alterations in the extracellular matrix components and cell adhesion 
molecules may also contribute to the medial changes seen in eutrophic remodeling (Diez et 
al. 1997; Sharifi & Schiffrin, 1998; Dickhaut & Lee, 1999; Intengan et al. 1999; Intengan 
& Schiffrin, 2000). 
Hypertrophic remodeling has been shown in several vascular beds of the SHR and 
SHR-SP, including in the aorta, mesenteric, ' carotid, renal, cerebral, interlobular and 
intramyocardial arteries (Mulvany et al. 1978, 1985; Mulvany & Korsgaard, 1983; Lee et 
al. 1983; Lee, 1985, 1987; Amann et al. 1995, 1997; Arribas et al. 1997; Mulvany, 1995; 
Dickhaut & Lee, 1997, 2000; Fujii et al. 1999; Rizzoni et al. · 1998). However, whether 
the increase in medial area result from hypertrophy or hyperplasia of smooth muscle cells 
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varies depending on the particular vascular bed, age and the species examined. Eutrophic 
remodeling has also been demonstrated in a number of vascular beds from the SHR 
(Baumbach & Heistad, 1989; Arribas et al. 1996;_ Mulvany et al. 1996; Intengan et al. 
1999). These studies support the heterogeneous nature of medial changes that occur in 
different regions of the same vascular bed and amongst different vascular beds, with both 
hypertrophic and eutrophic remodeling having been demonstrated in the SHR. 
1. 7.2.2 Remodeling of the vascular smooth muscle and the onset of hypertension 
In the thoracic aorta, mesenteric and interlobular arteries and the main renal artery 
of the pre-hypertensive SHR, an increase in the number of smooth muscle cell layers has 
been observed (Lee, 1985, 1987; Norrelund et al. 1994; Mulvany et al. 1995; Dickhaut & 
Lee, 1997; Van Gorp et al. 2000). Thus, structural changes have been demonstrated in the 
pre-hypertensive SHR indicating that such changes may contribute to the development of 
hypertension, in at least some vascular beds. For example, in mesenteric arteries of pre-
hypertensive SHR, prior to the increase in blood pressure, thickening of the medial wall 
results from hyperplasia of smooth muscle cells, while hypertrophy of smooth muscle cells 
occurs in parallel with increased blood pressure (Mulvany et al. 1978, 1985; Lee et al. 
1983; Lee & Smeda, 1985; Lee, 1985, 1987; Dickhaut & Lee, 1997). These secondary 
vascular changes may contribute to the maintenance of hypertension (Lee & Smeda, 1985). 
1. 7.2.3 Remodeling of the endothelium 
As detailed above, changes in shear stress are known to affect both endothelial cell 
structure and function, and therefore directly modulate vasomotor tone. Changes in shear 
stress have been implicated in the progression of atherosclerosis (Davies et al. 1992; 
Davies, 1997), while in hypertension altered vascular responses have been demonstrated in 
several vascular beds, following increased peripheral resistance and resultant changes in 
shear stress (see section 1.7.1 ). Several studies in vitro have demonstrated altered 
endothelial cell morphology and alignment in response to changed flow conditions. In 
situations of laminar flow, endothelial cells became aligned to the direction of flow, while 
under turbulent flow endothelial cells maintain a polygonal shape and display increased 
DNA synthesis (Davies et al. 1986; Barbee et al. 1994; DePaola et al. 1992, 1999). 
In vivo, most remodeling data has been derived from the rat thoracic aorta, with 
several more recent studies also examining the mesenteric artery. The results. of these 
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studies are somewhat conflicting; authors having reported both increased and decreased 
endothelial cell size and density depending on the model of hypertension examined. 
Arribas et al. (1997) have shown that there were fewer endothelial cells in the mesenteric 
artery of adult SHR-SP, associated with the decrease in luminal diameter. In rats made 
hypertensive by ligation of the abdominal aorta, initially, hypertrophy of endothelial cells 
within the aorta was observed, while several weeks after ligation, endothelial cells were 
smaller than in controls (Htittner et al. 1979). On the other hand, in renovascular 
hypertension and mineralocorticoid hypertensive models, an increase in endothelial cell 
density and replication was observed in the thoracic aorta early after induction of 
hypertension (Daniel et al. 1982; Buttner et al. 1982; De Chastonay et al. 1983). Cell 
replication was reduced to that of control in latter phases of most hypertensive models, 
while endothelial cell density remained elevated (Daniel et al. 1982; De Chastonay et al. 
1983). The exception were animals made hypertensive by high salt diets in which 
endothelial cell density returned to control levels (De Chastonay et al. 1983). In other 
experiments involving disruption of blood flow in the rat and rabbit coronary artery, 
hyperplasia of endothelial cells could be demonstrated (Emanueli et al. 2000; Masuda et 
al. 2003; Sho et al. 2003). This response was shown to precede remodeling of the 
vascular smooth muscle and involve AngII mediated proliferation of endothelial cells 
(Emanueli et al. 2000; Sho et al. 2003). 
It is clear from the above studies that remodeling occurs in both the vascular 
endothelium and smooth muscle in response to changes in hemodynamic conditions within 
the blood vessel. In some vessels· remodeling has been found to precede the development 
of hypertension, while in other vascular beds, remodeling occurs as an adaptive process in 
response to an increase in· blood pressure and may be associated with the maintenance of 
hypertension. These studies further highlight the heterogeneity in the form of both 
endothelial and smooth muscle cell remodeling in different models of hypertension and 
within different vascular beds. 
1.8 THESIS AIMS AND OUTLINE 
1.8.1 Aims 
The above literature review outlines a clear role for gap junctional coupling within 
the vascular wall in the coordination and control of a range of vascular responses, which 
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could impact on, or contribute to, blood flow and peripheral vascular resistance. 
Furthermore, examination of data concerning Cx expression within the vascular system has 
uncovered enormous variation in experimental results amongst different vascular beds. In 
particular, vessels with differing functional properties appear to demonstrate different 
patterns of Cx expression. While many studies have examined the expression of Cxs 
within the vascular endothelium and smooth muscle, in some cases results have been 
conflicting. The lack of specificity of Cx antibodies and poor experimental technique in 
some studies may account for some of these differing results. Analysis and quantification 
of cell specific Cx distribution within both the smooth muscle and endothelium of 
structurally and functionally different vessels has yet to be performed. 
Changes in vascular function are recognized · to be associated with altered 
hemodynamic conditions such as the changes in shear stress. Moreover, such changes may 
underlie the pathogenesis of several disease states including hypertension. Given that 
cellular communication is essential for vasomotor control, it may by hypothesized that 
changes in endothelial function can be directly correlated with altered gap junction 
expression. Indeed, this seems to be the case in several disease states including 
hypertension. To date, little is known regarding Cx expression during hypertension. Most 
studies have been concerned with changes to Cx43 in the rat aorta, while there is little or no 
data regarding the expression of Cxs 3 7, 40 and 45, or the cellular location of such changes. 
Indeed, such studies may therefore have little physiological relevance to studies of 
hypertension, given that the aorta is a large conduit artery and therefore not involved in the 
maintenance of peripheral vascular resistance. To date, no studies have compared gap 
junction expression in functionally different vascular beds of hypertensive animals. 
The aim of this thesis was to systematically examine Cx expression in the 
endothelium and smooth muscle of the thoracic aorta in comparison to the caudal artery of 
the Wistar rat through the quantification of messenger ribonucleic acid (mRNA) and 
protein expression using real-time polymerase chain reaction (PCR) and 
immunohistochemistry. Real-time PCR is a highly sensitive technique that allow the 
absolute quantification of mRNA from intact vessels. Immunohistochemistry was used in 
order to detect Cx protein specifically within the endothelial and smooth muscle cell layers. 
The thoracic aorta and caudal artery were chosen to represent two functionally different 
vascular beds. The thoracic aorta is an example of a large elastic artery, while the caudal 
artery is an example of a muscular artery and as such is more likely to be involved in the 
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control of peripheral vascular resistance (Mulvany & Aalkjaer, 1990; Christensen & 
Mulvany, 2001 ). 
Cx expression has also been examined in a hypertensive animal model , the SHR. 
Changes in Cx expression have been related to remodeling of the media and endothelium. 
Whether changes in Cx expression and cellular morphology occurred prior to the onset of 
hypertension has also been examined. Changes in Cx expression and cell morphology 
within the endothelium has been compared to those of mesenteric and basilar arteries which 
have a demonstrated role in determining peripheral resistance. 
Finally, the impact that changes in Cx expression and vascular remodeling, within 
both the endothelium and smooth muscle, may have on blood vessel function has been 
examined in the caudal and mesenteric arteries of the SHR in comparison to the WKY. 
Electrophysiological methods were used to record changes in membrane potential and to 
assess the conduction of endothelium-dependent vasodilatory responses, while tension 
myography was used to assess the contribution of endothelial-derived factors to vessel 
relaxation. 
1. 8.2 Thesis outline 
The results presented in this thesis have been divided into the following sections: 
• Chapter 2, methods 
• Chapter 3, characterization of affinity purified · Cx antibodies. Specificity was 
determined using Western blotting and immunohistochemical examination of cells 
transfected with the appropriate Cx sequence in tissues known to express each Cx. 
• Chapter 4, comparison of the distribution of Cx mRNA and protein in the thoracic 
aorta and caudal artery of the Wistar rat using real-time PCR and 
immunohistochemistry. 
• Chapter 5~ comparison of Cx mRNA and protein distribution and vascular 
remodeling of the thoracic aorta arid caudal artery of the adult hypertensive (SHR) 
and normotensive (WKY) rats using real-time PCR and immunohistochemistry. 
• Chapter 6, investigation of the relationship of vascular changes to the blood 
pressure increase using SHR and WKY. 
• Chapter 7, a comparison of the changes in Cx expression and vascular remodeling 
in other vascular beds within the hypertensive rat. 
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• Determination of the impact of changes in Cx expression and vascular remodeling 
on the functional responses in the caudal and mesenteric arteries of the SHR 
compared to the WKY, has been included into Chapters 5 and 7. · 
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2.1 ANIMALS 
CHAPTER2 
MATERIALS AND METHODS 
Experiments were performed on an inbred strain of male WKY rats and age 
matched SHR at 3 and 12 weeks of age. SHR were obtained from the Flinders University 
Medical Centre animal facility from stock originally derived from the National Institutes 
for Health, Bethesda, MD. Experiments in young adult animals were performed on out bred 
male Wistar rats at 4-6 weeks of age. Animals were killed humanely with an overdose of 
ether anaesthetic. In experiments where animals were perfused prior to dissection, rats 
were anaesthetised with an intraperitoneal injection of ketamine and rompun ( 44 and 8 
mg/kg, respectively). All experiments were conducted in line with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes, under a protocol 
approved by the Animal Experimentation Ethics committee of the Australian National 
University. 
2.2 BLOOD PRESSURE RECORDINGS 
Systolic blood pressure was recorded using the non-invasive tail cuff method 
(HyperRat, SDR Clinical Technology, Australia). SHR (n=4-15 animals) and WKY rats 
(n=4-8 animals) were acclimatized to the method of restraint over a period of 1 week prior 
to measuring blood pressure. In this time, animals were handled frequently and were 
placed on a heated base plate for periods of 30 min. For blood pressure recordings, animals 
were restrained on a base plate heated to 35-40°C and allowed to acclimatize for 
approximately 15 min before reading commenced (Mangos et al. 1999). Blood pressure 
measurements were recorded for each animal at weekly intervals beginning at 4 weeks of 
age until 14 weeks. Each experiment was carried out between 1000 and 1200 h and 
animals were restrained for maximum periods of 45 min. Blood pressure was not measured 
at ages less than 4 weeks owing to the variability of readings in very young animals using 
this technique. For each animal, four readings within 10 mmHg were obtained and used to 
determine mean systolic blood pressure. 
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2.3 ARTERIAL PREPARATIONS 
Four different arteries were examined, the thoracic aorta, caudal artery, primary 
mesenteric artery and the basilar artery. The thoracic aorta was dissected from the aortic 
arch to the diaphragm. The caudal artery was dissected from the base of the tail extending 
two thirds along its length. Primary mesenteric arteries supplying the upper ileum, were 
dissected free of the superior mesenteric artery and secondary mesenteric arteries. The 
basilar artery was dissected fro1n the vertebral arteries to the Ci_rcle of Willis . 
2.4 mRNA EXPRESSION FOR CONNEXINS IN RAT BLOOD VESSELS 
2.4.1 Extraction of RNA 
Messenger RNA was extracted from intact thoracic aorta and caudal arteries 
dissected from 4-5 week old Wistar rats and 3 and 12 week old WKY and SHR. Vessels 
were rapidly dissected into cold phosphate buffered saline (PBS), cleaned of adherent fat 
and stored in RNAlater (Ambion, USA) before being homogenized in cold RNAzol B (Tel-
test Inc., USA) for RNA extraction according to the manufacturer' s instructions. RNA was 
precipitated from the aqueous phase using isopropanol and the pellet washed with 75% 
ethanol. Any contaminating genomic DNA was removed from the total RNA using the 
MessageClean Kit (GenHunter Corp., USA) following the manufacturer' s instructions. 
Alternatively, vessels were rapidly frozen in liquid nitrogen and ground into a fine powder. 
RNA was extracted using the RNeasy RNA extraction kit (QIAGEN, USA), incorporating 
deoxyribonuclease I (DNase I) treatment for removal of genomic DNA. Four separate 
RNA extractions were prepared for each arterial type. The amount and purity of RNA was 
determined by optical density readings at 260, 280 and 320 nm. 
2.4.2 Complementary DNA (cDNA) synthesis 
Messenger RNA was reverse transcribed (42°C for lh, 50°C for lh, 90°C for 10 
min) in the presence of oligo dT primers (100 ng/µl , Stratagene, USA) and reverse 
transcriptase (200 U/µl, GIBCO BRL, USA). For each sample, a separate reaction was 
performed without the presence of reverse transcriptase enzyme to control for any residual 
geno1nic DNA contamination. 
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2.4.3 Cloning of vascular connexins 
Fragments of Cxs 37, 40, 43 and 45 cDNA were amplified from 4-6 week old 
Wistar thoracic aorta samples using a capillary thermal cycler (Corbett Research, 
Australia). Reacti_ons were performed in triplicate in a total reaction volume of 20 µl, each 
containing 100 ng of cDNA sample, 1 X PCR reaction buffer containing 1.5 mM MgCh 
(Roche, Germany), 0.2 mM dNTP mix, 1.2 µM of each primer and 1 U of Taq DNA 
polymerase (Roche, Germany). Primers specific for Cxs 37, 40 and 43 were designed from 
published rat sequences (see Table 2.1). Since the rat sequence for Cx45 was not known, 
forward (5'-ACAAGAAGGCAGCTCGGAGCAA-3') and reverse (5'-
CAAGGAAGTCTGCTGCACACATA-3') primers were designed to be 100% homologous 
with published human, mouse and wolf sequences. These primers amplified a product of 
321 bp from rat caudal artery (annealing at 63°C for 10 sec, extension at 72°C for 35 sec), 
and this product was purified and sequenced using the ABI PRISM Dye Terminator Cycle 
Sequencing Ready Reaction Kit (Applied Biosystems, USA). The rat Cx45 sequence 
obtained was aligned with the published human, mouse and wolf sequences and found to be 
98% homologous to the corresponding mouse sequence and 93% homologous to the 
consensus sequence for the four species. New primers were designed specifically to the rat 
Cx45 sequence (see Table 2.1), and these were used to amplify a product of 132 bp. 
Products were amplified using the following conditions, 2 min at 95°C, 35 cycles of 10 sec 
at 95°C, primer annealing for 10 sec· at temperatures shown in Table 2.2, and primer 
extension at 72°C for the times shown in Table 2.2. Each experiment included control 
reactions containing no cDNA. PCR products for each primer set were pooled and run on a 
2% agarose gel to confirm a single product of the appropriate size. 
PCR products were purified using High Pure PCR Product Purification Kit 
(Boehringer Mannheim, Germany) according to manufacturer's instructions. PCR products 
were eluted in 50 µl of Milli Q water and concentration was estimated by running samples 
on a 2% agarose gel against markers of known concentration. Ligation reactions were 
performed using the pGEM-T Vector System (Promega, USA) according to manufacturer's 
instructions. Following ligation, samples were electroporated into TOP 10 F' Cells 
(Invitrogen, USA) and transformants were plated onto LB plates containing ampicillin (100 
µg/ml), isopropylthio-~-D-galactosidase (IPTG, 25 mg/ml) and 5-bromo-4-chloro-3indolyl-
~-D-galactoside (X-Gal, 25 mg/ml). Plates were allowed to incubate overnight at 37°C 
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Forward primer Reverse primer Product 
size 
Connexin 37 AGCTCTGCATCCAAGAAGCAGTA AGTTGTCTCTCAAGTGCCTTTGA 133 
Connexin 40 GGAAAGAGGTGAACGGGAAGATT CACAGCCATCATAAAGACAATGAA 238 
Connexin 43 GAGATGCACCTGAAGCAGATTGAA GATGTTCAAAGCGAGAGACACCAA 308 
Connexin 45 AACAGAAGGCAGCTCGGAGCAA CAAGGAAGTCTGCTGCACACATA 132 
18S CCAGTAGCATATGCTTGTCTCAA CGACCAAACCAACCATAACTGATT 112 
SP6-T7 CATACGATTTAGGTGACACTATAG TAATACGACTCACTATAGGG 100 (no insert) 
Table 2.1 Oligonuclotide primer sequences used in PCR reactions. 
Annealing Extension 
temperature time temperature time 
Connexin 37 60°C 10 s 72°c 35 sec 
Connexin 40 60°C 10 s 72°c 25 sec 
Connexin 43 65°C 10 s 72°c 25 sec 
Connexin 45 63°C 10 s 72°c 20 sec 
18S 61 °C 10 s 72°c 15 sec 
SP6-T7 50°C 10 s 72°c 45 sec 
Table 2.2 PCR thermocycling conditions. 
before being screened for successful transformants. Successful inse1iion of the PCR 
product into the plasmid disrupts part of the coding region for the ~-galactosidase enzyme, . 
resulting in the formation of white colonies, while blue colonies arise from plasmids 
without the inserted PCR product. Single white colonies were selected and the presence of 
the plasmid and the inserted PCR product was confirmed with PCR. These clones were 
then grown overnight at 37°C in Luria-bertani (LB) medium containing ampicillin (100 
µg/ml). Plasmid DNA was isolated and purified from cultures using the QIAprep miniprep 
kit (QIAGEN, USA) according to the manufacturer's instructions, and DNA was quantified 
using a spectrophotometer. Plasmid DNA was amplified to confirm the presence of only 
one insert, using primers specific for the SP6 and T7 sequences of the plasmid which flank 
the plasmid cloning site (see Table 1). Each reaction contained 5 pg/µl plasmid DNA, lx 
PCR reaction buffer (Roche, Germany) with 1.5 mM MgCb, 250 nM of each primer, 0.2 
mM dNTP mix and 1 U of Taq DNA polymerase (Roche, Germany) in a 20 µl reaction 
volume. Products were amplified using the following conditions, 2 min at 95°C, followed 
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by 35 cycles of 10 sec at 95°C, 10 sec at 50°C, 45 sec at 72°C. 
2.4.4 Real time - polymerase chain reaction 
Quantitative real time PCR of cDNA samples _obtained from thoracic aorta and 
caudal arteries was performed using the Applied Biosystems ABI Prism 7700 sequence 
detection system and SYBR green core reagents kit (Applied Biosystems, USA). Reactions 
w~re performed in duplicate in a total reaction volume of 25 µl, each containing 50 ng of 
cDNA sample or 3 fold dilutions of plasmid standards. All samples were diluted in water 
containing tRNA (Sigma, USA, final concentration of 1 ng / reaction). Reactions contained 
IX SYBR green PCR buffer containing Passive Reference 1, 3 mM MgCb, 1.5 mM dNTP 
mix and 0.625 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, USA). 
Primers specific for Cxs 37, 40, 43 and 45 were used at a concentration of 800 nM (see 
Table 2.1 for primer sequences). Products were amplified using the following conditions, 
13 min at 95°C, to activate the AmpliTaq Gold DNA polymerase, followed by 40 cycles of 
15 sec at 95°C, primer annealing for 15 sec at temperatures shown in Table 2.3, and primer 
extension at 72°C for the times shown in Table 2.3. Each experiment included control 
reactions containing no enzyme or no cDNA, and RNA samples that had not been reverse 
transcribed, to test for amplification of genomic DNA. Increases in PCR product present in 
each sample were measured in the real time PCR system as increases in SYBR green 
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Annealing Extension 
te111perature time 
Connexin 37 60°C 60 sec 
Com1exin 40 60°C 60 sec 
Connexin 43 65°C 85 sec 
Connexin 45 63°C 60 sec 
18S 61 °C 60 sec 
Table 2.3 Real-time PCR thermocycling conditions. 
fluorescence. The threshold cycle (Ct) value calculated by the sequence detection software 
is defined as the cycle number when fluorescence was first detected above background. 
PCR products for each primer set were run on 2% agarose gels to confirm the presence of a 
single band. 
Quantification of samples was achieved after constructing standard curves using 
plasmid preparations containing each of the cloned PCR products. Standard curves were 
constructed in duplicate for each Cx by three-fold serial dilutions of the plasmid cDNA 
from 105 copies. The logarithm of the input plasmid cDNA concentration, as expressed in 
copy number, was plotted versus the mean Ct value obtained from the duplicate samples. 
In order to normalise samples for variations in RNA extraction, real-time PCR of tissue 
samples was performed using primers directed against a short segment of the 5' region of 
l 8S ribosomal RNA (see Tables 1 and 3 for primer sequences and thermocycling 
conditions respectively) and standard curves were constructed using plasmid preparations 
containing the cloned PCR product. The number of copies of each Cx was then expressed 
relative to l 8S ribosomal RNA. 
2.5 CHARACTERISATION OF CONNEXIN SPECIFIC ANTIBODIES 
2. 5.1 Antibodies 
Antibodies were raised in sheep against amino acids 266 to 281 of the C-terminus 
of rat Cx3 7 (Cx3 7 /266), amino acids 254 to 270 of the C-terminus of rat Cx40 (Cx40/254) 
and amino acids 354-367 of human Cx45 (Cx45/354, Coppen et al. 1998; Yeh et al. 1998; 
Yeh et al. 2000). This last peptide was 93% homologous to the mouse sequence while the 
rat sequence is unknown. Peptide sequence against which each of the above antibodies 
were generated are listed in Table 2.4. Antibodies were produced by the Institute of 
Medical and Veterinary Sciences, Adelaide, SA and affinity purified against the 
immunogenic peptides (Mimotopes Pty Ltd. , Australia). Antibodies against rat Cx43 were 
commercially raised in rabbits (Cx43/Zy, Zymed, USA) against an unknown peptide within 
the third cytoplasmic domain, and reactivity is independent of phosphorylation status. 
Commercial antibodies were raised in rabbits against amino acids 318-333 of mouse Cx37 
(Cx37/ADI), amino acids 340-358 of mouse Cx40 (Cx40/ADI). For Cx45 , antibodies 
raised in rabbits against amino acids 285-298 of mouse Cx45 (Cx45/ ADI, Alpha Diagnostic 
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Antibody Sequence origin Peptide sequence Host 
Cx37/266 Rat 266 YLPMGEGPSSPPCPTY 28 1 Sheep 
Cx40/254 Rat ~56 VQGLTPPPDFNQCLR 270 Sheep 
Cx45/354 Hu1nan 854 QA YSHQNNPHGPRE 367 Sheep 
Table 2.4 Peptide sequence for anti-connexin antibodies. 
International, USA), and amino acids 354-367 of human Cx45 (Cx45/Chem, Chemicon) 
were used. 
Specificity of Cx antibodies was subsequently determined in COS-7 cells 
transfected with DNA for each Cx and in tissues enriched for the expression of each Cx, 
using Western blotting and immunohistochemistry. 
2.5.2 Cell transfection 
I 
DNA encoding mouse Cxs 37, 40, 43, and 45 were a kind gift of Dr Klaus Willecke 
(Willecke et al. 1991; Hennemann et al. l 992a,b ). The regions encoding each Cx gene 
were individually subcloned into the eucaryotic expression vector pcDEF3 under the 
control of the human EF-la promoter as detailed by Goldman et al. (1996). Mouse and rat 
Cx genes share substantial identity and the regions encoding the antigenic determinants 
against .which the antibodies used in this work were raised are wholly conserved between 
these species. 
COS-7 cells were cultured in Dulbecco's Modified Eagle Medium Hl6 (DMEM) 
supplemented with 10% fetal bovine serum, penicillin (100 U mr1) and streptomycin (100 
µg mr1). COS-7 cells were harvested, counted and 1.8 x 107 cells were electroporated (960 
µF, 0.2 kV) in a 300 µl volume of DMEM using 25 µg plasmid DNA. Transfected cells 
were cultured at 3 7°C for 72 h then either prepared for immunohistochemistry or the 
membranes were harvested for Western blotting. 
2.5.3 Western blotting 
Transfected COS-7 cells were harvested, freeze-thawed, and centrifuged ( 600 x g, 
10 min, 4 °C). The supernatant was transferred into a clean tube and centrifuged (22,130 x 
g, 30 min, 4 °C) and the membrane-enriched pellet was aliquoted and stored at -20°C. 
Aliquots of transfected COS-7 cell membrane-enriched proteins (15 µg protein) were 
dissolved in lithium dodecyl sulfate (.LDS) sample buffer (2% LDS, 250 mM Tris-Cl, 10% 
glycerol, 2mM EDTA, pH 8.5) for 1 hat 37°C, then overnight at 4°C. The samples were 
separated by electrophoresis in bis-Tris polyacrylamide gels using 3-[N-
morpholino ]propanesulfonic acid (MOPS)-SDS running buffer and blotted onto 
nitrocellulose membranes according to the manufacturer's recommendations (In vitro gen, 
USA). Following transfer, blots were washed in PBS, blocked with 3% bovine serum 
albumin (BSA) and probed with sheep serum containing antibodies against Cx37 
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(1:100000, -Cx37/266), Cx40 (1:100000, Cx40/254) and Cx45 (1:100000, Cx45/354), or 
rabbit antibodies against Cx43 (1: 1000, Cx43/Zy, Zymed, USA). Specific binding was 
visualized using horseradish peroxidase-conjugated donkey anti-sheep IgG (1 :5000, 
Jackson ImmunoResearch Laboratories, USA) or goat anti-rabbit IgG (1 :5000, Sigma, 
USA,) and ECL chemiluminescence (Amersham Biosciences, UK). 
To confirm specificity, each antibody was incubated at 37°C for 1 h, then overnight 
at 4 °C, with a 2-fold molar excess of the peptide against which the antibody was raised. 
The blocked antibody was then used in Western blotting detection as described above. 
Brain, heart, liver, lung, thoracic aorta and caudal arteries were removed from 5-6 
week old Wistar rats and snap frozen in liquid nitrogen. Tissues were ground under liquid 
nitrogen in a mortar and pestle and resuspended in 1ml of lysis buffer (1 mM NaHCO3 pH 
7 .05, 10 mM EDTA, 10 mM iodoacetamide, 10 mM tetra-sodium pyrophosphate, 1 mM 
PMSF and 1 µg/ml each of antipain, aprotinin, pepstatin-A, chymostatin and leupeptiIJ.). 
Tissues were further disrupted by grinding in a polytron blender. Unbroken cells and large 
debris were removed by centrifugation at 1000 g for 5 mins at 4°C, the supernatant was 
then removed and centrifuged at 3000 g for 5 mins. The pellet was discarded and the 
supernatant centrifuged at 20000 g for 15 mins at 4°C. The supernatant was discarded and 
the membrane-enriched pellet was resuspended in lysis buffer. Protein concentration was 
measured using the Bio-Rad protein assay kit. 
Membrane-bound connexins were subsequently solubilized by incubation in 2X 
SDS sample buffer (5% SDS, 125 mM Tris-Cl (pH 6.8), 20% glycerol, 2 mM ~-
mercaptoethanol, 0.1 % (w/v) bromophenol blue) for 60 mins at 37°C. Aliquots containing 
5 µg of protein were separated by SDS-PAGE on 12% polyacrylamide gels, using Rainbow 
molecular weight markers (Amersham Biosciences, UK), and blotted onto Immobilon-P 
membranes (Millipore, USA). Blots were probed with sht.:ep antibodies against Cxs 37 
(1: 1000, Cx37 /266), 40 (1: 1000, Cx40/254) and 45 (1 :500, Cx45/354), rabbit anti-Cx43 
(1: 1000) and the commercial rabbit anti-Cx37 (1:300, 1: 1000) and anti-Cx45 (1 :500). 
Western blots were developed using horse-radish peroxidase-conjugated donkey anti-sheep 
IgG (1 :4000, Jackson ImmunoResearch Laboratories, USA) or goat anti-rabbit IgG 
(1: 10000, Sigma), and ECL chemiluminescence reagents (Amersham Biosciences, UK) 
according to the manufacturer ' s instructions. To confirm specificity, antibodies were 
incubated at 3 7°C for 1 h, then overnight at 4 °C, with a 10-fold excess by weight of the 
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peptide against which the antibody was raised. The blocked antibody was then used in 
Western blotting detection as described above. 
Identification of phosphorylated Cx43 isoforms was performed in samples of 
thoracic aorta, caudal artery and heart tissue, lysed in RIPA buffer (l 50mM NaCl, 1 % 
NP40, 0.25% deoxycholic acid, 0.1 % SDS, lmM EDTA containing lmM PMSF and 20 
µg/ml each of leupeptin, aprotinin, pepstatin, antipain and chymostatin accoq:ling to the 
method of Nagy et al. (1997). The phosphatase inhibitors NaF (l0mM) and sodium 
orthovanadate ( 1 0mM) were added to several samples of each tissue in order to compare 
the level of phosphorylation between samples. For dephosphorylation, samples were 
treated with calf intestinal alkaline phosphatase (CIP, Boehringer Mannheim, Germany) at 
a concentration of 1 U/µg tissue. Samples containing CIP were incubated at 37°C for 30 
mins prior to solubilisation of all proteins in 2X SDS sample buffer. Samples (10 µg 
protein) were separated by SDS-P AGE on 8% polyacrylamide gels and blotted onto 
Immobilon-P membranes (Millipore, USA). Protein was detected using rabbit anti-Cx43 
antibodies (Zymed, USA) at a concentration of 1: 1000. Blots were developed using an 
ECL kit (Amersham Biosciences, UK) as describe above. 
2.5.4 Immunohistochemistry 
The specificity of Cx37 /266 and Cx45/354 antibodies was determined in rat lung 
and ventricular endocardium respectively, tissues known to express each Cx. Tissues were 
removed and impregnated with 30% sucrose in phosphate buffered saline (PBS) before 
freezing in Cryo-M-Bed (Bright Instrument Company Ltd., England). 10 µm thick 
cryosections were cut for each tissue and mounted on slides coated with either 2% gelatin 
or 2% silane (3-aminopropyltrithoxysilane ). Tissues were pre-incubated for 30 mins in a 
blocking solution of 2% (w/v) BSA, 0.2% (v/v) Triton-X in PBS, followed by incubation 
for 1 hat room temperature in Cx37/266 (1 :250) for lung sections or Cx45/354 (1:500) for 
ventricle sections, diluted in blocking buffer. After washing in PBS, tissues were incubated 
for 1 h at room temperature with Cy3-conjugated anti-goat immunoglobulins (1: 100, 
Jackson ImmunoResearch Laboratories, USA) in 0.01 % (v/v) Triton-X in PBS. Lung 
sections were subsequently incubated for 1 h at room temperature with rabbit anti-human 
von Willebrand factor polycolonal antiserum (anti-vWF, 1 :300, Dako, Denmark) to 
specifically detect endothelial cells, followed by washes in PBS and then incubation in 
swine anti-rabbit fluorescein iso-thiocyanate (FITC) (1 :40, Dako, Denmark), for 1 h at 
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room temperature. All sections were washed 1n PBS pnor to mounting 1n buffered 
glycerol. 
2.6 PROTEIN EXPRESSION FOR CONNEXINS IN RAT BLOOD VESSELS 
2.6.1 Tissue preparation 
The thoracic aorta and caudal arteries from 4-5 week old Wistar rats, and 3 and 12 
week old WKY and SHR rats were prepared for immunohistochemical examination of the 
smooth muscle and the endothelium as tissue sections or . as whole mount preparations 
respectively.- Primary mesenteric and basilar arteries were also prepared from 3 and 12 
week old WKY and SHR rats for whole-mount examination of the ·endothelium. 
Tissue sections. To obtain tissue for cryosectioning, animals were anaesthetised 
with ether and killed by cervical dislocation. The thoracic aorta and caudal arteries were 
removed and impregnated with 30% sucrose in PBS before freezing in Cryo-M-Bed (Bright 
Instrument Company Ltd., England). 10 µm thick cryosections were cut transversely or 
longitudinally for each vessel and mounted on slides coated with 2% silane (Sigma, USA). 
Whole mount preparations. To obtain tissue for en face examination of the 
endothelium, animals were anesthetized by intraperitoneal injection of ketamine / rompun 
( 44 and 8 mg/kg respectively) and perfused via the left ventricle at a pressure of 60 mmHg, 
with 0.9% (w/v) NaCl containing 0.1 % (w/v) NaNO3, 0.1 % (w/v) BSA and 5 U/ml heparin 
at 25°C. The right atrium was cut in order to allow an outflow of perfusate. Once cleared 
of blood, animals were perfused with 2% (w/v) paraformaldehyde in 0.1 M sodium 
phosphate buffer. The thoracic aorta, caudal artery, primary mesenteric artery and basilar 
artery were removed into PBS, cut into 5 mm long segments, cut open longitudinally and 
pinned flat on Sylgard (Dow Corning, USA). 
2. 6.2 Immunohistochemistry 
Cryosections and whole-mount tissues were pre-incubated for 30 mins in a blocking 
solution of 2% (w/v) BSA, 0.2% (v/v) Triton-X in PBS, followed by incubation in Cx37, 
Cx40, Cx43 or Cx45 antibodies, diluted in blocking buffer. Cryosections were incubated in 
primary antibody solution (1:250 for Cx37/266, Cx37/ADI, Cx40/254, Cx40/ADI and 
Cx43, 1 :500 for Cx45/354) for 1 h at room temperature, while whole-mount tissues were 
incubated in primary antibody solution (1 : 100) for 2 hs at 37°C. After washing in PBS, 
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tissues were incubated for 1 h at room temperature with Cy3-conjugated anti rabbit or anti-
goat immunoglobulins (1:100, Jackson ImmunoResearch Laboratories, USA) in 0.01% 
(v/v) Iriton-X in PBS. Some tissue samples were subsequently incubated for 1 h at room 
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temperature with rabbit anti-human von Willebrand factor polycolonal antiserum (anti-
vWF, 1:300, Dako, Denmark) to specifically detect endothelial cells. Other samples were 
labelled with rabbit anti-chicken gizzard smooth muscle myosin (1: 100, kindly supplied by 
U. Groschel-Stewart), at room temperature for 1 h, to specifically label smooth muscle 
cells. After washing in PBS, tissues were incubated in swine anti-rabbit FITC (1 :40, Dako, 
Denmark), for 1 h at room temperature, washed and mounted in buffered glycerol. 
To test the specificity of each antibody, tissues were incubated either without 
primary antibody or with primary antibody that had previously been pre-incubated for 1 h at 
room temperature with a 10-fold excess by weight of the peptide against which the 
antibody was raised. 
2. 6.3 Con/ ocal microscopy 
All immunolabeled tissues were viewed using a Leica confocal laser scanning 
microscope (TCS 4D, Leica Instruments, Austria), equipped with an argon/krypton laser 
and fitted with the appropriate filters for the detection of Cy3 and FITC fluorescence. 
Optical sections of smooth muscle and endothelial cell layers were simultaneously obtained 
for both Cy3 (Cx staining) and FITC (anti-vWF staining or a-smooth muscle myosin) 
labels. For tissue sections, optical sections were collected at 1 µm intervals throughout the 
section thickness, while for whole mount tissue optical sections were collected at 1 µm 
intervals throughout the endothelial cell layer as determined by the extent of the anti-vWF 
labelling. Care was taken to maintain similar gain settings for comparisons of antibody 
staining between vessels. Each series of images was recombined to create a single image 
incorporating all smooth muscle or all endothelial cell labelling. For each vessel, images 
from 3 different fields were obtained for analysis and samples taken from 4 different 
animals. Cx labeling in the media was visualized using a higher zoom factor than that was 
required to view Cx labelling in the endothelium. 
2.6.4 Morphometric analysis 
Morphometric measurements of endothelial cell parameters and Cx expression 
within the endothelium and smooth muscle were made using the AIS imaging system 
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(Analytical imaging station, version 1.0, Imaging Research, Canada). Endothelial cells 
labelled for Cx37 were used to determine cell length, width, area and perimeter. Cx 
expression was quantified by first measuring the average size of the smallest labelled 
structures in each preparation and defining these as individual gap junctional plaques. The 
size of individual plaques was used in the grain counting function to determine the number 
of Cx plaques per square micrometer of smooth muscle or endothelium. Using this 
method, underestimation of plaque number in areas containing closely adjacent plaques is 
minimized. However, the method would overestimate the number of plaques if plaque size 
actually did vary significantly. By use of the endothelial cell parameters, counts were 
adjusted to give the number of plaques per endothelial cell and subsequently the number of 
plaques per 100 µm of endothelial cell perimeter. In the case of the smooth muscle cells, 
Cx expression was defined as the number of plaques per square micrometer of transverse or 
longitudinal medial area, because identification of individual cells in the multilayered 
media was not possible. For Cx expression in the smooth muscle, sections double labelled 
with vWF were used to ensure endothelial staining was not included. All analyses were 
performed on the recombined images of the endothelial and smooth muscle cells. In 
immunofluorescent studies, it should be noted that a number of different factors preclude 
comparisons of expression levels of proteins labelled with different antibodies. These 
factors include the affinity of primary antibody, saturation of the antibody signal and the 
effects of steric hindrance in cases where proteins are co-expressed (Severs et al. 2001 ), all 
of which may affect the intensity of the fluorescent signal. Therefore throughout this 
thesis, comparisons of immunofluorescent signals have been made predominately between 
vessels -labelled with a particular Cx antibody rather than comparing the intensity of each 
antibody in one tissue . 
. 2.7 STRUCTURAL CHARACTERISTICS OF RAT BLOOD VESSELS 
2. 7.1 Electron microscopy 
12 week old male WKY and SHR rats were anaesthetized with an intraperitoneal 
injection of ketamine and rompun ( 44 and 8 mg/kg, respectively) and perfused at a pressure 
of 60 mmHg with 0.9% NaCl containing 0.1 % NaNO3, 0.1 % BSA and 5 units/ml heparin at 
25°C, and then with 3% glutaraldehyde and 1 % paraformaldehyde in 0.1 M sodium 
cacodylate buffer for 10 min at room temperature. A portion of the thoracic aorta, caudal, 
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primary mesenteric and basilar arteries were removed and further immersion fixed at 4 °C 
for 1.5 h. Vessels were subsequently cut into 2 mm longitudinal segments, postfixed in 2% 
osmium tetroxide in 0.1 M sodium cacodylate buffer for 2 h, stained with saturated aqueous 
uranyl acetate for 2 h and embedded in Araldite 502 according to conventional procedures. 
Random sections were collected on Formvar (ProSciTech, Australia) and ,..., 10 nm carbon 
coated slot grids. Montages of electron micrographs taken on a Hitachi 7000 electron 
microscope (X2,500) were digitized and analysed for lumen diameter, the number of 
smooth muscle cell layers and medial cross-sectional area using methods similar to those 
previously described by Sandow et al. (2002). Vessel circumference was estimated as the 
length of the internal elastic lamina (IEL). Vessels circumference was then used to 
determine diameter at the level of the IEL. The number of medial smooth muscle cell 
layers was determined by averaging the number of smooth muscle cells from the outer edge 
of the IEL to the inner edge of the external elastic lamina along four linear plots 90° apart. 
The medial-cross sectional area was determined using the MCID imaging system (Imaging 
Research, Canada). 
In control experiments, SHR caudal arteries were perfused at high pressure ( 160 
mmHg) and vessel morphology was examined to determine the effect of different perfusion 
pressures on morphological data in the SHR. Results of these experiments showed no 
change in the number of medial smooth muscle cell layers, the luminal diameter or the area 
of endothelial cells when compared to vessels prepared by perfusion at 60 mmHg ( data not 
shown). These results are similar to those obtained in mesenteric arteries from WKY and 
SHR rats perfused at different pressures (Owen et al. 1988). 
2.8 FUNCTIONAL CHARACTERISTICS OF RAT BLOOD VESSELS 
2.8.1 Wire myography 
Endothelium-dependent relaxation was assessed in caudal arteries of the WKY and 
SHR at 12 weeks of age, using a Mulvany-Halpern type myograph (Mulvany & Halpern, 
1977; Sandow et al. 2003b). Ring segments, 1 mm in length, were mounted on two 40 µm 
diameter tungsten wires, secured between two supports, attached to either a micrometer 
screw or a force transducer. Vessels were continuously superfused with Krebs ' solution (in 
mM, NaCl, 120; KCl, 5.0; NaHCO3, 25.0; NaH2PO4, 1.0; CaCb, 2.5; MgCb , 2.0; glucose, 
22.0) gassed with 95% 0 2, 5% CO2 and maintained at 33-34 °C (Hill et al. 1999). 
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Following an equilibration period of 30 min, vessels were stretched 1n increments until 
their tension was equivalent to 80 mmHg (Mulvany & Halpern, 1977). Following a further 
10 min equilibration period, vessels were pre-constricted with phenylephrine (2.5 to 6 µM) 
to achieve a constriction of approximately 60% of maximal constriction, equivalent to 0.85 
g of tension. A single concentration of A Ch (1 µM) was added to the superfusate to assess 
endothelial integrity. Vessels displaying relaxations of 40% or greater of the maximal 
constriction to phenylephrine were used for subsequent experiments. Data was recorded 
using a MacLab chart recorder (ADinstruments, USA) and results were expressed as % 
relaxation of phenylephrine-induced constriction. Cumulative dose-response curves to 
ACh were performed in the presence and absence of Nw-nitro-L-arginine methyl ester 
hydrochloride (L-NAME, 100 µM) and indomethacin (10 µM), inhibitors of nitric oxide 
synthase and prostaglandins respectively. Basal nitric oxide was inhibited using the nitric 
oxide scavengers, hydroxocobalamin (100 µM) and carboxy-PTIO (100 µM). The role of 
B/I and S conductance Kea channels was examined using specific inhibitors, charybdotoxin 
(60 nM) and apamin (0.5 µM) respectively. In other experiments, gap junction antagonists 
18~-GA (20 µM) and Cx-mimetic peptides (43Gap26, 40Gap27 and 37'43Gap 27, 100 µM 
each in combination; purity >95%) were dissolved in the superfusate before addition of a 
single dose of ACh (1 µM). Cx-mimetic peptides were dissolved in the physiological 
saline and recirculated for 60 min before addition of ACh. Recirculation for a period of 60 
min was found to have no effect on endothelium-dependent responses to a single 
concentration of ACh .. In control experiments, responses to ACh were examined in the 
presence of indomethacin and Cx-mimetic peptides, before and after the addition of L-
NAME. All other experiments were performed in the presence of L-NAME and 
indomethacin. 
2.8.2 Electrophysiology 
Intracellular recordings of membrane potential were examined in caudal arteries 
obtained from 12 week old WKY and SHR. Arterial segments were pinned flat in a 
Sylgard coated recording chamber and superfused with Krebs' solution, gassed with 95% 
02, 5% CO2. Membrane potential of smooth muscle cells was measured using fine glass 
microelectrodes (120-220 MO) (Flaming Brown micropipette puller, Sutter Instrument Co. 
USA) filled with 0.5 M KCl as previously described (Hill et al. 1999). Membrane potential 
was recorded using an Axoclamp 2B (Axon Instruments, USA) . A sharp decrease in 
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membrane potential of 20 to 40 m V indicated a successful impalement. Identification of 
impaled cells was determined using electrodes filled with 10% FITC conjugated-dextran 
(FITC-dextran, 3000 MW) or 3% Lucifer yellow, backfilled with 0.5 M KCl or LiCl 
(Sandow et al. 2002; Coleman et al. 2001 ). At the conclusion of each experiment, vessels 
were fixed in 4% paraformaldehyde in PBS, mounted in buffered glycerol and 
photographed with a Nikon Coolpix 950 digital camera on a compound microscope. 
In experiments examining smooth muscle cell coupling, bipolar electrodes placed 
on either side of the vessel were used to stimulate perivascular nerves. Smooth muscle 
cells were impaled at the adventitial border of the blood vessel, the surface closest to the 
perivascular nerve terminals, or immediately below the luminal surface, several cells away 
from the nerve terminals. Recordings at the luminal surface were obtained by the removal 
of side branches from the surface of the artery allowing the electrode to be advanced 
through the hole in the vessel wall through the exposed endothelium. Excitatory junction 
potentials (EJPs) were recorded following a single neural stimulus of 0.1 ms pulse width, 
delivered by a DS2 isolated stimulator (Axon Instruments, UK). Stimulus strength was 
increased until a maximal response was achieved. In each experiment, amplitude, rise time 
. (10 to 90 % of the peak amplitude) and time constant of decay ofEJPs were measured. 
Endothelium-dependent smooth muscle cell hyperpolarization was determined by 
impaling cells at the adventitial border of the caudal · artery. Cumulative dose-response 
curves to ACh were performed in the presence and absence of L-NAME (100 µM) and 
indomethacin (10 µM). Vessels were incubated in the presence of L-NAME and 
indomethacin for 30 min prior to the addition of ACh. In other experiments ACh (1 M) 
was applied iontophoretically (200 nA, 10 s) in the presence of charybdotoxin ( 60 nM) and 
apamin (0.5 µM) or following the removal of the endothelium. Responses were also 
examined using iberiotoxin (100 nM), 18~-GA and hydroxocobalamin (100 µM) , inhibitors 
of BKca channels, gap junctions and basal NO, respectively. 
2.8.3 Conducted hyperpolarization and vasodilation 
The conduction of EDHF-mediated smooth muscle cell hyperpolarisation was 
determined in the mesenteric artery of the 12 week WKY and SHR. Following an 
equilibration period, smooth muscle cells were impaled at the adventitial border of the 
blood vessel and ACh (1 M) was applied iontophoretically (500 nA, 0.5 s) at the local site 
(0 mm), and at sites 0.5, 1, 1.5, 2 and 2.5 mm downstream. ACh induced hyperpolarization 
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was recorded in smooth muscle cells impaled at the local site. In some experiments, 
vessels were incubated in barium (Ba2+, 30 µm) for 15 minutes, prior to recording ACh 
induced hyperpolarization in order to examine the role of inwardly rectifying potassium 
channels (K1R) in the conducted response. In all experiments, vessels were incubated in the 
presence of L-NAME (100 µM) and indomethacin (10 µM) for 40 min prior to the addition 
of ACh. Identification of impaled cells was determined using electrodes filled with 0.2% 
propridium iodide. 
In separate experiments, arterial segments were pinned flat using the outer 
connective tissue layer in a Sylgard coated recording chamber and superfused with Krebs' 
solution, gassed with 95% 02, 5% CO2. Following an equilibration period, vessels were pre-
constricted with phenylephrine (1 o-6 M), to achieve a · standardised constriction of 
approximately 60% of maximal constriction in all vessels, and ACh (1 M), was 
iontophoreticlly applied at the local site and at sites 0.5, 1, 1.5 and 2 mm downstream. 
Changes in vessel diameter in response to ACh were recorded at the local site, using the 
edge-tracking program, DIAMTRAK (T.O. Neild, Flinders University, Australia). ACh · 
induced relaxation was also recorded in the presence and absence of Ba2+. Data was 
expressed as % change in relaxation. In control experiments, responses to ACh were 
examined as the iontophoretic pipette was moved away from the surface of the vessel in 0.1 
mm steps, to as distance of 0'.5 mm. These experiments were performed to ensure that 
responses were not due to diffusion of ACh from the iontophoretic pipette to the recording 
site. The flow of superfusate along the vessel was in the opposite direction to the recording 
electrode. All experiments were performed in the presence of L-NAME (100 µM) ahd 
indomethacin (10 µM). 
2.9 STATISTICAL ANALYSIS 
Results are expressed as the mean + the standard error of the mean (SEM). For 
immunohistochemical experiments, data from the individual fields was used to calculate a 
mean for each animal. Statistical significance was tested using one way analysis of 
variance followed by t-tests using Bonferroni correction for multiple groups. A P value of 
<0.05 was taken as significant. 
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2.10 DRUGS, CHEMICALS AND SOLUTIONS 
All drugs and chemicals used are listed below. ACh, apamin, ampicillin, carboxy-
PTIO, charybdotoxin, hydroxocobalamin, iberiotoxin, indomethacin, Lucifer yellow, 
phenylephrine and 18~-GA were purchased from Sigma, USA. Cx-mimetic peptides, 
43Gap26 (VCYDKSFPISHVR), 40Gap27 (SRPTEKNVFIV), '37'43Gap27 (SRPTEKTIFII) 
(Chaytor et al. 2001) were synthesised and purified by the Biomolecular Resource Facility, . 
John Curtin School of Medical Research. L-NAME was purchased from Sapphire 
Bioscience Pty Ltd., (Australia). IPTG was purchased from Astral Scientific (Australia), 
X-Gal was obtained from Progen Industries Pty Ltd., (USA). FITC-dextran was purchased 
from Molecular Probes Inc., (USA). All other reagents used were of standard analytical 
grade. 
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CHAPTER3 
CHARACTERISATION OF CONNEXIN ANTIBODIES 
3.1 INTRODUCTION 
As discussed in a recent review by Severs et al. (2001 ), the use of improperly 
characterised antibodies can lead to the misinterpretation of immunohistochemical data. 
For example, previous studies using a commercially available Cx45 antibody (Kanter et al. 
1992; Davis et al. 1995; Verheule et al. 1997), described extensive expression of Cx45 
throughout the ventricular myocardium in a pattern similar to Cx43. In contrast, using a 
fully characterised Cx45 antibody directed against amino acids 354-367 of human Cx45, 
Coppen et al. (1998) demonstrated highly localized expression of Cx45 in the sinoatrial 
node (SA) of the rat and mouse heart. This area was also Cx40 positive (Bastide et al. 
1993; Coppen et al. 1998), while Cx43 was restricted to cells located at the periphery of 
the SA node and in surrounding atrial myocytes (Coppen et al. 1998, 1999; Honjo et al. 
2002). Cx45 was also detected in the atrioventricular node and His bundle of the rodent 
heart (Coppen et al. 1999), but was absent from ventricular myocytes (Coppen et al. 1998; 
Vozzi et al. 1999), where Cx43 was expressed extensively (Coppen et al. 1998, 1999; 
Vozzi et al. 1999). Coppen et al. (1998) further demonstrated that the commercial Cx45 
antibody used in the earlier studies cross-reacted with Cx43 and thus resulted in the 
apparent widespread distribution of Cx45 in the ventricular myocardium. It was 
subsequently shown that an identical 4 amino acid sequence motif was present in the 
epitopes that were recognised by both the commercial Cx45 and Cx43 antibodies. 
Furthermore, when the commercial Cx45 antibody was pre-incubated with an immunogenic 
peptide encompassing the Cx43 peptide sequence, Cx45 staining was completely abolished 
(Coppen et al. 1998). These data therefore highlight the problems associated with 
incompletely characterised antibodies. · 
Since immunohistochemical analysis forms the basis for the protein studies carried 
out in this thesis, the antibodies used here have been specifically characterised to avoid the 
problems alluded to above. Once specificity was demonstrated, Cx antibodies have been 
used to assess Cx distribution within rat blood vessels, results of which will be presented in 
subsequent Chapters. For Cxs 37, 40 and 45, purified antibodies were obtained by affinity 
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chromatography of the serum of sheep that had been immunized with synthetic peptides 
specific for each Cx. Previous researchers have used these peptide sequences to develop 
Cx isotype specific antibodies (Coppen et al. 1998; Yeh et al. 1998; Severs, 1999; Yeh et 
al. 2000). Affinity-purified antibodies are denoted as Cx37/266, Cx40/254 and Cx45/354 
corresponding to anti-Cx37, 40 and 45, respectively. Commercially available antibodies 
for Cxs 37 (Cx37/ADI), 40 (Cx40/ADI), 43 (Cx43/Zy) and 45 (Cx45/ADI and 
Cx45/Chem) were also tested. 
Western blotting and immunohistochemical studies were carried out using these 
antibodies to examine cells that had been transfected with plasmid DNA expressing each 
Cx isotype and in a range of rat tissues known to specifically express each Cx. The tissues 
chosen were rat heart, brain, lung, liver and thoracic aorta. Cx37 has previously been 
identified in rat heart, brain, lung and liver (Haefliger et al. 1992; Reed et al. 1993; 
Nakamura et al. 1999), Cx40 has been identified in the rat heart and lungs (Haefliger et al. 
1992; Beyer et al. 1992; Bastide et al. 1993), Cx43 in rat heart, brain and thoracic aorta ( el 
Aoumari et al. 1991; Kadle et al. 1991; Dupont et al. 1991) and Cx45 in rat heart, brain 
and lung (Coppen et al. 1998; Jacob & Beyer, 2001). 
3.2 RESULTS 
3.2.1 Transfected cells 
Immunohistochemistry. Immunolabelling was also performed on COS-7 cells that 
had been transiently transfected with plasmid DNA expressing either Cxs 37 (COS-Cx37, 
Figure 3.lA,F,K,P), 40 (COS-Cx40, Figure 3. lB,G,L,Q), 43 (COS-Cx43, Figure 
3.1 C,H,M,R) or 45 (COS-Cx45, Figure 3. lD,I,N,S) and in untransfected cells (Figure 3.2 
E,J,O,T) using Cx37/266, Cx40/254, Cx43/Zy and Cx45/354. Only transfectants 
expressing the Cx to which the antibody was directed were positively labelled (Figure 
3. lA-S). Cx labelling was found predominatly within the cytoplasm of each cell. 
Specificity of each antibody was confirmed by the absence of labelling in transfectants 
expressing the other Cx types. No labelling was detected for any Cx antibody in the 
untransfected cells (Figure 3.lE,J,O,T). Similarly, Cx37/ADI and Cx45/Chem labelled 
only transfected cells expressing Cx37 or Cx45, respectively (Sandow et al. 2003d). 
Western blotting. Western blotting analysis was performed on membranes of COS-
7 cells that had been transiently transfected with plasmid DNA expressing either, Cx37, 40, 
52 
Figure 3.1 
Figure 3.1. 
Characterisation of affinity-purified connexin (Cx) antibodies. COS-7 cells that 
had been transfected with plasmid expressing DNA for Cxs 37 (COS-Cx37, A,F,K,P) , 
40 (COS-Cx40, B,G,L,Q), 43 (COS-Cx43, C,H,M,R), and 45 (COS-Cx45, D,I,N,S), 
were labelled with antibodies specific for each Cx (Cx37/266, A-D; Cx40/254, F-I; 
Cx43/Zy, K-N; Cx45/354, P-S). Only transfectants expressing the Cx to which the 
antibody was directed were positively labelled (COS-Cx37, A; COS-Cx40, G, COS-
Cx43, M; COS-Cx45, S). Specificity of each antibody was confirmed by absence of 
labelling in transfectants expressing the other Cx types, and by the absence of labelling 
in untransfected cells (E,J,O,T). Calibration bar represents 20 µm. 
Cx37/266 Cx40/254 Cx43/Zy Cx45/354 
43 or 45 (COS-Cx37, COS-Cx40, COS-Cx43 and COS-Cx45, respectively, Figure 3.2A-
D). Cx37 /266-antiserum recognised two bands, corresponding to the expected sizes of the 
phosphorylated and non-phosphorylated forms of the protein, in COS-Cx37 cells (Figure 
3 .2A, -control peptide). No specific bands were found in transfected cells expressing other 
Cx isotypes, nor following incubation of the antibodies with the appropriate immunogenic 
peptide (Figure 3.2A, -/+control peptide). Similarly, Cx37/ADI recognised two bands of 
the appropriate molecular weight, specifically in COS-Cx37 cells, which were blocked 
following i11:cubation ·with the appropriate immunogenic peptide (Figure 3 .2B, -/+ control 
peptide). Cx40/254-antiserum (Figure 3 .2C, -control peptide) recognised two specific 
bands at the appropriate mol~cular weight exclusively in transfected COS-7 cells 
expressing Cx40. Cx43/Zy revealed the presence of multiple isoforms of Cx43 in 
transfected cells expressing Cx43 (Figure 3.2D, -peptide). Cx45/354-antiserum (Figure 
3.2E, -control peptide) recognised one band at the appropriate molecular weight, in 
transfected cells expression Cx45. Labelling of these bands was abolished following 
incubation of the antibodies with the appropriate immunogenic peptide (Figures 3.2C, D, E, 
+control peptide). On Western blots, no bands specific for Cx45 were detected using 
Cx45/Chem to probe extracts of transfected cells expressing Cx45 (Figure 3 .2F, -/+control 
peptide). No specific bands were detected in transfected cells expressing Cxs other than the 
isotype against which antisera were raised (Figure 3 .2C,D,E, -peptide). 
3.2.2 Connexin specific tissues . 
Immunohistochemistry. When tested on sections of rat lung, Cx3 7 /266 showed 
that Cx37 was abundantly expressed within the endothelium of blood vessels throughout 
the lung, and within the smooth muscle layers of the bronchioles (Figure 3.3A). Staining 
was completely blocked by peptide (Figure 3.3B). Using Cx40/ADI, punctate labelling 
was observed in the media of the rat thoracic aorta. Staining of the rat ventricle with 
Cx45/ ADI and Cx45/354, revealed differences in the extent of labelling. Cx45/ ADI stained 
cardiac myocytes throughout the ventricular myocardium (Figure 3.3C), while Cx45/354 
only stained myocytes along the endocardial border (Figure 3.3D). 
Western blotting. Cx43/Zy revealed the presence of multiple isoforms of Cx43 in 
extracts of brain, heart and lung, but not in the liver. Higher molecular weight isoforms 
appeared to predominate in the heart (Figure 3.4A5 -peptide). All isoforms were blocked by 
pre-incubation of Cx43/Zy with immunogenic peptide (Figure 3.4A, +peptide). When 
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Figure 3.2 
Figure 3.2. 
Characterisation of Cx antisera by Western blotting. COS-7 cells transfected 
with plasmid DNA expressing Cxs 37, 40, 43 and 45, were labelled with antibodies 
specific for each Cx (Cx37 /266-antiserum, A; Cx37 / ADI, B; Cx40/254-antiserum, C; 
Cx43/Zy, D; Cx45/354-antiserum, E; Cx45/Chem, F). Arrows show the position of 
expected Cx bands. The left panel represents incubation with Cx antibody whereas the 
right panel represents pre-incubation of the antibody with the appropriate immunogenic 
peptide. Only transfectants expressing the Cx to which the antibody was directed 
showed a band of the correct molecular weight, as indicated by arrows in the -peptide 
panels. Specificity of each antibody was confirmed by the absence of specific bands in 
transfectants expressing the other Cx types, or in the presence of the appropriate control 
peptide (+peptide). 
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Figure 3.3 
Figure 3.3. 
Cx37 expression in the lung and Cx45 expression in the heart of 4 week old 
Wistar rat. (A) Sections of the rat lung were stained with Cx37 /266. Cx37 labelling is 
seen in the endothelium of blood vessels (bv) within the lung and in smooth muscle 
cells (arrows) of the bronchiole (br). (B) Cx37 labelling was abolished when the 
antibody is incubated in antigenic peptide prior to incubating with tissue. (C-D) Heart 
sections were incubated with Cx45/ADI (C) and Cx45/354 (D). Punctate staining with 
Cx45/ ADI was detected along the edges of cardiac myocytes throughout the ventricle 
(C), while Cx45/354 labelled Cx45 only along the endocardial border (D). Calibration 
bars represent' 10 µm. 
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Figure 3.4 
Figure 3.4. 
Tissue specific expression of Cx43. (A) Tissue extracts (5 µg) from rat brain, 
heart, lung, liver, caudal artery (CA) and thoracic aorta (ThA) were separated on 12% 
SDS PAGE gels and probed with Cx43/Zy. Unphosphorylated and phosphorylated (*) 
forms are indicated by arrows (- control peptide). All forms disappeared when the 
antibody was pre-incubated with the immunogenic peptide ( + control peptide). (B) 
Tissue extracts (10 µg) from rat heart, CA and ThA were separated on 8% SDS PAGE 
gels and probed with Cx43/Zy. Extracts were prepared in buffer either containing (first 
panel) or not containing (second panel) the phosphatase inhibitors sodium fluoride and 
sodium orthovanadate (NaF/PhI) or were incubated with alkaline phosphatase 
(AlkPhos, second panel). Higher molecular weight forms of Cx43 were removed by 
treatment of all three tissues with alkaline phosphatase. Prot Inh, protease inhibitor. 
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Figure 3.5. 
Western blotting of tissue extracts from rat brain, heart, lung and liver using 
Cx40/254 (A), Cx45/354 (B) and Cx45/ADI (C). Arrows show the position of the 
expected Cx bands. The left panels represent incubation wit~ Cx antibody whereas 
right panels represent pre-incubation of the antibody with immunogenic peptide. Lower 
molecular weight proteins that cross-react with the commercial Cx45 antibody are 
marked(*). 
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samples of heart, thoracic aorta and caudal artery were not treated with phosphatase 
inhibitor (Figure 3.4B, - NaF/PhI) or were treated with phosphates (Figure 3.4B, + Alk 
Phos), a shift in mobility towards the lower molecular weight form was found, confirming 
that the high molecular weight forms were phosphorylated Cx43 . 
Although Cx37/266 and Cx37/ADI worked well in immunohistochemistry, 
numerous bands were stained on Western blots of rat tissues, and the staining of these 
bands was unaffected when blots were probed with peptide-blocked antibody ( data not 
shown). Cx40/254 and Cx40/ADI also stained numerous bands on Western blots of rat 
lung and liver extracts, as did Cx45/354 and Cx45/ ADI in Western blots of brain, heart and 
lung extracts. In each case only a small number of bands disappeared when the antibodies 
were pre-incubated with immunogenic peptide (Figure 3.5A-C). Thus, Cx40/254 
specifically recognised a band of 40 kDa that was present in tissue from the lung, but not 
the liver (Figure 3 .5A, -/+peptide). In addition, the staining intensity of a 45 kDa band in 
extracts of lung tissue was reduced on blots probed with peptide blocked antibody. On the 
other hand, Cx40/ ADI cross reacted with Cx43 as evidenced by the appearance of bands on 
Western blots of brain tissue, that were equivalent in size to those stained with antibodies 
against Cx43 ( data not shown). Cx45/354 revealed the presence of a specific 45 kDa band 
in all tissues tested. A higher molecular weight band, which was blocked by peptide, was 
also present in brain extracts (Figure 3.5B, -/+peptide). In contrast, Cx45/ADI labelled a 
45 kDa band and also a lower molecular weight species in brain and heart extracts (Figure 
3.5C, asterisk). 
3.3 DISCUSSION 
COS-7 cells that had been transfected with plasmid DNA expressing either Cxs 37, 
40, 43 or 45 confirmed the specificity of Cx37 /266, Cx40/254, Cx45/354 affinity-purified 
antibodies and the commercially available antibodies Cx43/Zy, Cx37/ADI and Cx45/Chem. 
Antibodies to each Cx only labelled those cells that had been transfected with DNA 
. expressing the corresponding Cx, and this specific staining was blocked by pre-incubation 
of antibodies with the appropriate immunogenic peptide. The affinity-purified antibodies 
that were used in this study were raised against short synthetic peptides that were derived 
from the published sequences for each Cx. Antibodies against the same sequences have 
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been · shown previously to be subtype selective using Western blotting and 
immunohistochemistry of transfected cells (Coppen et al. 1998; Yeh et al. 1998; Yeh et 
al. 2000), as well as immunoelectron microscopy (Yeh et al. 1998). 
For Cxs 37, 40 and 45, two different antibodies directed against distinct epitopes 
within each Cx were used to examine expression of each of the Cxs in transfected cells as 
well as rat tissues. Immunohistochemical studies using Cx3 7 /266 specifically labelled 
transfected cells expressing Cx37 and also extensively stained the blood vessels and 
bronchioles of the lung, as previously described by Nakamura et al. (1999). However, 
while both antibodies labelled appropriate bands in Western blots of transfected cells, 
neither labelled any specific bands in Western blots of Cx3 7 enriched rat tissues. This may 
be due to the higher concentration of Cx3 7 protein in transfected cell extracts as compared 
to rat tissues. 
Cx40/254 detected a 40 kDa protein in Western blots of tissue samples, as well as in 
transfected cells expressing Cx40, in parallel to results previously published for an antibody 
directed to a similar amino acid sequence (Yeh et al. 1998). Cx40/ADI however, appeared 
to cross-react with Cx43 on Western blots of rat brain extracts and in immunohistochemical 
studies of the rat aorta, so its use was discontinued. 
Cx45/354 labelled a restricted area within the ventricular endocardium~ which is 
consistent with the studies of Coppen et al. (1998) who developed an antibody against the 
same epitope. Cx45/ ADI however, cross-reacted with Cx43, in the same pattern as that 
described by Coppen et al. (1998) using another commercial antibody directed against a 
similar epitope. Coppen et al. ( 1998) have elegantly identified the cross reacting peptide 
as residues 283 to 286 of Cx43. In contrast to Cx45/ ADI, Cx45/Chem is directed to the 
same amino acid sequence as Cx45/354. Using this antibody, specific 
immunohistochemical labelling was obtained in cells transfected with Cx45, but not in cells 
transfected with other Cx isotypes. However, this antibody did not detect specific bands for 
Cx45 on Western blots of transfected cell extracts. The reason for this discrepancy is 
unknown. 
Cx43/Zy stained a number of molecular weight bands which were confirmed here to 
represent unphosphorylated and phosphorylated Cx43 (see van Veen et al. 2001) . Using a 
similar antibody, Hossain et al. (1994) found no differences in immunohistochemical 
staining of brain tissues in which different relative amounts of these phosphorylated forms 
existed. Similarly, Western blotting and immunohistochemistry of transfected cells 
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expressing Cx43 showed specific labelling when probed with Cx43/Zy. Tissue specific 
distribution of the unphosphorylated and phosphorylated forms of Cx43 has been 
previously reported (Kadle et al. 1991 ). In the present study, the higher molecular weight 
phosphorylated forms predominated in extracts of the heart and thoracic aorta, while the 
lower molecular weight forms were more prevalent in extracts of the brain and caudal 
artery. Hossain et al. (1994) demonstrated that the predominance of the lower molecular 
weight forms in the brain was due to rapid dephosphorylation of Cx43. Since Cx43 in the 
caudal artery is restricted to the endothelium, while Cx43 in the thoracic aorta was 
predominantly expressed in the smooth muscle (see Chapter 4), differences in specific 
kinases or phosphatases may exist between these two tissues. 
In conclusion, the results of this Chapter have shown that Cx3 7 /266, Cx40/254, and 
Cx45/354 antibodies and the commercially available Cx43/Zy, Cx37/ADI and Cx45/Chem 
antibodies are isotype specific in both transfected cells and rat tissues. While working well 
in Western blots of transfected cells and for the immunohistochemistry of transfected cells 
and rat tissues, these antibodies, with the exception of Cx43/Zy did not work efficiently on 
Western blots of rat tissues. · Consequently, Cx37 /266, Cx40/254 and Cx45/354 affinity 
purified antibodies and the Cx43/Zy antibody were chosen for subsequent 
immunohistochemical examination of Cx protein expression in rat blood vessels, the results 
of which are presented in the following Chapters. 
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CHAPTER4 
EXPRESSION OF CONNEXINS IN THE MEDIA AND 
ENDOTHELIUM OF THE WISTAR RAT THORACIC AORTA AND 
CAUDAL ARTERY 
4.1 INTRODUCTION 
As discussed in Chapter 1, four Cx proteins, Cxs 37, 40, 43 and 45 have been 
identified in vascular tissue (see Severs, 1999; Krliger et al. 2000; Kumai et al. 2000). 
While three of the four vascular Cxs have been shown to be expressed by endothelial cells 
of most vessels (see Hill et al. 2001), the identity of the Cxs connecting adjacent smooth 
muscle cells in arteries is less clear. 
In large elastic arteries, such as the aorta, Cx43 is thought to be the major gap 
junctional protein expressed in the smooth muscle (Hong & Hill, 1998; Yeh et al. 1998; 
Nakamura et al. 1999; van Kempen & Jongsma, 1999). More recently, some studies have 
shown expression of other Cxs in addition to Cx43 in the media of elastic arteries, although 
some of these differences may be attributed to heterogeneity amongst animal species, in 
addition to questionable specificity of the antibodies used (Hill et al. 2001 ). For example, 
Cx40 has been shown in the aorta of the cow and pig but not the rat (van Kempen & 
Jongsma, 1999), while Cx37 has been reported in the pulmonary artery and aorta of the rat 
in some studies (Nakamura et al. 1999), but not in other studies (van Kempen & Jongsma, 
1999). 
In muscular arteries, identification of the major Cx isoform has been more difficult. 
Cx43 has not been found in the media of a number of large muscular arteries including the 
caudal, basilar, mesenteric and coronary. arteries (Hong & Hill, 1998; Bastide et al. 1993; 
Bruzzone et al. 1993; Gros et al. 1994; Yeh et al. 1997b), although it has been reported in 
pial and cremaster arterioles in rats and cheek pouch arterioles in hamsters (Little et al. 
1995). On the other hand, Cx40 appears to be a potential candidate in the media, having 
been identified in the coronary artery in a number of species (van Kempen & Jongsma, 
1999), in the basilar artery (Li & Simard, 1999), and in a number of different arterioles of 
rats and hamsters (Little et al. 1995; Arensbak et al. 2001; Haefliger et al. 2001 ). Recent 
data from our laboratory have, however, failed to confirm the results in hamster arterioles 
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(Sandow et al. 2003d). Cx45 is also receiving some · attention (Ko et al. 2001; Li & 
Simard, 2001), since its identification in arterial smooth muscle in embryonic and adult 
mice (Alcolea et al. 1999; Krtiger et al. 2000; Kumai et al. · 2000). On the other hand, 
Cx37 is generally considered to be an endothelial Cx, although it has been described in the 
media of the larger coronary arteries of the rat (van Kempen & Jongsma, 1999) and in the 
media of collateral vessels during coronary arteriogenesis in dogs (Cai et al. 2001 ). 
Considering the absence of a clearly identifiable Cx in the media of muscular 
arteries and the potential for some confusion due to non specificity of antibodies (see 
Chapter 3), in this Chapter, we chose to compare Cx expression at both mRNA and protein 
levels in a large muscular artery with expression in an elastic artery. For this purpose we 
have chosen the caudal artery and thoracic aorta, respectively. By using real time PCR, we 
have quantified mRNA expression in the two vessels and related this to protein expression 
using both immunohistochemistry and Western blotting. 
4.2 RESULTS 
4.2.1 Expression of mRNA for vascular connexins 
Quantification of mRNA expression of the vascular Cxs using real time PCR was achieved 
by constructing standard curves from the plasmid clones of the four Cxs and of l 8S RNA 
(see Figure 4.1 for Cx40). mRNA in the arterial samples was therefore expressed as Cx 
copy number and normalized to the number of copies of l 8S RNA. Data showed that in the 
thoracic aorta, expression of mRNA for Cx43 was significantly greater than mRNA 
expression for Cxs 37, 40 and 45 (P<0.05, Figure 4.2). In the caudal artery, expression of 
mRNA for Cx37 was significantly greater than expression of mRNA for Cxs 40, 43 , and 45 
(P<0.05 , Figure 4.2). Expression of Cx37 mRNA was also significantly greater in the 
caudal artery than in the thoracic aorta (P<0.05 , Figure 4.2), while mRNA for Cx43 was 
significantly greater in the thoracic aorta than in the caudal artery (P<0.05, Figure 4.2) . 
Expression of mRNA for Cx37 in the caudal artery was not significantly different from 
mRNA expression for Cx43 in the thoracic aorta. Expression of mRNA for Cxs 40 and 45 
were not significantly different between the two arteries (Figure 4.2). 
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Figure 4.1 
Figure 4.1. 
Amplification plot of serially diluted Cx40 plasmid cDNA, showing duplicate 
samples (A). Plasmid standard curve c9nstructed by plotting input plasmid cDNA copy 
number versus mean Ct value obtained from the duplicate samples (B). 
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Figure 4.2 
Figure 4.2. 
mRNA expression of Cxs 37, 40, 43 and 45 in the Wistar rat thoracic aorta and 
caudal artery. Copy numbers for each Cx are expressed per copy of 18S ribosomal 
RNA using plasmid standard curves. Values are mean± SEM. *P<0.05, significantly 
different from the caudal artery. tP<0.05, significantly different from Cxs 37, 40 and 
45 in the thoracic aorta. tP<0.05, significantly -different from Cxs 40, 43 and 45 in the 
caudal artery. n=4 separate RNA preparations. 
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Figure 4.3. 
Cx expression in endothelial cells of the Wistar rat thoracic aorta (ThA) (A-D) 
and caudal artery (CA) (E-H). The endothelium is viewed en face and is labelled with 
antibodies to Cx37 (A,E), Cx40 (B,F), Cx43 (C,G) and Cx45 (D,H). Labelling of Cxs 
37, 40 and 43 is evident along the perimeter of endothelial cells, while labelling of 
Cx45 was not detected. Calibration bar represent 20 µm. 
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Figure 4.4. 
Length (A), surface area (B), width (C) and perimeter (D) of endothelial cells 
from the Wistar rat thoracic aorta (ThA) and caudal artery (CA). Values are mean + 
SEM. *P<0.05 , significantly different from the ThA. n=4 animals. 
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Figure 4.5. 
Protein expression for Cxs 37, 40, 43 and 45 in the endothelium of the Wistar rat 
thoracic aorta and caudal artery. Values are expressed as Cx plaques per endothelial 
cell (A) and as the density of Cx plaques per 100 µm of endothelial cell perimeter (B). 
Values are mean + SEM. *P<0.05, significantly different from Cx expression in the 
caudal artery. n=4 animals. 
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4.2.2 Immunohistochemistry of vascular connexins 
For each of the Cx antisera used here, no staining at all was observed in the absence 
of the primary antibody or when the primary antibody was pre-incubated with the 
appropriate antigenic peptide 
Morphology of endothelial cells. En face views of the luminal surface showed 
punctate staining for Cxs 37, 40 and 43 along the periphery of endothelial cells in both 
thoracic aorta and caudal artery (Figures 4.3A-C and E-G respectively). Cx45 was not 
found in the endothelium of either artery (Figures 4.3D). Surface area, length and 
perimeter of endothelial cells tended to be greater in the caudal artery than in the thoracic 
aorta, resulting in statisitical significance for perimeter (P<0.05). Width of endothelial 
cells did not differ between thoracic aorta and caudal artery (Figure 4.4). 
Endothelial cells. Expression of Cxs 37 and 43 per endothelial cell was similar 
between the thoracic aorta and caudal artery, while expression of Cx40 was significantly 
less in the thoracic aorta than in the caudal artery (P<0.05, Figure 4.3, 4.5A). As Cx 
expression in the endothelium was seen exclusively around the cell periphery (Figure 4.3), 
the density of Cx plaques in the cell membrane was also calculated. The density of Cx40 
plaques was significantly greater in the caudal than in the thoracic aorta while no such 
difference was seen for Cxs 37 and 43 (P<0.05, Figure 4.5B). Plaque sizes for each Cx did 
not vary between endothelial cells in either artery. 
Smooth muscle cells. Longitudinal and transverse sections of the rat thoracic aorta 
and caudal artery were analysed for expression of Cxs 37, 40, 43 and 45. No significant 
difference was found in the data for either orientation for any of the four Cxs in either 
artery. In the media of the caudal artery, Cx37 was highly expressed (Figures 4.6E, 
4.7 A,B), while Cx37 expression in the thoracic aorta was very sparse (P<0.05, Figures 
4.6A, 4.7 A,B). Expression of Cx40 was absent from the media of both arteries (Figures 
4.6B,F, 4.7 A,B). Cx43 was abundantly expressed in the media of the thoracic aorta 
(Figures 4.6, 4.7 A,B), but was absent from the media of the caudal artery (Figures 4.6G, 
4.7 A,B). Cx45 could be detected sparsely in the media of both caudal artery and thoracic 
aorta (Figures 4.6D,H, 4. 7 A,B). Double labelling experiments confirmed that Cx45 
expression was located between adjacent smooth muscle cells (Figure 4.8). 
Plaques of Cxs 3 7 and 45 in the media of the caudal artery and Cx45 in the thoracic 
aorta were significantly smaller than Cx43 plaques in the thoracic aorta (P<0.001, caudal 
artery: Cx37, 0.08 + 0.003 µm; Cx45, 0.06 + 0.001 µm; thoracic aorta: Cx43 , 0.11 + 0.01 
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Figure 4.6 
Figure 4.6. 
Cx expression in transverse sections of the Wistar rat thoracic aorta (ThA) (A-
D) and caudal artery (CA) (E-H), incubated with antibodies against Cxs 37 (A, E), 40 
(B, F), 43 (C, G) and Cx45 (D, H). e, endothelium, sm, smooth muscle. Calibration bar 
represents 10 µm. 
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Figure 4.7 
Figure 4.7. 
Protein expression for Cxs 37, 40, 43 and 45 in the smooth muscle of the Wistar 
rat thoracic aorta and caudal artery. Values are expressed as plaques per µm 2 in 
longitudinal sections (A) and transverse sections (B). Values are mean + SEM. 
*P<0.05 , significantly different from Cx expression in the caudal artery. n=4 animals. 
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Figure 4.8 
Figure 4.8. 
Expression of Cx45 (green) and smooth muscle myosin (red) in the Wistar rat 
caudal artery. Smooth muscle myosin specifically labels smooth muscle cells, while 
Cx45 labelling appears between adjacent smooth muscle cells. Calibration bar 
represents 10 µm. 

µm; Cx45, 0.06 + 0.004 µm). Similarly, in the caudal artery, Cx37 plaques between 
endothelial cells were significantly larger than plaques between smooth muscle cells 
(P<0.0001, endothelial cells: 0.15 + 0.01 µm, smooth muscle cells: 0.08 + 0.003 µm), while 
in the thoracic aorta, plaques for Cx43 were greater in the endothelium than in the smooth 
muscle (P<0.001, endothelial cells: 0.14 + 0.01 µm, smooth muscle cells: 0.11 + 0.01 µm). 
4.2.3 Western blotting of vascular connexins 
Rabbit Cx43 antibodies revealed the presence of multiple isoforms of Cx43 in 
Western blots of extracts of caudal artery and ThA (Figure 4.9A,B), with the higher 
molecular weight isoforms appearing to predominate in the ThA (Figure 4.9B). All 
isoforms were blocked by pre-incubation of the Cx43 antibody with immunogenic peptide 
(Figure 4.9A, +peptide). Cx43 was only detectable in extracts of CA when 10 µg of -
protein was loaded on the gel (Figure 4.9B), but not when 5 µg was used (Figure 4.9A). 
Quantification of Cx43 by phosphoimaging revealed that ThA contained at least nine times 
more Cx43 than the CA ( data not shown). When samples of ThA and CA were treated with 
phosphatase, a shift in mobility towards the lower molecular weight form was found (see 
Figure 3.4B), confirming that the high molecular weight forms were phosphorylated Cx43. 
4.3 DISCUSSION 
Significant differences have been found in the Cx make-up of the media, but not the 
endothelium of an elastic and a muscular artery of the rat using real time PCR and 
immunohistochemistry. In the caudal artery, rriRNA for Cx37 was the most prevalent of 
the four Cxs and immunohistochemically demonstrable staining was found in the media of 
that artery but not to any great extent in the thoracic aorta. Using high-resolution confocal 
microscopy, a single fluorescent spot was defined as a gap junctional plaque, as validated 
previously (Green et al. 1993; Yeh et al. 1997b). On the other hand, mRNA for Cx43 was 
the most prevalent Cx in the thoracic aorta and greatly exceeded expression of Cx43 in the 
caudal artery. In similar fashion, the specific activity of Cx43 protein on Western blots was 
significantly greater in the aorta than in the caudal artery, in agreement with the extensive 
punctate staining in the aortic media and absence in the caudal artery as described 
previously (Hong & Hill, 1998). In the endothelium, protein for Cxs 3 7, 40 and 43 was 
detected in both vessels, as was Cx45 in the media of the two vessels. These data strongly 
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Figure 4.9 
Figure 4.9. 
Expression of Cx43 in tissue extracts from the Wistar rat thoracic aorta (ThA) 
and caudal artery (CA). 5 µg (A) and 10 µg (B) were run on 8% SDS PAGE gels and 
probed with antibodies to Cx43. Unphosphorylated and phosphorylated forms are 
indicated by arrows (- peptide). All forms disappeared when the antibody was pre-
incubated with the immunogenic peptide ( + peptide). 
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suggest that the predominant Cx connecting smooth muscle cells in the caudal artery is 
Cx37, in contrast to the aorta where the predominant Cx is confirmed to be Cx43, Cx45 
playing a minor role in both arteries. 
Although the mRNA preparations of both arteries included smooth muscle cells and 
endothelial cells, the predominant cell type was the smooth muscle cell as our 
ultrastructural studies have demonstrated that there are seven or more layers of smooth 
muscle cells surrounding the single layer of endothelial cells in the two vessels (see Chapter 
5). Thus when protein expression for each of the Cx subtypes ii;i the media of the two 
arteries was compared with the mRNA expression in the vessels, a good correlation was 
found for all four Cxs in both art~ries. In contrast, in cultured smooth muscle cells from 
preglomerular arterioles of the rat, only Cx40 protein was detected in spite of mRNA 
expression for Cxs 37, 40 and 43 (Arensbak et al. 2001). While Cx40 protein was also 
found in sections of preglomerular arterioles in vivo, no mRNA analyses of this and other 
Cxs were performed (Arensbak et al. 2001 ). In preliminary experiments for the present 
study, attempts were made to rub off the endothelium in order to attribute mRNA for 
specific Cx isoforms to specific cellular layers. Unfortunately, these experiments were not 
entirely successful, as real time PCR showed that expression of mRNA for the endothelial 
cell marker von Willebrand factor could still be detected in these "endothelium-denuded" 
preparations. 
While Cx37 was extensively expressed in the media of the caudal artery, it was 
effectively absent from the media of the thoracic aorta. These results are in agreement with 
van Kempen et al. ( 1999) who failed to find any Cx3 7 labelling in the aorta of several 
species but in contrast to studies by Nakamura et al. (1999) who described the presence of 
Cx37 in the smooth muscle of the rat aorta and pulmonary artery. However, the authors did 
not define which region of the aorta was used and since expression of other Cxs has been 
shown to vary along the length of the aorta (Hong & Hill, 1998; Ko et al. 2001), it may be 
difficult to directly compare the results. In the caudal artery, expression of mRNA for 
Cx37 was 10 fold greater than in the thoracic aorta, in line with the observed staining 
within the muscle layers. In the same species, Cx3 7 has also been identified in the media 
of large coronary arteries (van Kempen & Jongsma, 1999), perhaps suggesting a more 
widespread role for Cx37 in cell coupling in the media of large muscular arteries of the rat. 
In the present study, Cx40 was not detected in the media of either the aorta or 
caudal arteries or in rat mesenteric arterioles as described by Gustafsson et al. (2003 ). 
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These results are in contrast to several previous studies, which have described Cx40 in the 
media of blood vessels from several species, including preglomerular and pial arterioles of 
the rat (Little et al. 1995; Arensbak et al. 2001 ), hamster cremaster muscle arterioles 
(Little et al. 1995), and coronary arteries from the cow, pig and rat (van Kempen & 
Jongsma, 1999). Taken together, these results may suggest a greater role for Cx40 in 
smaller vessels, supporting the idea that heterogeneity exists in the expression of Cxs 
within different parts of the vascular tree. 
In the thoracic aorta, Cx45 was relatively sparsely expressed in contrast to the dense 
. expression of Cx43. A reciprocal relationship between these two Cxs was found 
throughout the aortic vessels to the iliac artery (Ko et al. 2001 ). In the caudal artery, 
double labelling with antibodies against smooth muscle myosin showed Cx45 between 
smooth muscle cells, and using real time PCR, expression was similar to that in the thoracic 
aorta. The greater expression of Cx37 than of Cx45 in the caudal artery suggests that Cx37 
may share a similar inverse relationship to Cx45 in the media of the caudal artery. 
Alternatively, expression of the two Cxs may have implications for radial versus · 
longitudinal coupling of smooth muscle cells. Recent dye coupling studies in the caudal 
artery from our lab (Sandow et al. 2002) have shown selective spread of lucifer yellow dye 
between smooth muscle cells in the radial, but not the longitudinal direction. However, in 
the present study, in the media of both arteries, protein expression of Cxs 3 7 and 45 did not 
. differ between longitudinal and transverse orientations. 
As previously demonstrated, protein for Cxs 37, 40 and 43 was expressed in the 
endothelium of both the thoracic aorta and caudal artery (Yeh et al. 1997 a), while 
expression of Cx45 was not detected in the endothelium of either artery (Krliger et al. 
2000; Ko et al. 2001). Staining was essentially confined to the intercellular borders. In the 
endothelium of the caudal artery, expression of Cx40 was significantly greater than in the 
thoracic aorta, while expression of Cxs 37 and 43 was not significantly different between 
the . two arteries. Studies by Gabri els & Paul ( 1998) have shown that Cx43 expression 
within the endothelium of the rat thoracic aorta is heterogeneous in distribution, with 
staining particularly restricted to areas of aortic bifurcation and to small clumps of cells 
away from bifurcations. In contrast, in the present study the distribution of Cx43 
expression was found to be homogenous. This discrepancy is likely to result from the area 
of aorta examined or the affinity of the antibodies used. Morphological measurements 
demonstrated some differences in the shape of endothelial cells between the two arteries, 
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resulting in an increase in cell perimeter in the caudal artery relative to that in the thoracic 
aorta. In spite of this increase in cell perimeter, the density of Cx40 plaques was still 
significantly greater in the caudal artery than in the thoracic aorta. 
As discussed by Severs et al. (2001 ), the definitive identification of Cx protein 
localized at a gap junction requires electron microscopy, as gap junction channels are too 
small to be viewed at the light microscope level. Thus, while clear evidence demonstrating 
the expression pattern of each Cx has been presented, future experiments involving 
immunogold electron microscopy would confirm the result presented in this here. 
The data presented in this Chapter have demonstrated that Cx37 is the major Cx 
expressed in the media of the caudal artery, while Cx43 predominates in the thoracic aorta. 
The sparse expression of Cx45 suggests that it plays a minor role in the media of both 
arteries, while Cx40 is not expressed in the muscle of either vessel. In contrast, three Cxs 
are expressed in the endothelium of both vessels and, of these Cx40 is more prevalent in the 
caudal artery than in the thoracic aorta. 
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CHAPTERS 
/ 
CONNEXIN EXPRESSION AND VASCULAR REMODELING IN THE 
RAT THORACIC AORTA AND CAUDAL ARTERY DURING 
HYPERTENSION 
5.1 INTRODUCTION 
In hypertension, an increase in total peripheral resistance gives rise to the increase 
in blood pressure that is characteristic of the disease (Mulvany & Aalkjaer, 1990). 
Increased peripheral resistance is accompanied by structural remodeling of the blood vessel 
wall, of which several categories have been described. Hypertrophic remodeling results in 
a decrease in luminal diameter and hypertrophy of the vascular smooth muscle, which may 
arise from changes in the morphology or number of smooth muscle number cells (Mulvany 
et al. 1996; Dickhout & Lee, 1999, 2000; Intengan & Schiffrin, 2000; Touyz, 2000). 
Eu trophic remodeling occurs when both the outer and luminal diameters of the blood vessel 
are decreased. In this type of remodeling, changes in the medial layer arise from the 
rearrangement of existing smooth muscle cells around the smaller lumen (Baumbach & 
Reistad, 1989; Intengan & Schiffrin, 2000). In the SHR, blood vessels have been shown to 
undergo both hypertrophic (Sandow et al. 2003b) and eutrophic remodeling (Mulvany et 
al. 1996), fuelling suggestions that the type of remodeling may vary according to the 
vascular bed examined. In contrast, little is known regarding the morphological changes 
that may occur in vascular endothelial cells during hypertension. Most data has been 
confined to the thoracic aorta. As reviewed in Chapter 1, the results of these studies show 
that both increases and decreases in endothelial cell size and density can occur depending 
on the vascular bed and the model of hypertension examined (Gabbiani et al. 1979; 
Hiittner et al. 1979, 1982; De Chastonay et al. 1983; Kowala et al. 1988; Arribas et al. 
1997). 
Gap junctional coupling of adjacent cells in the endothelial and smooth muscle cell 
layers is essential for the coordination of vasomotor responses. However, despite the 
extensive literature demonstrating cellular remodeling within hypertensive vessels, little is 
known regarding Cx expression in the blood vessels of hypertensive rat models . As 
discussed in Chapter 1, most studies have concentrated on Cx43 expression in the aorta of 
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the rat where increased or decreased Cx expression have been described, depending on the 
model of hypertension examined (Watts & Webb, 1996; Haefliger et al. 1997a,b, 1999, 
2001; Haefliger & M"eda, 2000). This is surprising given that the aorta is a large elastic 
artery and is thus not directly inv<?lved in the maintenance of peripheral resistance 
(Mulvany & Aalkjaer, 1990). Such studies are therefore unlikely to be relevant to 
elucidating the mechanisms associated with the etiology of diseases such as hypertension. 
Recent studies by Li & Simard (2002) have examined Cxs 43 and 45 in cerebral and 
systemic vessels of SHR and L-NAME induced hypertensive rats and suggest that changes 
in Cx expression during hypertension may vary depending on the specific Cx, the vascular 
bed, the particular model of hypertension and the method employed for analysis. Whether 
the changes observed in their study were confined to one cell layer or involved both smooth 
muscle and endoth~lial cells is not known. Indeed, no studies have focused on Cx 
expression in endothelial cells during hypertension. 
Together with structural changes in the blood vessel wall, hypertension is also 
associated with endothelial dysfunction, characterised by the altered production and action 
of vasoactive factors, which include vasodilators such as NO, prostaglandins and EDHF 
(Mombouli & Vanhoutte, 1999; Shimokawa, 1999). Indeed, several studies have shown a 
reduction in both NO and EDHF-mediated hyperpolarization in the coronary and 
mesenteric arteries of the SHR and SHR-SP (Fujii et al. 1992; Sunano et al. 1999; 
Vazquez-Perez et al. 2001 ). In contrast, studies in mesenteric arteries of rats made 
hypertensive with a high salt diet, demonstrate an up-regulation of EDHF-mediated 
relaxation, while vasodilation to A Ch is not altered, thus suggesting the loss of NO activity 
in this model of hypertension (Sofola et al. 2002). Given these results, it is apparent that 
the ability of an endothelial-derived factor to effect a smooth muscle cell response may be 
influenced by changes in the number of smooth muscle cell layers, the size of smooth 
muscle cells and cellular coupling within the media of hypertensive vessels. Indeed, this is 
of particular relevance for the effect of EDHF, whose action is dependent on gap junctions 
in many vascular beds (McGuire et al. 2001; Sandow et al. 2002). In a similar manner, 
altered molJ)hology and coupling within the endothelial cell layer may further impact on 
the normal function of vasoactive factors within the blood vessel wall and thus contribute to 
the hypertension associated endothelial dysfunction. 
Given the heterogeneous nature of vascular remodeling during hypertension and the 
nature of cellular coupling in different vascular beds as described in Chapter 4, the aim of 
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this Chapter is to investigate alterations in cell morphology and expression of the four 
vascular Cxs in the smooth muscle and endothelial layers of funct ional ly different vessels 
in an individual model of hypertension. The thoracic aorta and the caudal artery were 
chosen as examples of elastic and muscular arteries, respectively as described in the 
previous Ch~pter. Structural changes observed here in the caudal artery have also been 
correlated with electrophysiological studies of cell coupling in the media and the action of 
the vasodilatory factors NO and EDHF during hypertension. 
5.2 RESULTS 
5.2.1 Blood pressure 
A significant increase in systolic blood pressure in the SHR (n=4- l 5) compared 
with WKY (n=4-8) was first seen at 9 weeks of age (P<0.05 , WKY, 121 + 3.8; SHR, 162 + 
6.7 mmHg) and blood pressure continued to rise until approximately 11-12 weeks of age 
after which time blood pressure values reached a plateau (P<0.05 , WKY, 125 + 3.8; SHR, 
193 + 7.5 mmHg at 12 weeks; Figure 5.1). 12-week old rats were therefore chosen;.for the 
subsequent studies. 
5.2.2 Vessel morphology 
There was no significant difference in luminal diameter, the number of smooth 
muscle cell layers, or the medial cross-sectional area between the thoracic aorta of WKY 
and SHR (P>0.05 , Table 5.1). In the caudal artery, the luminal diameter was significantly 
smaller in the SHR compared to the WKY, while the number of smooth muscle cell layers 
and the medial cross sectional area were significantly larger (29% and 26%, respectively), 
in the SHR compared to the WKY (P<0.05 , Table 5.1) . 
Smooth muscle cell morphology was determined in the caudal artery by measuring 
the surface area, length and width of cells following intracellular labelling with 
microelectrodes filled with FITC-dextran. The surface area of smooth muscle cells was not 
significantly different between WKY and SHR (P>0.05 ; WKY, 75 7 + 41 µm 2; SHR, 782 + 
56 µm 2) , however the length and width of smooth muscle cells differed significantly 
between the two strains (P<0.05 , Figure 5.2A,B ; length, 138 + 4.4 µm for WKY, 171 + 6.7 
µm for SHR; width, 9.8 + 0.5 µm for WKY, 8.1 + 0.4 µm for SHR). 
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Figure 5.1 
Figure 5.1 . 
Systolic blood pressure of SHR and WKY measured weekly from 4 weeks of 
age. Values are mean± SEM. *P<0.05, significantly greater than age-matched WKY. 
n=4-l 5 animals. 
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SHR ThA 1503 ± 73 7.9±0.1 375,323 ± 18,525 
WKY ThA 1372 ± 105 7.7 ± 0.3 274,186 ± 42,032 
SHR CA 889+18* 8.8 + 0.5 * 51 ,943 + 3,533 * 
WKY CA 1088+51 7.0 + 0.3 41,035 + 3,310 
Table 5.1. Characteristics of the thoracic aorta (ThA) and caudal artery (CA) from 12 
week WKY and SHR rats. Values are mean+ SEM. *P<0.05 , significantly different to 
WKY. n=3. 
Figure 5.2 
Figure 5.2. 
Morphology of smooth muscle cells (A,B) and characteristics of EJPs recorded 
(C,D) from the caudal artery of WKY and SHR rats. Smooth muscle cells from the 
WKY (A) and SHR (B) impaled during electrophysiological experiments were 
positively identified following the injection of 10% FITC-dextran. Calibration bar 
represents 50 µm. Membrane potential recordings were taken from smooth muscle cells 
at the adventitial (a) and luminal (b) borders of the WKY (C) and SHR (D). Excitatory 
junction potentials (EJPs) were evoked by a single supramaximal stimulus (100 mA, 0.1 
ms; arrow). Resting membrane potential, -60 m V (C) and -57 m V (D). 
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Figure 5.3 
Figure 5.3. 
Length (A), surface area (B), width (C) and perimeter (D) of endothelial cells 
from the WKY and SHR thoracic aorta (ThA) and caudal artery (CA). Values are mean 
+ SEM. *P<0.05 , significantly different from WKY. n=4-5 animals 
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Endothelial cell morphology, as measured by surface area, length, width and 
perimeter, was not significantly different between WKY and SHR in the thoracic aorta 
(Figure 5.3). However, in the caudal artery of the SHR, surface area, perimeter and length 
of endothelial cells were significantly less than in the WKY (P<0.05, Figure 5.3). In the 
WKY, surface area, length and perimeter of endothelial cells was similar in both the 
thoracic aorta and caudal artery, while width was significantly less in the caudal artery than 
in the thoracic aorta. In the SHR, all four parameters were significantly less in the caudal 
artery than in the thoracic aorta (P<0.05, Figure 5.3). 
5.2.3 Connexin mRNA expression 
The expression of Cx43 mRNA in the thoracic aorta in both WKY and SHR was 
significantly greater than mRNA expression for Cxs 40 and 45 (P<0.05, Figure 5.4A), 
while expression of mRNA for Cx43 was also significantly greater than Cx37 in the WKY, 
but not in the SHR. In the thoracic aorta, mRNA expression for Cxs 43 and 45 were 
significantly less in the SHR compared to the WKY (P<0.05, Figure 5.4A), while mRNAs 
for Cxs 37 and 40 were similar in both WKY and SHR. In the caudal artery, expression of 
mRNA for Cx37 in the WKY and SHR was significantly greater than mRNA for Cxs 40 . 
and 43 (P<0.05, Figure 5.4B). There was no significant difference between the expression 
of mRNA for Cxs 37 and 45 in the WKY or the SHR (Figure 5.4B). There was little 
mRNA for Cxs 40 and 43 detected in the caudal artery of either the WKY or SHR (Figure 
5.4B). In the caudal artery, there was no significant difference between the expressions of 
any of the four Cxs in the WKY compared to the SHR (Figure 5.4B). 
5.2.4 Connexin protein expression 
For each of the Cx antisera used here, no staining was observed in the absence of 
the primary antibody or when the primary antibody was pre-incubated with the appropriate 
antigenic peptide. 
Endothelial cells. En face views of the luminal surface of the thoracic aorta and 
caudal artery showed punctate staining for Cxs 37, 40 and 43 along the periphery of 
endothelial cells of both the WKY and SHR (Figure 5.5A-C, D-F and 5.6A-C, D-F, for 
thoracic aorta and caudal artery, respectively) , while Cx45 was not detected in the 
endothelium of either artery ( data not shown). 
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Figure 5.4 
Figure 5.4. 
mRNA expression of Cxs 37, 40, 43 and 45 in the WKY and SHR thoracic aorta 
(A) and caudal artery (B). Copy numbers are expressed per copy of 18S ribosomal 
RNA by using plasmid standard curves. *P<0.05, significantly less than WKY. 
t P<0.05 , significantly less than the thoracic aorta. n=4-6 animals. 
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Figure 5.5 
Figure 5.5. 
Cx expression in the endothelium of the thoracic aorta of the 12 week old WKY 
and SHR. The endothelium is viewed en face and is labelled with antibodies to Cx3 7 
(A,D), Cx40 (B,E) and Cx43 (C,F). Labelling of Cxs 37, 40 and 43 is evident along the 
perimeter of endothelial cells. Calibration bar represents 20 µm. 
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Figure 5.6 
Figure 5.6. 
Cx expression in the endothelium of the caudal artery of the 12 week old WKY 
and SHR. The endothelium is viewed en face and is labelled with antibodies to Cx3 7 
(A,D), Cx40 (B,E) and Cx43 (C,F). Labelling of Cxs 37, 40 and 43 is evident along the 
perimeter of endothelial cells. Calibration bar represents 20 µm. 
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Figure 5.7 
Figure 5.7. 
Expression of protein for Cxs 37, 40, 43 and 45 in the endothelium of the WKY 
and SHR thoracic aorta (A, C) and caudal artery (B, D). Cx plaques expressed per 
endothelial cell in the thoracic aorta (A) and _ caudal artery (B), and the density of Cx 
plaques per 100 µm of endothelial cell perimeter in the thoracic aorta (C) and caudal 
artery (D). Values are mean + SEM. *P<0.05, significantly different from Cx 
expression in the WKY. n=4-5 animals. 
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In the thoracic aorta, expression of Cx37 per endothelial cell, but not Cx40 or Cx43, 
was significantly less in the SHR compared to the WKY (P<0.05, Figures 5.5A,D, 5.7 A). 
Cx40 was the most abundantly expressed Cx in the endothelium of the thoracic aorta of 
both the WKY and SHR. In the WKY, expression of Cx40 was significantly greater than 
expression of Cx43, while in the SHR, Cx40 expression was significantly greater than 
expression of Cx37 (P<0.05, Figures 5.5B,C, D-E, 5.7A,C). In the caudal artery, Cx43 
expression per endothelial cell was significantly lower in WKY rats than that of Cx3 7 or of 
Cx40 (Figures 5.6A-C, 5.7B). In the SHR, Cxs 37, 40 and 43 were equally expressed in 
endothelial cells (Figure 5.6D-F, 5.7B,D), and this expression was significantly lower than 
the corresponding Cx expression in WKY rats (P<0.05, Figure 5.7B,D). 
As Cx expression in the endothelium was seen exclusively around the cell 
periphery, and the size of endothelial cells in the caudal artery are smaller in the SHR than 
in the WKY, the density of Cx plaques in the cell membrane was also calculated. In the 
thoracic aorta, the density of Cx3 7 staining per 100 µm of endothelial cell perimeter was 
significantly less in the SHR than the WKY (P<0.05, Figures 5.7C). Again, the density of 
Cx40 in the endothelium of the thoracic aorta of both the WKY and SHR was significantly 
greater than Cx43 in the WKY and Cx37 in the SHR respectively (P<0.05, Figure 5.7C). 
In the caudal artery, the density of Cxs 37 and 43 plaques per 100 µm of cell membrane 
was not significantly different in SHR and WKY, however, the density of Cx40 plaques 
was significantly reduced in SHR compared to WKY (P<0.05, Figure 5.7D). In WKY the 
density of Cx43 plaques was significantly lower than that of Cxs 37 or 40 (P<0.05, Figure 
5.7D). 
Smooth muscle cells. Longitudinal and transverse sections of the rat thoracic aorta 
and caudal artery taken from the WKY and SHR were analysed for the expression of Cxs 
37, 40, 43 and 45 (Figures 5.8, 5.9). Expression of Cx37 in longitudinal and transverse 
sections of both the thoracic aorta and caudal artery did not differ between WKY and SHR 
rats (P>0.05, thoracic aorta, Figure 5.8A,E; caudal artery, Figure 5.9A,E; Figure 5.10). 
Cx40 could not be detected in the media of the thoracic aorta or caudal artery from either 
strain (thoracic aorta, Figure 5.8B,F; caudal artery, Figure 5.9B,F; Figure 5.10). 
Cx43 was abundantly expressed in the media of the thoracic aorta of both the WKY 
and SHR, but was not detected in the media of the caudal artery of either strain (thoracic 
aorta, Figures 5.8C,G; caudal artery, Figures 5.9C,G). Expression of Cx43 in longtitudinal 
sections of the thoracic aorta did not differ in WKY and SHR rats (P>0.05 , Figure 5.1 0A), 
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Figure 5.8 
Figure 5.8. 
Expression of Cxs 37 (A,E), 40 (B,F), 43 (C,G) and 45 (D,H) in'the media of the 
thoracic aorta from the WKY (A-D) and SHR (E-H) (transverse sections). e, 
endothelium. sm, smooth muscle. Calibration bar represents 10 µm. 
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Figure 5.9 
Figure 5.9. 
Expression of Cxs 37 (A,E), 40 (B,F), 43 (C,G) and 45 (D,H) in the media of the 
caudal. artery from the WKY (A-D) and SHR (E-H) (transverse sections). e, 
endothelium, sm, smooth muscle . Calibration bar represents 10 µm . 
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Figure 5.10 
Figure 5.10. 
Protein expression for Cxs 37, 40, 43 and 45 in the smooth muscle of_the WKY 
and SHR thoracic aorta (A,C) and caudal artery (B,D) at 12 weeks. Values are 
expressed as plaques per µm 2 in longitudinal (A,B) and transverse (C,D) sections. 
Values are mean+ SEM. *P<0.05, significantly less than WKY. tP<0.05, significantly 
less than the thoracic aorta. n=4 animals. 
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while .in transverse sections Cx43 was significantly lower in the SHR compared to the 
WKY (P<0.05 , Figures 5.1 0C). The expression of Cx43 in the thoracic aorta of both the 
WKY and SHR was significantly greater than expression of any other Cx (P<0.05, Figure 
5.l0A,C). 
Cx45 was detected . in the media of both arteries studied (thoracic aorta, Figures 
5.8D,H; caudal artery, Figures, 5.9D,H). In transverse sections of the thoracic aorta and 
caudal artery, expression of Cx45 wa~ significantly lower in the SHR compared to the 
WKY (P<0.05, Figures 5 .1 0C,D),, while in longitudinal sections, there was no significant 
difference between the two strains (P>0.05, Figures 5. l0A,B) . . 
5.2.5 Electrical coupling within the media of the caudal artery 
In smooth muscle cells of the caudal artery, resting membrane potential did not 
differ between WKY and SHR (P>0.05; WKY -59 ± 1 m V, n=23 cells from 7 animals; 
SHR, -59 ± lmV, n=19 cells from 7 animals). Stimulation of nerves located at the 
adventitial border of the media evoked excitatory junction potentials (EJPs ), which were 
significantly larger in smooth muscle cells at the adventitial border in the caudal artery of 
the SHR compared to similar recordings in the WKY (P<0.05, Figure 5.2C,D, Table 5.2). 
Time constants of EJPs did not differ between WKY and SHR (P>0.05; WKY, 278 ± 18 
ms; SHR, 239 ± 15 ms). Repetitive stimulation (2-10 impulses at 10 Hz) produced 
summation of EJPs and subsequent contraction. Action potentials were recorded in some 
cases, however the incidence of these did not differ between WKY and SHR. Stimulation 
of nerves at the adventitial border evoked EJPs in smooth muscle cells at the luminal border 
of both WKY and SHR. Cells from which intracellular recordings were made were 
identified by intracellular dye labelling (Figure 5 .2A,B). EJPs recorded at the luminal 
surface did not differ in amplitude or rise time between WKY and SHR (P>0.05, Table 
5 .2B). However, between the adventitial and luminal borders there was a significant 
increase in the rise time of EJPs in both WKY and SHR (P<0.05, Table 5.2). In the WKY, 
the amplitude of EJPs recorded in smooth muscle cells did not differ between the 
adventitial and luminal borders (P>0.05). However, in the SHR, the amplitude of EJPs was 
significantly reduced by 52% in smooth muscle cells at the luminal border compared to the 
adventitial border (P<0.05, Table 5.2B). EJPs recorded in both WKY and SHR were 
followed by a small, slow membrane depolarization consistent with the action of 
noradrenaline as described previously (Jobling & McLachlan, 1992). 
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5.2. 6 Activity of endothelium-derived hyperpolarizing factor in the caudal artery 
In the caudal artery, in the presence of L-NAME and indomethacin, dose dependent 
ACh induced relaxation, did not differ between WKY and SHR (P<0.05 , Figure 5.1 lA). 
This relaxation can be attributed to EDHF, since the addition of charybdotoxin (60 nM) and 
apamin (0.5 µM) abolished the relaxation in both the WKY and SHR. In addition, in the 
presence of charybdotoxin and apamin, a contraction was uncovered, although the 
magnitude of this did not differ between WKY and SHR (P>0.05, Table 5.3). The addition 
of 18~-GA significantly reduced the EDHF-mediated relaxation by 100% in the WKY and 
73% in the SHR (Table 5.3). Recirculation of Krebs' solution containing the Cx-mimetic 
peptide combination (43Gap26, 40Gap27, and 37'43Gap27), L-NAME and indomethacin 
significantly reduced the EDHF-mediated relaxation in the WKY by 78% and in the SHR 
by 95% (Table 5.3). The EDHF-mediated relaxation was not altered following 
recirculation of control Krebs' soloution for 60 min. 
In order to examine the specificity of the Cx-mimetic peptide combination for 
EDHF, a number of control studies were performed in vessels from WKY rats (Figure 
5.12). In the presence of L-NAME and indomethacin, an EDHF-mediated relaxation was 
present (Figure 5.12A,B). Addition of Cx-mimetic peptide combination abolished the 
EDHF-mediated relaxation but had no effect on the NO-mediated relaxation (Figure 5.12A-
D)o In the presence of L-NAME, indomethacin and either hydroxocobalamin or carboxy-
PTIO, the EDHF mediated relaxation was not different from control in either WKY or SHR 
(P>0.05, Table 5.3). 
In the caudal artery, concentration-dependent hyperpolarization induced by ACh, in 
the presence of L-NAME and indomethacin, was 28% less in the SHR than in the WKY 
(P<0.05 , WKY, -18 mV; SHR, -13 mV; Figure 5.11B). L-NAME had no effect on resting 
membrane potential in either WKY or SHR, although indomethacin depolarised membrane 
potentials by 5-10 m V. Cumulative addition of A Ch did not result in desensitisation of 
responses, since application of single concentrations of ACh produced similar results. 
In both WKY and SHR, the addition of charypdotoxin and apamin significantly 
attenuated the EDHF-mediated hyperpolarization induced by ACh (Table 5.4). However, 
in all SHRs and in 4 out of 8 WKY animals, a depolarization was uncovered (Figure 5.11 C, 
Table 5.4). _ Removal of the endothelium abolished both hyperpolarization and 
depolarizations in both strains. The addition of iberiotoxin had no effect on ACh induced 
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strain location number of number of amplitude (mV) rise time (ms) 
animals cells 
A. 
SHR adventitial 7 19 19 ± 1 * 24± 3 
WKY adventitial 7 23 14 ± 1 34 ± 3 
B. 
SHR adventitial 6 17 21 ± 3tt 20 ± 5t 
SHR luminal 6 6 10 ± 3 50 ± 6 
WKY adventitial 6 20 15 ± 1 32 ± 6 
WKY luminal 6 6 13 ± 3 50 ± 5 
Table 5.2. Characteristics of EJPs recorded from smooth muscle cells of the caudal 
artery from WKY and SHR. (A) Data for all adventitial smooth muscle cells impaled, 
(B) preparations in which both adventitial and luminal smooth muscle cells were 
impaled. Values are mean± SEM. *P<0.05, significantly greater than WKY in A. 
tP <0.05, significantly different from corresponding luminal impale1nents in B. 
tP <0.05, significantly greater than WKY adventitial impalements in B. 
Figure 5.11 
Figure 5.11. 
Endothelium-dependent relaxation and hyperpolarization in response to ACh in 
caudal arteries of SHR and WKY rats. (A) Vasodilation, expressed as % of 
phenylephrine (PE)-induced constriction, to cumulative application of ACh. (B) 
Membrane hyperpolarizations in smooth muscle cells induced by cumulative 
application of ACh. (C) Hyperpolarizations recorded in adventitial smooth muscle cells 
in SHR following the iontophoretic application of ACh (1 M, 200 nA, 10 s), in the 
absence (a) and presence (b) of charybdotoxin (ChTx, 60 nM) and apamin (0.5 µM). 
(D) Hyperpolarizations recorded in smooth muscle cells in SHR following the 
iontophoretic application of ACh (1 M, 200 nA, 10 s), in the absence (a) and presence 
(b) of iberiotoxin (100 nM). All experiments were performed in the presence of L-
NAME (100 µm) and indomethacin (10 µm). Values in (A) and (B) are expressed as 
mean± SEM. 
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WKY SHR 
ACh 32 + 2.9 37 + 6 
A Ch + charybdotoxin ( 60 nM) + * * 
apamin (0.5 µM) -39 + 11 -25 + 5 
ACh + 18~-GA (20 µM) o + o* 10 + 5* 
ACh + Gap peptide combination * 2 + 2* (100 µMeach) 7+3 
ACh + hydroxocobalamin (100 µM) 38 + 10 52 + 8 
ACh + carboxy-PTIO (100 µM) 35 + 5 27 + 5 
Table 5.3. Endothelium-dependent relaxation in response to ACh in caudal arteries of 
WKY and SHR. Vasodilation, expressed as % of phenylephrine-induced constriction, 
to application of ACh (1 µM) in the WKY and SHR. Negative values indicate 
constriction. All experiments were performed in the presence ofL-NAME (100 µM) 
and indo1nethacin (10 µM). Values are mean± SEM. *r<0.05, significantly different 
from corresponding control. n=3-5. 
Figure 5.12 
Figure 5.12. 
Endothelium-dependent relaxation in response to ACh (1 µM) in caudal arteries 
of SHR and WKY rats ( expressed as % of phenylephrine (PE)-induced constriction). 
(A) EDHF, but not NO mediated relaxation was abolished by the addition of the Cx-
mimetic peptide combination, 43 Gap26, 40Gap27 and 37'43 Gap27 (100 µM each), while 
NO mediated vasodilation was abolished by L-NAME (100 µM). Values are expressed 
as mean ± SEM. n=4-7. EDHF mediated vasodilation, before (B) and after (C) the 
addition of the gap mimetic peptide combination. (D) NO mediated relaxation was 
unaffected by the addition of indomethacin (1 0µm) and the Gap mimetic peptide 
combination. 
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+2 + 1 +3 + 1 
-13 + 3 -4 + 2 
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-12 + 2 -5 + 1 
0+0 o + o* 
-9 + 2 -8 + 1 
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Table 5.4. EDHF-mediated hyperpolarization recorded in smooth muscle cells in the 
caudal artery of WKY and SHR rats. Hyperpolarizations were recorded in smooth 
muscle cells following the ionophoretic application of ACh (1 M, 200 nA, 10s), before 
and after the addition of charybdotoxin and apamin, iberiotoxin, 18~-GA and 
hydoxocobalamin. Positive values indicate depolarization. All experiments were 
performed in the presence of L-NAME and indomethacin. Values are expressed as 
mean± SEM. *P<0.05, significantly different from corresponding control. n=3-8. 
hyperpolarization in either strain (Figure 5.1 lD, Table 5.4), while, 18~-GA abolished the 
ACh-induced hyperpolarization in both strains (Table 5.4). In the presence of L-NAME 
and indomethacin, the addition of hydroxocobalamin had no effect on the hyperpolarization 
to ACh in either strain (Table 5.4). 
5.3 DISCUSSION 
Differences between normotensive WKY and hypertensive SHR rats have been 
identified in the morphology and coupling of cells in the endothelium and media of the 
thoracic aorta and caudal artery. Furthermore, changes in cellular coupling that involve 
distinct Cxs within the two cellular layers have been identified in both vessels. In the 
thoracic aorta, which is an example of a large conduit artery, anatomical remodeling of 
vascular smooth muscle and endothelial cells was not evident in the SHR, although there 
was a significant decrease in mRNA expression for Cxs 43 and 45 in intact vessels. In 
addition, protein expression for Cx37 was decreased in the endothelium while protein for 
Cxs 43 and 45 was decreased in the smooth muscle. In contrast, in the caudal artery, which 
is an example of a muscular artery, anatomical remodeling of both the vascular smooth 
muscle (Sandow et al. 2003b) and endothelial cells occurred in the ~ypertensive rats. This 
was acco_mpanied by a decrease in the expression of mRNA for Cx45 in intact vessels, and 
by a decrease in Cx40 protein in the endothelium and Cx45 protein in the smooth muscle, 
relative to the vessels from notmotensive animals. In the caudal artery, decreased Cx 
expression in the media was accompanied by a decrease in cell coupling. 
In the caudal artery of SHR, the remodeling of the arterial wall comprised a 
decrease in lumen diameter and an increase in the number of smooth muscle cell layers; 
changes that are characteristic of hypertrophic remodeling. In addition, endothelial cells 
were found to be smaller in surface area, perimeter and cell length. In contrast, no 
remodeling of either the smooth muscle or endothelial cell layers was found in the thoracic 
aorta of SHR. Previous studies in the thoracic aorta of 4 and 15 month old SHR have 
de1nonstrated an increase in the medial cross-sectional area and media to lumen ratio 
(Otsuka et al. 1998; Fujii et al. 1999; Giummelly et al. 1999; Saleh & Jurjus, 2001 ), 
although other studies found no difference in the media to lumen ratio at 4 months, or 
during ageing (Marque et al. 1999). Together, the data suggest that within the thoracic 
aorta, medial remodeling may be limited or may only occur in response to a prolonged 
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increase in blood pressure. On the other hand, the presence of vascular remodeling in a 
muscular artery at an early stage suggests a role for such changes in the development of 
hypertension. 
The distribution of Cxs in the media and endothelium of the thoracic aorta and 
caudal artery of both WKY and SHR followed a similar pattern of expression to that 
described in young adult Wistar rats (Chapter 4 ). Thus, Cx43 was the most abundantly 
expressed Cx in the media of the thoracic aorta, while Cx37 was sparsely detected. In 
contrast, Cx3 7 was the most abundantly expressed Cx in the smooth muscle of the caudal 
artery, while Cx43 was detected only in the endothelium. Cx45 was detected in the smooth 
muscle of both vessels, while Cx40 was not detected in the media of either vessel. In the 
endothelium of both arteries, Cxs 37, 40 and 43, but not Cx45, were expressed in a punctate 
manner, delineating the endothelial cell borders. In general, there was a good correlation 
between mRNA and protein expression given that the smooth muscle significantly 
outweighed the contribution of the endothelium in both vessels. 
The present study is the first to correlate anatomical remodeling of the vascular wall · 
with functional changes in cellular coupling during hypertension. In the caudal artery, 
results demonstrate a reduction in electrical coupling within the media of the SHR 
compared to the WKY in line with the decrease in Cx expression. In WKY rats, the rise 
time of EJPs evoked by neural stimulation and the release of ATP (Hirst et al. 1996) in 
smooth muscle cells at the adventitial border, was faster than that recorded at the luminal 
border, while there was no change in amplitude. On the other hand, in the SHR, both 
amplitude and rise time of EJPs recorded at the luminal border, were significantly different 
to those recorded at the adventitial border. The decrease in amplitude of EJPs (52%) was 
greater than that which would be expected to result simply from hypertrophy of the media 
(29% ). Concomitant with these changes, we found a significant decrease in Cx45 protein 
' 
expression, which provides an explanation for the decrease in electrical coupling between 
smooth muscle cells within the media of the caudal artery of SHR compared to WKY. 
Other differences were apparent in the nerve-mediated response within the caudal artery of 
SHR in that of the amplitude of the EJPs recorded in smooth muscle cells at the adventitial 
border were larger than those recorded in the WKY. These results are similar to those 
observed in mesenteric arteries of the SHR (Brock & van Heiden, 1995) and are thought to 
result from the increased sympathetic innervation of the caudal artery in the SHR (Cassis et 
al. 1985). As a consequence of the differential attenuation of EJPs in the media, EJPs 
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recorded in smooth muscle cells at the luminal border of the caudal artery were not 
different between WKY and SHR. It is interesting to note that expression of protein for 
Cx45 was reduced in transverse, but not longitudinal sections of the SHR compared to the 
WKY, suggesting a greater role for radial rather than longitudinal coupling within the 
media. Furthermore, in the rat caudal artery, smooth muscle cells filled with Lucifer 
Yellow dye, show movement of the dye in the radial but not the longitudinal direction 
(Sandow et al. 2002). 
In contrast to the caudal artery, in the thoracic aorta of the SHR, both Cxs 43 and 45 
were reduced in the vascular smooth muscle in the absence of other signs of anatomical 
remodeling. A similar decrease in the expression of mRNA and protein for Cx43 has been 
reported in rats made hypertensive by L-NAME treatment, but not in 2 kidney, 1 clip and 
DOCA-salt hypertensive rats, where increased Cx43 has been described (Watts & Webb, 
1996; Haefliger et al. 1999, 2000). Together, the results suggest that changes in cellular 
coupling in any particular artery may vary depending on the aetiology of the model of 
hypertension and may arise independently of any anatomical reorganisation of the smooth 
muscle layers. In contrast to the results presented here, Li & Simard (2002), found no 
change in the expression of protein for Cx45 in Western blots of intact thoracic aortae from 
SHR. At present the reasons for this discrepancy are unknown. 
In the aortic endothelium, despite the lack of morphological remodeling, the 
staining of pr0tein for Cx3 7 was significantly reduced during hypertension. On the other 
hand, in the caudal artery, significantly reduced Cx40 expression accompanied a significant 
decrease in endothelial cell length. Longitudinal conduction of vasodilatory responses is 
known to occur in the vascular endothelium, and is thought to be dependent on gap 
junctions for the coupling of adjacent cells (Segal et al. 1999; Emerson & Segal, 2001; 
Sandow et al. 2003d). It can be hypothesised that a reduction in Cx expression and 
therefore cellular coupling, in addition to changes in cell size in the endothelium, would 
result in reduced conducted vasodilation. Indeed, studies examining mice lacking Cx40 
showed a reduction in the propagation of vasodilatory signals in cremaster muscle 
arterioles, along with an increase in systemic blood pressure ( de Wit et al. 2000). It is 
interesting that Simon & Mc Whorter (2003) found that endothelial cell dye transfer was 
reduced to a greater extent in Cx40-1- compared to Cx37_1_ mice. Taken together, the results 
suggest a greater role for Cx40 rather than Cx37 within the endothelium of blood vessels 
and that decreased Cx40 expression, but not Cx37, may be involved in the development of 
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hypertension. Whether similar differential reductions in propagation can be demonstrated 
in the endothelium of the thoracic aorta and caudal artery in the SHR remains to be 
determined. 
Reduction in the coupling of cells within both the media and endothelium of the 
caudal artery in the SHR were not correlated with a reduction in EDHF-mediated relaxation 
in the SHR. While relaxation was not significantly different in WKY and SHR, the ACh 
induced ED HF-mediated hyperpolarization in SHR was 28% less than that in WKY. This 
reduction is likely to be due to the pr~sence of a depolarization and contraction in the SHR, 
which was uncovered following the blockade of EDHF with charybdotoxin and apamin. In 
the WKY, a similar contraction was found following the blockade of EDHF however, this 
was not consistently associated with a depolarization (4 out of 8 animals). Furthermore, the 
EDH~-mediated response, but not the NO-mediated response, in the caudal artery of the 
WKY and SHR, is dependent on gap junctional coupling within the vascular wall since it 
was blocked by the Cx mimetic peptides. Indeed, these results concur with other studies 
which demonstrate that a blockade of gap junctions with 18~-GA and / or Cx-mimetic 
peptides is associated with a significant attenuation of EDHF relaxation (Chaytor et al. 
2001; Griffith et al. 2002; Sandow et al. 2002), but not the relaxation attributed to NO. 
The maintenance of the EDHF response in the face of reduced coupling in the media and 
endothelium of the SHR thus appears to be due to the up-regulation of MEGJs in the SHR 
(Sandow et al. 2003b). No role was found for the involvement of an epoxyeicosatrienoic 
acid- mediated activation of BKca channels, or for L-NAME insensitive NO in the EDHF 
mediated response in the caudal artery. This is in contrast to other vessels such as the 
mesenteric artery, where an L-NAME insensitive NO component has been described 
(Chauhan et al. 2003). 
In conclusion, the results presented in this Chapter demonstrate that heterogeneity in 
anatomical remodeling and electrical coupling of the smooth muscle and endothelium 
occurs between different vascular beds in a single model of hypertension. Alterations in Cx 
expression were found in the media and endothelium of both vessels, although the specific 
isoform of Cx involved was different in the two vessels and within the two cellular layers. 
The presence of vascular remodeling in a muscular artery, but not in conduit vessels, 
supports a role for such changes in the development of hypertension. In the aorta, 
significant changes could be identified in cellular coupling even in the absence of gross 
anatomical remodeling, suggesting that such changes may not be associated with 
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hypertension. Changes in Cx expression 1n the caudal artery of hypertensive rats 
corresponded with changes in cellular coupling in the media, and thus could have important 
implications for vascular disease. 
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CHAPTER6 
VASCULAR CHANGES AND CONNEXIN EXPRESSION IN THE 
THORACIC AORTA AND CAUDAL ARTERY IN RELATION TO 
THE ONSET OF HYPERTENSION 
6.1 INTRODUCTION 
As discussed in Chapter 5, Cx expression and cellular morphology are altered in 
both vascular layers of arteries from adult hypertensive rats, with the type and nature of the 
remodeling observed during hypertension depending on the vessel examined. However, 
whether vascular remodeling is a cause or a consequence of increased blood pressure is 
controversial. Early studies examining vascular remodeling in the SHR have shown that 
morphological changes can be characterized as either primary or secondary. It has 
generally been noted that in large elastic arteries such as the superior mesenteric artery and 
the aorta, vascular remodeling is a secondary adaptive response, developing after the 
increase in blood pressure has become evident. In contrast, in large and small muscular 
arteries, including the peripheral mesenteric arterial bed, structural changes have been 
observed in the pre-hypertensive SHR. These primary changes usually involve an increase 
in the medial cross-sectional area and an increase in the number of smooth muscle cell 
layers. The exact nature underlying the vascular remodeling varies with the blood vessel 
being examined and the specific stages in the development of hypertension (Lee, 1985; 
1987; Norrelund et al. 1994; Dickhaut & Lee, 1997; Van Gorp et al. 2000). Thus, there 
is evidence to suggest that vascular remodeling can occur prior to increased blood pressure, 
or as an adaptive response, whereby remodeling may contribute to the maintenance of 
elevated blood pressure. 
As discussed in Chapter 5, changes in vascular morphology occur in parallel with 
altered cellular coupling in the caudal artery, but not in the thoracic aorta. In this Chapter, 
Cx expression within the endothelial and smooth muscle cell layers of the aorta and caudal 
artery from pre-hypertensive animals is investigated. Changes in endothelial cell 
morphology were also examined in parallel with changes in Cx expression. In the SHR, a 
significant increase in blood pressure does not occur until 9 weeks of age (Chapter 5), 
although blood pressure shows a trend to increase from 4 weeks of age. Consequently, 3-
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week old animals were defined to be pre-hypertensive in the present study, as blood 
pressure at this age was not different from normotensive age-matched animals. Endothelial 
cell morphology and vascular Cx expression at 3 weeks in WKY and SHR was compared 
with that of 12 week old normotensive and hyp·ertensive animals, as examined in Chapter 5. 
The data from the 12 week rats is included in some of the Figures to facilitate comparisons. 
Little is ~own regarding the changes that occur in Cx expression in the 
cardiovascular system during development and aging. Recently, the pattern of Cx 
expression in rat aortic endothelium has been shown to vary during development (Yeh et al. 
2000). Within the endothelium, Cxs 37, 40 and 43 were shown to have distinct patterns of 
expression. All were highly expressed at birth; however, expression was immediately 
down-regulated within the first weeks following birth. Following this period, Cxs 37 and 
43 continued to be down-regulated in a Cx specific pattern, while Cx40 expression was 
maintained at a constant level throughout . development and into adulthood (Yeh et al. 
2000). Changes in Cx expression were also accompanied by increases in endothelial cell 
size in the aorta (Yeh et al. 2000). 
In the vascular smooth muscle, changes in Cx expression have been shown to occur 
in parallel with changes in cell function in the aorta. During postnatal development, 
smooth muscle cells of the synthetic phenotype predominate in the aortic wall where they 
undergo mitosis and synthesize large amounts of extracellular matrix to result in a 
thickening of the media and the formation of elastic laminae (Nakamura, 1988; Blackburn 
et al. 1997). In fully developed vessels, smooth muscle cells of the contractile phenotype 
predominate. In the prenatal rat aorta, smooth muscle cells show increased levels of Cx43, 
in parallel with rapid growth of the aortic media and the presence of the synthetic smooth 
muscle cell phenotype. Cx43 expression was at its highest 1 week postnatal, with 
expression decreasing to be maintained a constant level into adulthood (Blackburn et al. 
1997). Therefore in the vascular media, an increase in Cx43 expression may act to 
maintain smooth muscle cells in the synthetically active phenotype that is required for the 
rapid growth of the media. Interestingly, the. peak in Cx43 expression at 1 week 
corresponded with a transient increase in blood pressure (Blackburn et al. 1997). In 
contrast to these studies, results of the previous Chapter suggest that Cx expression is 
decreased in the aorta of hypertensive rats, although it is not known what happens during 
the pre-hypertensive phase. No studies have yet examined the expression of all 4 vascular 
Cxs in other blood vessels during development. 
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6.2 RESULTS 
6.2.1 Expression ofmRNAfor vascular connexins in 3 week old rats 
Expression of mRNA for all four Cxs was similar in the thoracic aorta, and did not 
differ between WKY and SHR (P>0.05, Figure 6. lA). In the caudal artery the expression 
of mRNA for Cx37 was significantly greater than mRNA expression of Cxs 40, 43 and 45 
in both the WKY and SHR. Expression of Cxs 37 and 45 in the SHR was significantly 
greater than in the WKY (P<0.05, Figure 6. lB). Cxs 40 and 43 were also detected in small 
amounts in the caudal artery, however expression did not differ between WKY and SHR 
(Figure 6. lB). 
During development between 3 and 12 weeks of age, expression of mRNA for Cxs 
43 and 45 in the thoracic aorta increased in the WKY at 12 compared to 3 weeks of age 
(P<0.05, Figure 6. lA,C), while in the SHR expression did not differ (P>0.05). The 
expression of mRNA for Cxs 37 and 40 did not differ between 3 and 12 weeks in either the 
WKY or SHR (P>0.05, Figure 6. lA,C). In the caudal artery, mRNA for Cxs 37, 40 and 43 
were decreased at 12 weeks compared to 3 weeks of age in both WKY and SHR (P<0 .05 , 
Figure 6.IB,D). In a similar manner, expression of mRNA for Cx45 was decreased in the 
caudal artery of the SHR at 12 weeks (P<0.05), while there was no change in Cx45 mRNA 
in the WKY between 3 and 12 weeks of age (P>0.05, Figure 6.IB,D). 
6.2.2 Endothelial cell morphology 
En face views of the luminal surface showed · a typical pattern of Cx expression, 
with punctate staining along the periphery of endothelial cells (Figure 6.3). No areas 
devoid of endothelial cells were found. 
At 3 weeks of age, endothelial cell surface area, length, width and perimeter were 
not significantly different between SHR and WKY in either the thoracic aorta or caudal 
artery (P>0.05, Figure 6.2). 
In the thoracic aorta of WKY rats, between 3 and 12 weeks of age, surface area, 
length, width and perimeter of endothelial cells was significantly greater at 12 weeks than 
at 3 weeks of age (P<0.05 , Figure 6.2A). In SHR rats between 3 and 12 weeks, surface 
area, width and perimeter of endothelial cells was significantly greater at 12 weeks than at 3 
weeks (P<0.05), however, length of endothelial cells did not differ (P>0.05 , Figure 6.2A). 
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Figure 6.1 
Figure 6.1. 
mRNA expression of Cxs 37, 40, 43 and 45 in the thoracic aorta (A,C) and 
caudal artery (B,D) of 3 (A,B) and 12 (C,D) week old WKY and SHR. Values are 
mean± SEM. *P<0.05, significantly different from the WKY. tP<0.05, significantly 
different from 3 week animals. Copy numbers are expressed per copy of 18S ribosomal 
RNA by using plasmid standard curves. Data for 12 week animals is duplicated from 
Chapter 5 for comparison. 
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Figure 6.2 
Figure 6.2. 
Morphology of endothelial cells from the thoracic aorta (A) and caudal artery 
* (B) of 3 and 12 week old WKY and SHR rats. Values are mean± SEM. P<0.05, 
significantly less than age matched WKY. tP<0.05, significantly different from 3 week 
old strain matched rats. n=3-4. Data for 12 week animals is duplicated from Chapter 5 
for comparison. 
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In the caudal artery of WKY rats, between 3 and 12 weeks of age, there was no 
significant change in the surface area, length, width or perimeter of endothelial cells 
(P>0.05, Figure 6.2B). In SHR rats over the same developmental period, endothelial cell 
surface area, length and perimeter decreased significantly (P<0.05) , while width did not 
change during development (P>0.05, Figure 6.2B). 
6.2.3 Immunohistochemistry of vascular connexins 
Endothelium. In the thoracic aorta of the WKY at 3 weeks of age, expression of 
Cxs 37 and 40 was significantly greater than for Cx43 (P<0.05, Figure 6.3A-D). In the 
SHR, all 3 Cxs were expressed at similar levels (P>0.05, Figure 6.3E-H, 6.5A). Expression 
of Cxs 3 7, 40 or 43 per endothelial cell did not differ between WKY and SHR at 3 weeks of 
( 
age (P>0.05, Figure 6.5A). In the caudal artery, at 3 weeks of age, Cxs 37, 40 and 43 were 
all expressed equally per endothelial cell within both WKY and SHR rats (Figure 6.4, 
6.5B). Expression of Cxs 37 and 43 per endothelial cell in the SHR was not significantly 
different from that in WKY rats, while Cx40 was significantly lower than expression within 
the WKY (P<0.05, Figure 6.5B). 
When Cx expression per endothelial cell at 3 weeks was compared to 12 weeks of 
age (see Chapter 5) in the thoracic aorta, expression of all three Cxs was significantly 
greater at 12 weeks than at 3 weeks in both the WKY and SHR (P<0.05, Figure 6.5A,E). 
In contrast, in the caudal artery of the WKY, expression of Cxs 37, 40 and 43 showed no 
significant change between 3 and 12 weeks (P>0.05, Figure 6.5B,F). On the other hand, in 
SHR rats, the expression of all three Cxs was significantly lower at 12 weeks compared to 
expression at 3 weeks of age (P<0.05, Figure 6.5B,F). There was no significant difference 
in plaque size for any of the three Cxs between WKY and SHR rats at either age (P>0.05), 
however the size of Cx40 plaques increased between 3 and 12 weeks in the SHR (P<0 .05 , 
Table 6.1). 
Since the Cx expression in the endothelium was almost exclusively around the cell 
perimeter (Figures 6.3, 6.4), the density of Cx plaques per 100 µm of endothelial cell 
perimeter was also calculated. At 3 weeks of age, the density of Cx plaques in the thoracic 
aorta did not differ between WKY and SHR (P>0.05 , Figure 6.5C); however, in the caudal 
artery expression of Cx40 was significantly reduced in the SHR compared to the WKY 
(P<0.05, Figure 6.5D). In the thoracic aorta between 3 and 12 weeks of age, the density of 
Cxs 37 and 40 were significantly increased in the WKY at 12 weeks compared to 3 weeks 
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Figure 6.3 
Figure 6.3. 
Cx expression in endothelial cells from the thoracic aorta of WKY (A-D) and 
SHR (E-H) rats at 3 weeks of age. The endothelium is viewed en face following 
incubation in antibodies against Cxs 37 (B,F), 40 (A,C,E,G) and 43 (D,H). Typical 
punctate Cx expression delineates the borders of endothelial cells. Panels B-D and F-H 
are magnified images illustrating Cx plaques outlining the perimeter of endothelial 
cells. Calibration bars represent 20 µm. 
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Figure 6.4 
Figure 6.4. 
Cx expression in endothelial cells from the caudal artery of WKY (A-D) and 
SHR (E-H) rats at 3 weeks of age. The endothelium is viewed en face following 
incubation in antibodies against Cxs 37 (B,F), 40 (A,C,E,G) and 43 (D,H). Typical 
punctate Cx expression delineates the borders of endothelial cells. Panels B-D and F-H 
are magnified images illustrating Cx plaques outlining the perimeter of endothelial 
cells . Calibration bars represent 20 µm. 
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Figure 6.5 
Figure 6.5. 
Expression of protein for Cxs 37, 40 and 43 in the endothelium of the thoracic 
aorta (A,C,E,G) and caudal artery (B,D,F,H) of 3 (A-D) and 12 (E-H) week old WKY 
and SHR rats. Cx plaques are expressed per endothelial cell (A,B,E,F) and as the 
density of Cx plaques per 100 µm of endothelial cell perimeter (C,D,G,H) . Values are 
mean + SEM. *P<0.05 , significantly different from Cx expression in the WKY. 
tP<0.05, significantly greater than 3 week animals. n=3-4 animals. Data for 12 week 
animals is duplicated from Chapter 5 for compa~ison. 
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strain vessel age number of Cx37 Cx40 Cx43 (weeks) animals plaque size (µm 2) 
SHR ThA 3 3 0.13 + 0.001 0.13 + 0.001 * 0.13 + 0.004 
WKY ThA 3 3 0.13 + 0.003 0.13 + 0.002 0.14 + 0.004 
SHR CA 3 4 0.15 + 0.003 0.15 + 0.003 0.15+0.01 
WKY CA 3 4 0.15 + 0.002 0.14 + 0.002 0.16 + 0.003 
Table 6.1. Cx plaque size (µm 2) in the endothelium of the thoracic aorta (ThA) and 
caudal artery (CA) of the 3 week old WKY and SHR. Values are mean+ SEM. 
*P<0.05, significantly less then 12 weeks. n=4. 
* 
of age, while Cxs 40 and 43 were increased in the SHR at 12 weeks (P<0.05 , Figure 
6.5C,G). In the caudal artery between 3 and 12 weeks of age, the density of Cx plaques did 
not differ in either the WKY or SHR (P>0.05 , Figure 6.5D,H). 
In each case, no Cx labeling was observed in the absence of primary antibody, or 
following pre-incubation of primary antibody with its antigenic peptide. 
Smooth muscle. Longitudinal and transverse sections of the 3-week old thoracic 
aorta and caudal artery taken from the WKY and SHR were analyzed for the medial 
expression of Cxs 37, 40, 43 and 45. Cx37 was sparsely expressed in the thoracic aorta in 
both strains (Figures 6.6A,E). In the caudal artery Cx37 expression was more abundant, 
but did not differ between WKY and SHR rats (P>0.05, Figures 6.7 A,E, 6.8B,D). Cx40 
could not be detected in the media of the thoracic aorta or caudal artery from either strain 
(Figures 6.6B,F, 6.7B,F). Cx43 was abundantly expressed in the media of the thoracic 
aorta and did not differ between WKY and SHR (P>0.05, Figures 6.6C,G, 6.8A,C), but was 
not detected in the media of the caudal artery of either strain (Figures 6.7C,G). The 
expression of Cx43 in the thoracic aorta of both the WKY and SHR was significantly 
greater than expression of any other Cx (P<0.05, Figure 6.6, 6.7, 6.8A,C). Cx45 was 
sparsely detected in the media of both arteries studied and did not differ between 
longitudinal and transverse sections (P<0.05, Figure 6.6D,H, 6.7D,H, 6.8). In the thoracic 
aorta, Cx45 expression did not differ between WKY and SHR. However, in the caudal 
artery, Cx45 expression was significantly greater in transverse sections in the SHR 
compared to the WKY (P<0.05, Figures,6.8A-D). 
In transverse sections of the thoracic aorta, between 3 and 12 weeks of age ( see 
Chapter 5), expression of Cx3 7 was increased in both the WKY and SHR at 12 weeks 
compared to 3 weeks of age (P<0.05, Figure 6.8C,G). Cx43 was increased in transverse 
sections of the WKY thoracic aorta at 12 weeks of age (P<0.05, Figure 6.8C,G), while 
expression was not altered in the SHR during development. The expression of Cx45 in the 
thoracic aorta was increased during development in the WKY (Figure 6.8C,G). In 
transverse sections of the caudal artery, between 3 and 12 weeks, expression of Cx37 did 
not differ in either the WKY or the SHR. Expression of Cx45 was greater at 12 weeks 
compared to 3 weeks of age in transverse sections of both the WKY and SHR (P <0.05 , 
Figure 6.8D,H). Cx expression did not differ in longitudinal sections of either the thoracic 
aorta or caudal artery between 3 and 12 weeks . 
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Figure 6.6 
Figure 6.6. 
Expression of Cxs 37 (A,E), 40 (B,F), 43 (C,G) and 45 (D,H) in the media of the 
thoracic aorta from 3 week old WKY (A-D) and SHR (E-H) (transverse sections). e, 
endothelium, sm, smooth muscle. Calibration bar represents 10 µm. 
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Figure 6.7. 
Expression of Cxs 37 (A,E), 40 (B,F), 43 (C,G) and 45 (D,H) in the media of the 
caudal artery from 3 week old WKY (A-D) and SHR (E-H) (transverse sections). e, 
endothelium, sm, smooth muscle. Calibration bar represents 10 µm. 
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Figure 6.8. 
Protein expression for Cxs 37, 40, 43 and 45 in the smooth muscle of the 
thoracic aorta (A,C,E,G) and caudal artery (B,D,F,H) of 3 (A-D) and 12 (E-F) week old 
WKY and SHR rats. Values are expressed as plaques per µm 2 in longitudinal (A,B,E,F) 
and transverse (C,D,G,H) sections. Values are mean+ SEM. *P<0.05 , significantly 
different to WKY. t P<0.05, significantly different to 3 week animals. n=4 animals. 
Data for 12 week animals is duplicated from Chapter 5 for comparison. 
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6.3 DISCUSSION 
The results of the current Chapter have demonstrated several differences in the time 
course of the morphological development and Cx expression in the thoracic aorta and the 
caudal artery of WKY and SHR. While the caudal artery appeared to be developmentally 
mature at 3 weeks, the thoracic aorta was still relatively immature, in that changes in Cx 
expression and cell size continued to occur in the latter vessel. Thus, the morphological 
differences and alterations in Cx expression observed in the 3 month hypertensive rats 
compared to the normotensive rats represented a failure of the normal developmental 
increase in Cx expression in the aorta, but a selective decrease in cell size and Cx 
expression in the caudal artery. Furthermore, in the caudal artery of the SHR, a decrease in 
the expression of Cx40 within the endothelium and an increase in Cx45 within the smooth 
muscle precede the increase in blood pressure, thus suggesting a causative role for these 
Cxs in the development of hypertension. In contrast, in the thoracic aorta, Cx expression 
was similar in both the WKY and SHR in the pre-hypertensive period, suggesting no role in 
the development of hypertension. 
During normal .vascular development of the thoracic aorta in the WKY rat, 
endothelial cell size increased with age in a similar pattern to that previously reported (Yeh 
et al. 2000). In parallel, expression of protein for all 3 Cxs per endothelial cell was 
significantly increased during development. However, when expressed as the density of Cx 
plaques per length of cell membrane, the increase in Cx43 expression per endothelial cell 
resulted simply from the increase in cell size, while the density of Cxs 37 and 40 increased 
during development. In contrast to these results Yeh et al. (2000), reported that the 
expression of Cx43 was reduced in the thoracic aorta during development, while Cx40 
remained highly expressed throughout development and into old age, and expression of 
Cx37 fluctuated. The reason for this discrepancy in results may reflect the time points 
' examined in each study. While Yeh et al. (2000), studied expression between 4 weeks and 
16 months, no intermediate time points were examined. In contrast to the thoracic aorta, 
endothelial cell size and Cx protein expression in the caudal artery of the WKY were 
maximal at 3 weeks of age with no further increase seen at 12 weeks, suggesting that 
development of the caudal artery may occur more rapidly than that for the thoracic aorta. 
Furthermore, the differing results may reflect the functional differences between the two 
blood vessels. The thoracic aorta is a large conduit vessel and as such has little role in the 
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control of peripheral resistance and therefore blood pressure. On the contrary, control of 
peripheral resistance occurs within muscular arteries (Folkow, 1982; Christensen & 
Mulvany, 2001 ). Therefore it is likely that development of these latter vessels may be more 
advanced at a younger age to ensure the maintenance of vascular haemodynamics and 
efficient tissue perfusion. 
In the thoracic aorta of the SHR, endothelial ·cell size increased in a similar pattern 
during development to that observed in the WKY, suggesting that endothelial cell 
development is not affected by, or contributes to increased blood pressure. However, in 
other studies a transient increase in cell size has been described in the thoracic aorta of 
animals made hypertensive by aortic ligation, although such a possibility cannot be 
excluded in the present study (Hlittner et al. 1979). In parallel with the increase in cell 
size, expression of Cxs 37, 40 and 43 within the endothelium of the thoracic aorta also 
increased during development. The reduced expression of Cx3 7 in the SHR compared to 
the WKY at 12 weeks is likely to result from a failure of the developmental increase in 
Cx37 as seen in the WKY. The reduced Cx37 expression was apparently due to a smaller 
number of plaques per endothelial cell and not changes in individual plaque size. A lack of 
change in gap junctional area has also been reported in the thoracic aorta of various 
hypertensive models (Hlittner et al. 1982; McGuire & Twietmeyer, 1985), although 
transient increases in gap junctional area have been reported during the period prior to 
blood pressure reaching maximal levels (McGuire & Twietmeyer, 1985). In contrast to the 
thoracic aorta, in the caudal artery of the SHR, endothelial cell size and Cx expression are 
decreased during development, since endothelial cells at 12 weeks of age were significantly 
smaller (30%) than those in 3 week old, pre-hypertensive SHR. As the effect on cell size 
was due to a reduction in cell length rather than cell width, any increase in the total number 
of endothelial cells in the SHR would be manifest in the longitudinal, rather than in the 
radial direction. However since the smaller luminal circumference ( 18%) in the SHR 
compared to the WKY would result in a 33% reduction in endothelial surface area per unit 
length of artery then it is possible that the reduction in endothelial cell size occurs 
secondarily to alterations in vascular geometry. In parallel with reduced endothelial cell 
size, expression of protein for Cxs 3 7, 40 and 43 within the endothelium· of the caudal 
artery decreased significantly during development, due to a reduction in the number of gap 
junctional plaques per cell, rather than a reduction in individual plaque size. 
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As described in Chapter 4, mRNA preparations of arteries included smooth muscle 
cells and endothelial cells, however, in these preparations, smooth muscle cells 
predominate. In the thoracic aorta of WKY during development, expression of mRNA and 
protein for Cxs 43 and 45 in the smooth muscle increased, while expression of Cxs 3 7 and 
40 was maximal at 3 weeks of age. A transient peak in Cx43 expression has been reported 
in smooth muscle cells of the thoracic aorta of 7-day old normotensive rats (Blackburn et 
al. 1997), which occurred in association with a developmental rise in blood pressure and a 
period when smooth muscle cells were undergoing proliferation, before differentiating into 
the contractile phenotype (Nakamura, 1988). Similarly, in the present study, an increase in 
both Cxs 43 and 45 occurred in parallel with the normal developmental rise in blood 
pressure. While there was abundant expression of protein for Cx43 in the thoracic aorta at 
3 weeks, this was not reflected in mRNA expr,ession. This may reflect the differential 
turnover of Cxs in young animals. In the caudal artery of the WKY, expression of mRNA 
for Cxs 37, 40 and 43 was maximal at 3 weeks of age, mRNA expression decreasing 
between 3 and 12 weeks. In contrast, the expression of protein for Cx45 increased in the . 
smooth muscle during development. Together these results suggest that within the thoracic 
aorta, Cxs 43 and 45 are required for normal development, while in the caudal artery Cx45 
may be more important. In the caudal artery at 3 weeks of age, expression of Cx45 was 
significantly greater in transverse but not in longitudinal sections of the SHR. As detailed 
in Chapter 5, the difference between longitudinal and transverse sections may reflect an 
increased role for radial rather than longitudinal coupling of smooth muscle cells in the 
caudal artery. 
In the aorta of the SHR, the expression of mRNA and protein for all 4 Cxs was 
maximal at 3 weeks of age. During development, unlike in the WKY; there was no change 
in the expression of either Cxs 43 or 45. Together, these results suggest a role for Cx43 
and to a lesser extent, Cx45 during development of smooth muscle cells within 
normotensive rats, while such a role may be altered in the SHR. In the caudal artery, 
expression of mRNA for Cxs 37 and 45, the 2 major Cxs expressed in the caudal artery 
(Chapter 4), were increased in the SHR at 3 weeks and expression was down regulated 
during development. While expression of protein for Cx45 was also increased at 3 weeks 
of age in the SHR, no such change was seen for Cx37. The increase in Cx45 may be 
associated with early medial remodeling, which occurs in the SHR. 
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At 3 weeks of age, before a significant increase in blood pressure could be recorded 
in SHR animals, there was a trend for the expression of Cxs 3 7, 40 and 43 to be less in the 
endothelium of the caudal artery compared to the WKY, and this reached significance for 
Cx40. In contrast, in the media of the caudal artery, expression of Cx45 was greater in the 
SHR compared to the WKY at 3 weeks. The observed trend to a decrease in Cx expression 
in the endothelium and an increase in expression in the media at 3 weeks may suggest a 
causative role for these changes in the development of the hypertension. Alternatively, 
these differences may reflect inherent differences between the two strains. In terms of 
cause and effect, treatment of the SHR with anti-hypertensive drugs such as ACE 
inhibitors, will be necessary to differentiate between these two hypotheses. Other changes, 
' 
which are associated with hypertension, have been reported in the blood vessels of pre-
hypertensive rats, such as an up-regulation of Rho-kinase, which is thought to precede the 
development of hypertension (Mukai et al. 2001 ). In contrast to the caudal artery, there 
was no significant difference in Cx expression within the endothelium or in the medial 
layers of the thoracic aorta between WKY and SHR at 3 weeks of age. 
In conclusion, the results presented in this Chapter have demonstrated that the 
reductions in the expression of Cx40 in the endothelium of the caudal artery at 12 weeks of 
age (Chapter 5) are also present in pre-hypertensive rats. In a similar manner, there was an 
increase in the expression of Cx45 in the media, suggesting that such changes may 
contribute to the development of hypertension. In contrast, no changes in cellular 
morphology or Cx expression were found in the thoracic aorta before the onset of 
hypertension. These results indicate that remodeling of the endothelium in both the 
thoracic aorta and caudal artery, and the changes observed in Cx expression in the smooth 
muscle and endothelium of the thoracic aorta at 12 weeks of age, as demonstrated in 
Chapter 5, may occur in response to elevated blood pressure rather than contributing to the 
development of hypertension. 
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CHAPTER 7 
CONNEXIN EXPRESSION AND VASCULAR REMODELING IN 
RESISTANCE ARTERIES DURING HYPERTENSION 
7.1 INTRODUCTION 
Blood vessels contributing significantly to peripheral vascular resistance are termed 
resistance arteries and include arterioles and small arteries with diameters less than 500 µm 
(Johnson & Hanson, 1962). Resistance arteries are thought to play a major role in the 
development and or maintenance of diseases such as hypertension (Folkow, 1982; 
Christensen & Mulvany, 2001). Unlike the systemic circulation where small arteries and 
arterioles are the main sites of peripheral vascular resistance, in the cerebral circulation, the 
major site of resistance to blood flow occurs in larger arteries such as the basilar artery 
(Faraci & Heistad, 1990). 
During hypertension, alterations in vascular function have been reported in both the 
systemic and cerebral circulation. For example, reduced endothelium-dependent and flow-
mediated relaxation has been reported in mesenteric arteries of the SHR and SHR-SP (Fujii 
et al. 1990; Sunano et al. 1999). Similarly, in the basilar and middle cerebral arteries and 
in cerebral arterioles of the SHR and SHR-SP, agonist induced endothelium-dependent 
vasodilation is impaired (Faraci, 1992; Faraci & Heistad, 1998). Other functional 
properties including vasomotion are also altered in many vascular beds during hypertension 
(Lefer et al. 1990; Shimamura et al. 1999). Cell communication via gap junctions is 
known to play an important role in many functional properties including the conduction of 
endothelial responses and vasomotion (Chaytor et al. 1997; Segal et al. 1999; Shimamura 
et al. 1999; Emerson & Segal, 2001 ). Thus the altered expression of gap junctions may 
contribute to the alteration of many these functional responses during hypertension 
(Shimamura et al. 1999). 
Concomitant with the functional changes observed during hypertension, vascular 
remodeling has been reported in both the mesenteric and cerebral arteries of the 
hypertensive rat. Within cerebral vessels, eutrophic remodeling has pi:edominantly been 
described. For example, in the basilar artery and branches of the posterior cerebral artery 
of the adult SHR-SP, a reduction in both the external and luminal diameter has been 
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demonstrated, in combination with an increased medial to lumen ratio, all characteristics of 
eutrophic remodeling (Baumbach & Heistad, 1989; Hajdu & Baumbach, 1994; Arribas et 
al. 1996). Within the mesenteric arteries, hypertrophic remodeling has been consistently 
reported in the SHR and SHR-SP, however, whether such remodeling involves hypertrophy 
or hyperplasia of smooth muscle eel ls varies depending on factors such as the stage of 
hypertension and the region of vessel examined (Mulvany et al. 1978, 1985; Lee et al. 
1983; Lee & Smeda, 1985; Lee, 1985, 1987; Dickhaut & Lee, 1997). Thus these studies 
clearly indicate the heterogeneous nature of medial changes amongst different blood 
. vessels, with both hypertrophic and · eutrophic remodeling having been demonstrated in 
vessels of the SHR. In contrast to studies within the smooth muscle, data regarding 
morphological changes within the · endothelium during hypertension is limited, previous 
studies having focused on the thoracic aorta, as detailed in Chapter 1. 
, 
In Chapter 5, Cx expression was shown to be differentially altered in the 
endothelium and smooth muscle of functionally different blood vessels during 
hypertension. These changes were accompanied by altered cellular morphology in the 
caudal artery but not in the thoracic aorta during hypertension. In this Chapter, we have 
examined the morphology of endothelial and smooth muscle cell layers and the distribution 
of Cxs within the primary mesenteric and basilar arteries during hypertension. These 
arteries were chosen as they represent resistance arteries of the systemic and cerebral 
circulation respectively (Faraci & Heistad, 1998). The results presented in this Chapter, in 
parallel with Chapter 5, provide a systematic examination of vascular changes occurring in 
several different blood vessels within a single model of hypertension. As a functional 
correlate of endothelial cell changes, we have examined the conduction of vasodilatory 
responses within the endothelial layer of the mesenteric . artery in normotensive and 
hypertensive rats. 
7.2 RESULTS 
7.2.1 Vessel morphology 
Morphological characteristics of the vascular media were determined from electron 
micrographs of the mesenteric and basilar arteries of 12 week old WKY and SHR. The 
number of smooth muscle cell layers and the medial cross-sectional area were significantly 
greater in the 1nesenteric artery of the SHR compared to the WKY (P<0.05, Table 7.1). In 
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strain vessel luminal 
diameter (µm) 
SHR MA 205 + 99 
WKY MA 198 + 12 
SHR BA 212 + 14 
WKY BA 234 + 1.2 
smooth muscle 
layers 
9.4 + 1.4 
4.3 + 0.3 
5.1 + 0.5 
5.3 + 0.6 
* 
medial cross-
sectional area (µm 2) 
37,248 + 201 * 
7510 + 616 
9154 + 1065 
9257 + 260 
Table 7.1. Characteristics of mesenteric (MA) and basilar arteries (BA) from 12 week 
WKY and SHR rats. Values are mean+ SEM. *P<0.05 , significantly different to 
WKY. n=3. 
the mesenteric artery, the luminal diameter was similar in both the WKY and SHR (Table 
7.1). In the basilar artery, there was no change in luminal diameter, the number of smooth 
muscle cell layers or the medial cross-sectional area between the _WKY and SHR (Table 
7.1). 
7.2.2 Endothelial cell morphology 
En face views of the luminal surface showed a typical pattern of Cx expression, 
delineating the periphery of endothelial cells in both the mesenteric and basilar arteries 
(Figures 7 .2 and 7 .3 respectively). No areas devoid of endothelial cells were found. 
In the mesenteric artery, surface area and length of endothelial cells were 
significantly less in the SHR compared to the WKY (P<0.05, Figures 7.1, 7.2), while 
perimeter and width of endothelial cells were not significantly different. In the basilar 
artery there was no significant difference in surface area, length, perimeter or width of 
endothelial cells between the WKY and SHR (Figure 7 .1 ). Endothelial cell morphology 
was not significantly different between the two vessels in WKY (Figure 7 .1 ). 
7.2.3 Connexin protein expression in the vascular endothelium 
For each of the Cx antisera used here, no staining was observed in the absence of 
the primary antibody or when the primary antibody was pre-incubated with the appropriate 
antigenic peptide. 
En face views of the luminal surface showed punctate staining for Cxs 37, 40 and 
43 along the periphery of endothelial cells in the mesenteric artery (Figure 7 .2A-C, E-G), 
while in the basilar artery, Cx staining was arranged continuously along the periphery of 
endothelial cells rather than in a punctate fashion (Figure 7 .3A-C, E-G). Cx45 was not 
found in the endothelium of either artery (Figures 7.2D,H, 7.3D,H). 
As Cx labelling in the basilar artery did not appear in clearly defined plaques, Cx 
labelling was expressed as the area occupied by Cx staining per endothelial cell. In the 
mesenteric artery of the SHR, expression of both Cxs 37 and 40 were significantly reduced 
(P<0.05 , Figures 7.2, 7.4A). In the basilar artery, expression of Cx37 per endothelial cell 
was significantly less in the SHR compared to the WKY (P<0.05 , Figures 7.3A,E, 7.4B). 
As Cx expression in the endothelium was seen exclusively around the cell periphery 
and the surface area of endothelial cells was less in mesenteric arteries of the SHR, the 
density of Cx plaques in the cell membrane was also calculated. Area of Cx37 staining per 
87 
Figure 7.1 
Figure 7.1. 
Morphology of endothelial cells from 12 week old WKY and SHR mesenteric 
(MA) and basilar arteries (BA). Values are mean + SEM. *P<0.05, significantly 
different from the WK Y. n=4 animals. 
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Figure 7.2. 
Cx protein expression in the mesenteric artery of 12 week old WKY and SHR. 
The endothelium is viewed en face and is labelled with antibodies to Cx3 7 (A,E), Cx40 
(B,F), Cx43 (C,G) and Cx45 (D,H). Labelling of Cxs 37, 40 and 43 is evident along the 
perimeter of endothelial cells, while labelling of Cx45 was not detected. Calibration bar 
represents 20 µm. 
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Figure 7.3 
Figure 7.3. 
Cx protein expression in the basilar artery of 12 week old WKY and SHR. The 
endothelium is viewed en face and is labelled with antibodies to Cx37 (A,E), Cx40 
(B,F), Cx43 (C,G) and Cx45 (D,H). _Labelling of Cxs 37, 40 and 43 is evident along the 
perimeter of endothelial cells, while labelling of Cx45 was not detected. Calibration bar 
represents 20 µm. 
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Figure 7.4. 
Protein expression for Cxs 37, 40, 43 and 45 in the endothelium of the 12 week 
old WKY and SHR n1esenteric (A,C) and basilar arteries (B,D). Values are expressed 
as the area of Cx staining per endothelial cell (A,B) and area of Cx staining per 100 µm 
of endothelial cell perimeter (C,D). Values are mean+ SEM. *P<0.05, significantly 
different from Cx expression in the WKY. n=4 animals. 
A Mesenteric Artery 
-
-Q) 
0 
-n:s 
•-
-Q) 
.c: 
...., 
0 
-c 
C: 
Q) 
,_ 
Q) 
a. 
14 
· 12 
10 
8 
6 
4 
2 
0 
g> B 
•-c: 
•- 14 n:s 
U) 12 
>< 10 (.) 
'+- 8 0 
n:s 6 Q) 
~ 4 
2 
0 
Cx37 Cx40 Cx43 
Basilar Artery 
Cx37 Cx40 Cx43 
,_ 
Q) 
...., 
Q) 
E 
•-,_ 
Q) 
a. 
-
-Q) 
0 
'+-
0 
E 
::i. 
0 
0 
~ 
C 
12 
10 
8 
6 
4 
2 
0 
a; D 
a. 
c, 12 
C: 
•- 10 C: 
•-!9 8 ,.,, 
>< 6 (.) 
'+- 4 0 
n:s 2 Q) ,_ 
ct 0 
Mesenteric Artery 
Cx37 Cx40 Cx43 
Basilar Artery 
Cx37 Cx40 Cx43 
•wKY 
• SHR 
100 µm of endothelial cell perimeter in the mesenteric and basilar arteries was significantly 
less in the SHR than the WKY (P<0.05, Figures 7.4C,D). In the SHR, the density of Cxs 
37 and 40 expression in the mesenteric artery was significantly greater than in the basilar 
artery (P<0.05, Figures 7.4C,D), while Cx43 was not significantly different. In the WKY, 
there was no difference in Cx expression between the mesenteric and basilar arteries 
(Figures 7.4C,D). 
7.2.4 Conducted EDHF-mediated hyperpolarization and vasodilation 
The conduction of EDHF-mediated hyperpolarization and vasodilation was 
examined in the mesenteric artery of 12 week old WKY and SHR. The iontophoretic 
application of ACh (1 M), in the presence of L-NAME and indomethacin, to inhibit NO 
and prostaglandins respectively, produced an EDHF-mediated hyperpolarization and 
relaxation at the local site of application and when applied to sites 0.5, 1, 1.5, 2 and 2.5 mm 
downstream of the recording site in both WKY and SHR. At the local site, 
hyperpolarization and relaxation were not significantly different between WKY and SHR 
(P>0.05, hyperpolarization: WKY, -18.3 + 0.7, SHR, -15.8 + 0.8 mV; relaxation: WKY, 
26.0 + 2.5, SHR, 32.4 + 3.7 µm). When ACh was applied at sites 0.5, 1, 1.5 and 2 mm 
downstream .of the impaled cell, hyperpolarization was reduced in the SHR compared to the 
WKY (P<0.05, Figure 7.5A). In contrast, when ACh was applied at sites 0.5 mm and 1.5 
mm downstream of the recording site, relaxation was significantly less in the SHR than in 
the WKY (P<0.05 , Figure 7.6A). In WKY rats, incubation· of vessels in Ba2+ (30 µM) had 
no significant effect on hyperpolarization or relaxation when ACh was applied at the 
recording site (hyperpolarization: +Ba2+, -16.8 + 0.7 mV; relaxation: +Ba2+, 29.3 + 1.5 µm). 
However, hyperpolarization was reduced when ACh was applied at sites 0.5 and 1 mm 
downstream of the recording site, while the local relaxation was reduced when A Ch was 
applied 1 and 1.5 mm downstream (P<0.05 , Figures 7.5B, 7.6B). In the SHR, 
hyperpolarization and relaxation in response to ACh at the local site was not altered by the 
incubation of Ba2+ (P>0.05 , hyperpolarization: +Ba2+, -14.2 + 0.7 m V; relaxation: +Ba2+, 
31.1 + 3.8 µm) , nor was the conducted response to ACh altered (Figures 7.5C, 7.6C). 
When conducted hyperpolarization and relaxation responses in the presence of Ba2+ were 
compared in the WKY and SHR, there was no significant difference between the two 
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Figure 7.5 
Figure 7.5. 
Conducted EDHF-mediated hyperpolarization in the mesenteric artery of 12 week 
WKY and SHR. (A) EDHF-mediated hyperpolarization was recorded from smooth 
muscle cells following the iontophoretic application of ACh (1 M) at the local site and 
at defined distances downstream from the recording site. (B,C) Conducted EDHF-
mediated hyperpolarization recorded from smooth muscle cells of the WKY (B) and 
SHR (C) in the presence and absence of barium (Ba2+, 30 µM). (D) Conducted EDHF-
mediated hyperpolarization recorded from smooth muscle cells in the WKY and SHR, 
in the presence ofBa2+. All experiments were performed in the presence of L-NAME 
(100 µM) and indomethacin (10 µM). Values are expressed as the mean+ SEM of the 
% change in hyperpolarization. *P<0.05, significantly different from hyperpolarization 
recorded WKY (A) or Ba2+ (B). n=7 animals. 
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Figure 7.6 
Figure 7.6. 
Conducted EDHF-mediated vasodilatation in the mesenteric artery of 12 week 
WKY and SHR. (A) EDHF-mediated vasodilation was recorded following the 
iontophoretic application of ACh (1 M) at the local site and at defined distances 
downstream from the recording site. (B,C) Conducted EDHF-mediated vasodilation 
was also recorded in mesenteric arteries of the WKY (B) and SHR (C) in the presence 
and absence of barium (Ba2+, 30 µM). (D) Conducted EDHF-mediated vasodilation 
recorded from mesenteric arteries of the WKY and SHR, in the presence of Ba2+. All 
experiments were performed in the presence of L-NAME (100 µM) and indomethacin 
(10 µM). Values are expressed as the mean + SEM of the % change in vessel diameter. 
*P<0.05, significantly different from vasodilation recorded in WKY (A) or Ba2+ (B). 
n=7-8 animals. 
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strains (P>0.05, Figure 7.5D, 7.6D). Responses were completely abolished when the 
iontophoretic pipette was moved away from the preparation by 0.5 mm. 
7.3 DISCUSSION 
Alterations in the morphology of both the endothelium and media occurred in the 
mesenteric artery but not in the basilar artery of hypertensive rats, providing further 
evidence of the heterogeneous nature of vascular remodeling amongst different vascular 
beds within the SHR. In the mesenteric artery, cellular remodeling was accompanied by 
reduced expression of Cx37 in the endothelial cell layer, while in the basilar artery, the 
density of Cx3 7 expression was also reduced in the endothelium, however this occurred in 
the absence of changes in endothelial cell morphology. 
Irt the mesenteric artery, medial hypertrophy occurred in the SHR as a result of a 
doubling in the number of smooth muscle cell layers. The results presented in Chapter 5, 
demonstrated a similar, but smaller increase in the number of smooth muscle cell layers in 
the caudal artery of the SHR due to increases in smooth muscle cell number (Sandow et al. 
2003 b ). However in contrast to the caudal artery, luminal diameter of the mesenteric artery 
was similar in both the adult (> 3 months) WKY and SHR. These results are similar to 
results reported by others in the mesenteric artery of the SHR (Lee et al. 1983; Lee & 
Smeda, 1985; Mulvany et al. 1985). In contrast, other studies have reported a reduction in 
luminal diameter of the mesenteric artery of the adult (>3 months) SHR and SHR-SP 
(Mulvany et al. 1978; Mulvany, 1986; Arribas et al. 1997; Rizzoni et al. 1998). In light 
of these results, it has been suggested by some that due to the elasticity of the vascular wall , 
a reduction in lumen diameter may occur only in the event of changes in wall compliance 
(Dickhout & Lee, 1997). The results presented for the mesenteric artery in this study may 
represent the initial stages of more extensive vascular remodeling in the SHR. 
In contrast to the mesenteric and caudal arteries, no evidence of medial remodeling 
was found in the basilar artery of hypertensive rats. These results suggest that hypertrophic 
remodeling is present in systemic vessels of the SHR but not in vessels of the cerebral 
circulation or in large conduit vessels such as the thoracic aorta (Chapter 5). Medial 
remodeling within the basilar artery may occur in response to prolonged increases in blood 
pressure or in more severe forms of hypertension as described for the thoracic aorta. 
Indeed, vascular remodeling has been demonstrated in cerebral vessels of the 12 week old 
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SHR-SP and in the aging SHR (Mulvany, 1986; Baumbach & Heistad, 1989; Arribas et al. 
1996; Baumbach & Hajdu, 1993; Hajdu & Baumbach, 1994; Baumbach et al. 2003). The 
heterogeneity seen here between the basilar and mesenteric arteries may reflect different 
functional properties of each vascular bed. Within the cerebral circulation the mechanisms 
underlying the regulation of vascular tone differ from systemic vessels in several ways 
(Faraci, 1992; Faraci & Heistad, 1998). Unlike the systemic circulation, large vessels are 
the primary site of peripheral vascular resistance in the cerebral circulation, thus flow-
mediated dilation is likely to be more important in these vessels than in smaller arteries and 
arterioles (Faraci & Heistad, 1998). Furthermore, several studies have shown that the 
activity of vasodilatory factors is increased in cerebral vessels of the SHR while the reverse 
is true for the mesenteric vessels. Indeed, the activity of large conductance Kea is increased 
in the basilar artery of the SHR compared to the WKY (Paterno et al. 1997). Similarly, the 
expression of NADPH-oxidase and the production of superoxide is greater in the basilar 
artery of the SHR compared to the WKY (Sobey, 2003), while in the basilar artery of the 
adult (>6 months) SHR-SP, vasodilatory function of NO is impaired (Kitazono et al. 
1996). Thus, the lack of morphological changes in the cerebral vasculature of the 12 week 
SHR may reflect the up-regulation of vasodilatory factors and the maintenance of near 
normal blood pressure in this vascular bed ensuring adequate blood flow to the brain 
(Faraci & Heistad, 1990). 
A decrease in endothelial cell size was found in the mesenteric artery but not the 
basilar artery of the SHR. Similarly, in Chapter 5, a reduction in the size of endothelial 
cells was found in the caudal artery of the SHR, while there was no change in endothelial 
cell size in the thoracic aorta. Together these results suggest that during hypertension, 
cellular remodeling within the endothelium may be heterogeneous, like the changes in the 
media of functionally different vascular beds. In the mesenteric artery, endothelial cells 
were smaller in the SHR compared to the WKY, but there was no significant change to 
lumen diameter, suggesting hyperplasia within the intimal layer. In contrast to these 
studies Arribas et al. (1997) demonstrated a reduction in the total number of endothelial 
cells in the mesenteric artery of the SHR-SP however this study reported large areas devoid 
of endothelial cells, suggesting damage tC? the luminal surface of the blood vessel during 
tissue preparation. In other studies, ligation of the mouse carotid artery resulted in 
hyperplasia of intimal cells and a reduction in lumen diameter (Emanueli et al. 2000). The 
vascular endothelium is exposed to varying hemodynamic forces arising from the flow of 
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blood (Davies & Tripathi, 1992; DePola et al. 1992). Changes in blood flow and 
consequently shear stress have been shown to affect both endothelial cell morphology and 
function (Davies et al. 1992; Resnick et al. 2003). For example, during atherosclerosis, 
diseased regions of the blood vessel are subject to turbulent blood flow (Davies, 1989), and 
display altered endothelial cell morphology and gene expression (Garbriels & Paul , 1998; 
DePaola et al. 1999). In a similar manner, during hypertension, increased peripheral 
reistance and blood viscosity can result in altered haemodynamic forces and subsequent 
vascular remodeling (Pries & Secomb, 2002). Furthermore, several studies have shown 
that shear stress dependent dilation is impaired in arterioles of the SHR (Koller & Huang, 
1999). Taken together, the results presented here suggest that when the endothelium is 
subject to altered hemodynamic forces as a result of ligation or increased peripheral 
resistance endothelial cell morphology may be altered in some blood vessels. The lack of 
endothelial cell remodeling in the basilar artery of the SHR suggests that similar alterations 
in hemodynamic forces described above are not present in this vascular bed. 
In the caudal artery, Cx40 was found to be significantly decreased 1n the 
endothelium of the SHR compared to the WKY (Chapter 5). In contrast, Cx37 was 
decreased in the endothelium of both the mesenteric and basilar arteries during 
hypertension, and in the thoracic aorta as demonstrated in Chapter 5. Interestingly in the 
aorta (Chapter 5), mesenteric and basilar arteries, the density of Cx40 showed a trend to be 
decreased during hypertension, although this did not reach significance in any vessel. 
Similarly, in the caudal artery of the SHR, expression of Cx37 also showed a trend to be 
decreased, again this did not reach significance (Chapter 5). Such results suggest an 
important role for both Cxs 37 and 40 in the endothelium of both elastic and muscular 
arteries. Indeed, recent studies have demonstrated a co-dependent relation between 
expression of Cxs 37 and 40 within the vascular endothelium (Simon & McWhorter, 2003) . 
As discussed in Chapters 1 and 5, longitudinal conduction of vasodilatory responses 
is known to occur in the vascular endothelium via the gap junctional coupling of adjacent 
endothelial cells (Segal et al. 1999; Emerson & Segal, 2001 ). Therefore it seems likely 
that a reduction in endothelial cell size and Cx expression would result in reduced cellular 
coupling and conduction of vasomotor responses. It is known that junctional resistance is 
greater than axial resistance, thus reduced endothelial cell size would increase the number 
of gap junctions an electrical signal must pass through as it is conducted longitudinally 
along the endothelium resulting in the attenuation of the conducted response (Zaniboni et 
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al. 2003). Indeed, in the SHR hyperpolarization and relaxation seen within the mesenteric 
artery was significantly reduced at sites downstream of ACh stimulation compared to the 
WKY. However, further investigation found that the reduction in conducted responses was 
due to the decreased involvement of KrR channels in the SHR. Blockade of KrR channels 
with Ba2+ in the WKY, reduced both the conducted-hyperpolarization and the relaxation to 
the same level as the SHR. In contrast, blockade of KIR channels in the mesenteric artery of 
the SHR had no effect on either the conducted hyperpolarization or relaxation. Indeed, 
studies by Chrissobolis et al. (2002), show decreased activity of KrR channels in the basilar 
artery of the SHR. Hence, unlike studies in the Cx40 deficient mouse ( de Wit et al. 2000) 
reduced Cx37 expression within the endothelium of the mesenteric artery during 
hypertension did not result in reduced conducted vasodilation. The absence of an effect on 
conduction may be due to the magnitude of the change in Cx37 expression, i.e. 25% in the 
present study versus 100% in Cx40 deficient mice, or to the nature of the Cx altered. In 
this context, it is interesting that deletion of Cx40 in the mouse aortic endothelium inhibited 
intercellular dye transfer to a much greater extent -than did deletion of Cx37 (Simon & 
Mc Whorter, 2003). Together these results suggest that Cx40 may play a more important 
role than Cx37 in conducted responses. Alternatively, since the hyperpolarization and 
relaxation at the local site did not differ between the WKY and SHR, while the conducted 
responses due to KrR were reduced in the SHR, it is possible that conduction of these 
responses may be mediated by Cx37 however, this hypothesis requires further examination. 
Finaly,. recent studies in rat cerebral arteries demonstrate that KrR channels present within 
the smooth muscle, not the endothelium, are involved in conducted K+ induced relaxation 
(Horiuchi et al. 2002), suggesting that altered Cx expression may not be involved in the 
reduced conducted responses in this vessel. 
From the above results, it is clear that cellular remodeling occurs in both the 
endothelial and smooth muscle cell layers of different blood vessels during hypertension, 
however the nature of such remodeling depends on the particular vascular bed examined. 
Remodeling is more extensive in muscular arteries of the systemic circulation rather than in 
cerebral vessels. Changes in coupling within the endothelium are accompanied by cellular 
remodeling in muscular arteries of the systemic circulation. It is likely that such changes 
may be involved in the development of hypertension, given that medial remodeling has 
been described in the mesenteric arteries of pre-hypertensive rats and changes in 
endothelial cell morphology and Cx expression were found in the caudal artery prior to the 
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onset of hypertension. However, whether such changes within the endothelium are present 
in the mesenteric artery before the onset of hypertension, awaits further studies. In 
contrast, in the basilar artery, reduced Cx . expression occurred in the absence of altered 
endothelial cell morphology. The lack of anatomical remodeling within the basilar artery in 
this study may suggest that cerebral vessels undergo other functional alterations, which 
protect them from the systemic increase in blood pressure. More prolonged or severe 
changes in blood pressure, as occurs in aged rats and within the SHR-SP, may be required 
before secondary structural changes take place in cerebral vessels. 
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CHAPTERS 
GENERAL DISCUSSION 
The results presented in this thesis demonstrate distinct differences in the expression 
of Cxs between functionally different blood vessels. This -expression is significantly altered 
during hypertension. During hypertension, morphological changes were observed in the 
endothelium and media of some, but not all blood vessels examined, while Cx expression 
was reduced in all vessels. The nature of the medial remodeling and the specific Cx isotype 
altered during hypertension was heterogeneous depending on the vascular bed. These and 
several other important issues have arisen from the work presented in this thesis and these 
will be addressed in the following discussion. 
8.1 GAP JUNCTION EXPRESSION IN VASCULAR TISSUE 
To date, studies examining gap junction coupling within the blood vessel wall have 
reported significant heterogeneity in Cx expression amongst different vascular beds. 
Indeed, the results of Chapter 4, which examined the expression of Cx mRNA and protein 
in the thoracic aorta and caudal artery of the Wistar rat, found a profile of Cx expression 
that was different in the smooth muscle, but not the endothelium of the two vessels. The 
thoracic aorta and caudal artery were chosen as they represent functionally different blood 
vessels, thus providing the first systematic investigation of the expression of all four 
vascular Cxs in arteries of the rat. Expression of Cxs 37, 40 and 43 was found in the 
endothelium of both the thoracic aorta and caudal artery, thus confirming reports by others 
indicating that all three Cxs are expressed within the endothelium throughout the 
vasculature (Severs, 1999; Hill et al. 2001 ). Similar expression was also found in 
mesenteric and basilar arteries. The expression of Cx43 within the aortic endothelium has 
been shown by some to vary along the length of the vessel. For example, Cx43 expression 
was greater in the thoracic versus the abdominal aorta and expression was higher in regions 
of increased shear stress (Gabriels & Paul, 1999). Such variation was not evident in the 
regions of thoracic aorta examined in this study. This discrepancy may simply reflect 
differences in experimental technique or in the affinity of the antibodies used. 
In contrast to the expression of Cxs within the endothelium, in the smooth muscle, 
Cx expression was much more variable between vascular beds. Expression of Cx43 within 
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the smooth muscle of the rat thoracic aorta has been extensively reported (Hill et al. 2001 ), 
and this was confirmed in the current study. In contrast, it has been noted in this and other 
studies that Cx43 labeling is not detectable in the media of both large and small muscular 
arteries (Hill et al. 2001 ). In these arteries; reports suggest that the predominant Cx 
present varies throughout the vasculature (Severs, 1999; Hill et al. 2001). In this study, Cx 
37 was the principal Cx expressed within the media of the caudal artery. The differences in 
Cx expression amongst different arteries are likely to reflect the functional significance of 
each Cx and its specific role in arteries throughout the vasculature. 
8.2 VASCULAR REMODELING 'AND CONNEXIN EXPRESSION DURING 
HYPERTENSION 
Gap junctions play an important role in the control of vasomotor tone (Christ et al. 
1996) and thus altered Cx · expression has been implicated in the mechanisms underlying 
altered vascular function of many disease states including hypertension. Indeed, Cx 
expression is altered in the aorta of various rat hypertensive models including the SHR 
(Haefliger et al. 1997a,b, 1999, 2001; Haefliger & Meda, 2000). However, results 
presented in Chapters 5 and 7 provide the first comprehensive examination of all four 
vascular Cxs in other arteries of greater physiological relevance to hypertension. 
During hypertension, changes in Cx expression were present in the thoracic aorta, 
caudal, mesenteric and basilar arteries, indicating that the effects of hypertension on the 
vasculature are widespread, affecting a number of functionally distinct blood vessels. 
However, the Cx isotype involved varied with each vascular bed. In the endothelium, 
expression of Cx3 7 was decreased in the thoracic aorta, mesenteric and basilar arteries of 
the SHR, while in the caudal artery, Cx40 expression was decreased. It is interesting to 
note that in all four vessels, both Cxs 37 and 40 were reduced in the SHR, although in some 
cases this did not reach significance. However, it is clear that both Cxs play an important 
role in the endothelium of both elastic and muscular arteries. On the other hand 5 Cx43 was 
not altered in any of the four vessels during hypertension, suggesting that this Cx is 
unlikely to have an important role in the vascular endothelium in this disease state. In 
contrast, changes in Cxs 43 and 45 were found in the smooth muscle of the thoracic aorta 
during hypertension, while Cx45 was also altered in the media of the caudal artery. 
During hypertension, vascular re1nodeling has been described in a number of blood 
vessels throughout the vasculature (Mulvany et al. 1996; Intengan & Schiffrin, 2000). In 
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the present study, morphological changes occurring in association with hypertension were 
found to be restricted to the caudal and mesenteric arteries, which are both muscular 
arteries. Vascular remodeling was absent in both the thoracic aorta and basilar arteries. It 
is possible that these blood vessels have distinct functional characteristics that preclude the 
necessity for vascular remodeling. The thoracic aorta is purely a conduit vessel with 
extensive. elastic laminae, while the basilar artery is essential for normal vascular 
hemodynamics in the brain, and therefore may be more resistant to changes that occur in 
the systemic circulation in response to altered blood pressure, due to the up-regulation of 
compensatory vasodilatory mechanisms (Paterno et al. 1997; Sobey, 2003). 
8.3 VASCULAR REMODELING, CONNEXIN EXPRESSION AND THE 
ONSET OF HYPERTENSION 
Vascular remodeling has been described both before and after the onset of 
hypertension however, the underlying nature of the remodeling varies with the blood vessel 
being examined and the specific stages in the development of hypertension (Lee & Smeda, 
1985; Lee, 1987). In Chapter 6, no changes in vessel morphology were found in either the 
thoracic aorta or the caudal artery of pre-hypertensive S~R. Taken together, these results 
suggest that during the development of hypertension, morphological changes _may be either 
primary or secondary in nature. Primary changes are present shortly after the onset of 
hypertension, while secondary changes occur following prolonged _periods of increased 
blood pressure, and therefore represent adaptive changes in response to increased peripheral 
resistance. Whether or not changes in cellular coupling might contribute to the 
development of hypertension has been examined for the first time in this study. 
In the pre-hypertensive SHR, altered Cx expression was observed 1n the 
endothelium and media of the caudal artery, but not in the thoracic aorta. In the 
endothelium of the caudal artery, this reduction was present despite the absence of cellular 
remodeling, suggesting that a reduction in Cx expression may play a causative role in the 
development of hypertension in this vessel, whilst cellular remodeling may be a 
consequence of increased blood pressure. On the other hand, in the thoracic aorta, the 
absence of morphological differences in the pre-hypertensive SHR suggest that alterations 
observed at 12 weeks of age occur secondarily to increased blood pressure and thus reflect 
an adaptive response to hypertension. 
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The results presented in Chapter 6 concerning pre-hypertensive animals may be 
complicated by developmental differences between the WKY and SHR. It is possible that 
within the caudal artery, the decrease in Cx expression in the endothelium observed at 3 
weeks may simply reflect inherent differences between the 2 strains. Indeed, strain 
variation between the WKY and SHR is recognized to present potential problems in 
comparing data between the two types of rat (Louis & Howes, 1990). Future studies, 
whereby hypertensive animals are treated with anti-hypertensive drugs, are required to 
address this hypothesis. Reversal of vascular remodeling and the changes in Cx expression 
following the reduction of blood pressure with anti-hypertensive drugs would confirm the 
relationship between hypertension, vascular remodeling and altered Cx expression. In 
contrast, any differences remaining following anti-hypertensive treatment, consistent with 
those seen in the pre-_hypertensive phase, would be indicative of differences between the 
two strains. Various drugs have been used to lower blood pressure in hypertensive animals. 
These included ACE inhibitors, AT receptor antagonists, Ca2+ channel blockers, and 
inhibition of superoxide anion production. Inhibition of ACE has been shown to reverse 
vascular remodeling and blood pressure in various vascular beds of the SHR (Otsuka et al. 
1998; Sharifi et al. 1998b; Intengan et al. 1999; Saleh & Jurjus, 2001 ). However the 
underlying mechanisms by which ACE inhibitors reverse vascular remodeling vary 
depending on the vascular bed (Kett et al. 1995; Bergstrom et al. 1998). In a similar 
manner, AT 1 receptor antagonists, Ca2+ channel blockers, ET A receptor antagonists and the 
inhibition of superoxide anion also reduce blood pressure and vascular remodeling in the 
SHR (Rao & Berk, 1992; Lacolley et al. 1995-; Levy et al. 1996; Otsuka et al. 1998; Fujii 
et al. 1999; Koffi et al. 1999; Park et al. 2002) . 
8.4 GAP JUNCTIONS AND VASCULAR FUNCTION DURING 
HYPERTENSION 
Cellular remodeling and changes in Cx expression have potentially important 
implications for the propagation of vascular responses within both the endothelium and 
smooth muscle. · Reduced electrical coupling within the media of the caudal artery 
demonstrated here during hypertension was consistent with the observed increase in the 
number of smooth muscle ceil layers and reduction in Cx expression. However, EDHF-
mediated relaxation was not affected in this vessel during hypertension, despite the 
significant reduction in Cx40 within the endothelium and the reduction in EDHF-mediated 
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hyperpolarization. The maintenance of this response results from the increased incidence 
of MEGJs coupling the endothelium and smooth muscle of the SHR (Sandow et al. 
2003b). Several studies have reported a reduction in EDHF-mediated hyperpolarization 
and relaxation in the mesenteric artery of the aged SHR compared to WKY (Fujii et al. 
1992; Onaka et al. 1998) and therefore an absence of such a response in this study may 
simply reflect the age of animals or the nature of the vascular bed examined. The incidence 
of MEGJs in aged animals is unknown and thus requires further examination. 
Given that the conduction of vasodilator responses occurs principally 1n the 
endothelium (Dora, 2001; Segal et al. 2001; Yamamoto et al. 2001; Sandow et al. 
2003d), a reduction in endothelial cell size and Cx expression is likely to result in reduced 
conducted vasodilation. Indeed, reduced conducted vasodilation has been reported in 
cremaster arterioles of the Cx40 knockout mouse ( de Wit et al. 2000). In contrast, the 
results of Chapter 7 demonstrate that while the involvement of KrR channels in conduction 
is altered in the mesenteric artery during hypertension, the residual conducted vasodilation 
was unaltered. From these results it may be hypothesised that Cx40 may have greater 
functional importance than Cx37 within the endothelium. In contrast, since conducted 
responses due to KrR were reduced in the SHR, it is possible that conduction of these 
responses may involve Cx3 7, although, this hypothesis requires further examination. 
Alternatively, the reducti9n in Cx37 expression observed in the mesenteric artery (25%) 
may not be sufficiently significant to impact on endothelial function. Studies in Cx 
knockout mice, whereby Cx37 can be abolished specifically in the endothelium, in a similar 
manner to Cx43 endothelial knockout mice (Liao et al. 2001; Theis et al. 2001 ), may 
provide further answers to these questions. Furthermore, experiments examining conduct~d 
vasodilation within the caudal artery of the SHR, where a 31 % reduction in endothelial 
expression of Cx40 was observed, will be required to determine whether this reduction is 
sufficient to compromise conducted vasodilatory responses. 
8.5 EXPERIMENTAL HYPERTENSION 
Worldwide, essential hypertension in humans affects 25-35% of the population 
(Staessen et al. 2003). Several animal models are used in the study of hypertension, with 
the SHR being most commonly used as a model for human essential hypertension (Stoll & 
Jacob, 2001). In this model of hypertension, the renin-angiotensin system plays a major 
role in both the development and maintenance of hypertension (Li & Jackson, 1987). 
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Inbred WKY rats were initially developed as a normotensive control for the SHR (Hansen 
et al. 1973), however, the validity of using the WKY as a genetic control for the SHR has 
recently been questioned. The distribution of both WKY and SHR animals before they 
were fully inbred, has lead to significant genetic diversity between the two strains (Louis & 
Howes, 1990; Johnson et al. 1992; Kurtz & Morris, 1987; Kurtz et al. 1989; Alemayehu et 
al. 2002). Given these concerns, it may be argued that the SHR is not the most appropriate 
model for the examination of hypertension. Given the impracticalities of re-deriving the 
SHR and its normotensive WKY control, one way to overcome the genetic variability 
between the two strains in comparative studies, is to use several normotensive rat strains. 
A complementary approach is to use models whereby hypertension within a normotensive 
rat is induced with drug treatment, thus permitting the untreated rat to serve as. the 
normotensive control. Induced models of hypertension include, DOCA-salt, 
adrenocorticotropic hormone (ACTH) and 2, kidney, 1 clip hypertensive rats, which 
represent models of glucocorticoid-induced hypertension, mineralocorticoid-induced 
hypertension and renovascular hypertension respectively (Whitworth, 1990; Hollenber et 
al. 1992; Webb et al. 1984). Unfortunately however, these types of hypertension 
comprise only a minority of hypertension cases in humans and therefore, their use as 
models for human essential hypertension, which is multifactorial in nature, is limited. 
Alternatively, like the SHR, it has been suggested that L-NAME induced hypertension in 
the rat represents a renin-angiotensin model of hypertension (Takemoto et al. 1997 a,b) and 
this may represent a suitable model for relevant studies of hypertension in the future. 
8.6 CONCLUSION 
In conclusion, the results presented in this thesis have outlined clear evidence 
supporting a link between reduced Cx expression, vascular remodeling and altered cellular 
coupling in the hypertensive rat. In muscular arteries of the systemic circulation, but not in 
elastic arteries, some of these changes in Cx expression may precede the development of 
hypertension and thus contribute to the increase in blood pressure. Changes in cellular 
coupling were found to occur throughout the vasculature and were not limited to vessels 
involved in peripheral resistance. However, the heterogeneous nature of changes occurring 
within the vasculature during hypertension is likely to reflect the functional properties of 
each vascular bed. The regulation of gap junction channels and thus cellular coupling may 
provide potential therapeutic targets for the future treatment of hypertension. 
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